THE ROLE OF BOVINE ADENOVIRUS-3 PROTEIN V (pV) IN VIRUS REPLICATION by Zhao, Xin 1984-
  
 
THE ROLE OF BOVINE ADENOVIRUS-3 PROTEIN V (pV) IN VIRUS 
REPLICATION 
 
 
A Thesis   
Submitted to the Faculty of Graduate Studies and Research  
in Partial Fulfillment of the Requirements for the  
Degree of Doctor of Philosophy 
in the 
Department of Veterinary Microbiology  
University of Saskatchewan  
Saskatoon 
 
 
By  
Xin Zhao 
 
 
 
 
 
 
 
 
 
 
 
© Copyright Xin Zhao, June 2016. All rights reserved
 i 
PERMISSION TO USE 
In presenting this thesis in partial fulfillment of the requirements for a postgraduate 
degree from the University of Saskatchewan, I agree that the libraries of this university 
may make it freely available for inspection. I further agree that permission for copying of 
this thesis in any manner, whole or in part, for scholarly purposes may be granted by the 
professors who supervised my thesis work or in their absence, the Head of the 
Department or the Dean of the college in which my thesis work was done. It is 
understood that any copying or publication or use of this thesis or parts thereof for 
financial gain shall not be allowed without any written permission. It is also understood 
that due recognition shall be given to me and to the University of Saskatchewan in any 
scholarly use which may be made of any material in my thesis. 
Request for permission to copy or to make other use of material in this thesis in 
whole or part should be addressed to: 
Head of the Department of Veterinary Microbiology 
University of Saskatchewan, 
Saskatoon, Saskatchewan, 
S7N 5B4 
 
 
 
 
 
 
 
 ii 
ABSTRACT 
Bovine adenovirus type 3 (BAdV-3), which is a non-enveloped icosahedral particle 
with a double-stranded DNA genome of 34,446 base pair, has been developed as a 
vaccine vector. It belongs to mastadenovirus genus in adenoviridae family. Like other 
mastadenovirus members, BAdV-3 genome is composed of early, intermediate and late 
regions. The seven late regions (L1-7) of BAdV-3 genome all belong to one major late 
transcription unit (MLTU), which is controlled by the major late promoter (MLP). L2 
region encodes only one protein V (pV), which is a core protein and functions as a bridge 
between the viral capsid and DNA genome. It also has been shown to interact with 
cellular protein p32, which shuttles between nucleus and mitochondria, and redistribute 
nucleolar proteins B23 and nucleolin. Both of the cellular protein interaction and 
redistribution suggest that pV may have other functions in viral replication rather than 
just being a structural protein. Therefore, the objective of this study is to characterize pV, 
elucidate the functions of pV in viral replication and identify the viral/cellular proteins 
interacting with pV. 
The open reading frame of BAdV-3 pV was confirmed by DNA sequencing 
analysis to be shown to correspond to 423 amino acids rather than 412 amino acids 
reported previously. A 55 kDa protein indicating pV was detected by Western blot using 
anti-pV sera at 24 to 48 hours post-infection in BAdV-3 infected cells, and the same sized 
protein was detected in pV expressing plasmid transfected cells. pV was distributed in the 
nucleus, especially in the nucleolus in both infected and transfected cells. Analysis of 
BAdV-3 pV protein sequence by protein analysis program “PredictProtein” predicted 
potential motifs act as nuclear localization signals. However, indirect 
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immunofluorescence result suggested that amino acids 21-50 and 380-389 are essential 
for the nucleolar localization of pV. Further analysis identified three motifs, which are 
essential for amino acids 21-50 mediated nucleolar localization of pV. GST pulldown 
assay identified pV nuclear localization was mediated by the importin α/β pathway since 
pV was detected to interact with importin α3 rather than other nuclear transport factors. 
Three nuclear localization signals (NLS) were detected in pV by sequential deletion and 
confocal microscopy. Deletion of all of these NLSs abrogates not only pV nuclear 
localization but also its interaction with import α3. 
To determine the function of pV nucleolar localization signals (NoLSs) in BAdV-3 
replication, we isolated recombinant BAdV-3s, BAV.pVd1 (deletion of amino acids 21-
50), BAV.pVm123 (containing substitutions of basic residues of all three motifs of amino 
acids 21-50), BAV.pVd3 (containing deletion of amino acids 380-389) and BAV.pVd1 
d3 (deletion of amino acids 21-50 and 380-389). Analysis of mutant BAdV-3s suggested 
that the deletion of single pV NoLS did not influence the replication of BAdV-3 in vitro. 
However, deletion of both NoLSs rendered BAV.pVd1d3 replication incompetent in non-
pV expressing cells. Moreover, the double, but not single, deletion of pV NoLSs, 
decreased late viral protein expression, viral particle assembly in MDBK cells and viral 
thermostablity. These results demonstrate that pV contains two NoLSs, which are 
essential for BAdV-3 replication. 
To elucidate the biological significance of pV in BAdV-3 replication, a plasmid 
pUC304A.dV, which contains BAV304a genome except pV gene was replaced by an 
SbfI site, was constructed and used to transfect VIDO DT1 (cotton rat lung [CRL] cells 
expressing I-SceI) cells. However, pV deleted BAdV-3 cannot be rescued in this non-pV 
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expressing cells, suggesting pV is indispensible for BAdV-3 replication. Therefore, a pV 
expressing CRL cell line (CRL.pV) was constructed to support the pV deleted 
recombinant BAdV-3 (BAV.dV) replication in vitro. Protein analysis revealed that 
deletion of pV from BAdV-3 genome decreased viral late proteins expression such as pX, 
100K and pVII. Electron microscopy analysis revealed that pV deletion results in the 
dramatic reduction in viral assembly. Moreover, thermostablity assay suggested that the 
viral thermostablity was significantly decreased without pV incorporation. 
To determine viral/cellular proteins interacting with pV, an eight amino acids 
Strep-tag was introduced between pV amino acids 18EI19 to construct a recombinant 
BAdV-3 with strep-tagged pV. Although expression of viral late proteins was decreased 
to some extent, the introduction of Strep-tag in pV did not influence viral growth 
characteristics significantly. Mass spectrometry analysis identified many viral/cellular 
proteins can interact with pV. The interaction of pV with nucleolin was confirmed by Co-
immunoprecipitation (Co-IP) and co-localization. Further analysis indicated that deletion 
of pV NoLSs did not abrogate pV interaction with nucleolin, suggesting that pV NoLSs 
are not binding sites for nucleolin. Future work remains to elucidate the function of 
nucleolin in BAdV-3 replication. 
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1.0 LITERATURE REVIEW 
This literature review consists of four sections: Adenovirus; protein 
nucleocytoplasmic transport; nucleolus and protein-protein interaction. In the first section, 
I talk about the characteristics of adenovirus, especially human adenovirus and bovine 
adenovirus 3 (BAdV-3), as well as the feasibility of adenovirus as gene delivery vectors. 
The second section discusses the mechanism of protein transportation between the 
cytoplasm and the nucleus including the structure and components of the nuclear pore 
complex (NPC), protein signal peptides that direct the transportation and cellular 
transport factors. The third section summarizes the structure, components and functions 
of the nucleolus. Moreover, the most important nucleolar function, ribosome biosynthesis, 
is described in detail. In the last section, I discuss the characteristics of protein-protein 
interactions and what roles they play in adenovirus replication. 
 
1.1 ADENOVRIUS 
Adenoviruses are non-enveloped icosahedral particles of 70-100 nm in diameter. 
The outer capsid is composed of 240 hexons, 12 pentons, and 12 fibers, which projects 
from each penton base and determines adenovirus tropism (Russell, 2009).The capsid 
contains a double stranded (ds)-DNA genome of 26-48 kilobases pairs (bp) (Davison et 
al., 2000; Kovacs et al., 2003) with 29-368 base pair (bp) inverted terminal repeats 
(ITRs), which are essential for viral DNA replication. The linear viral genomic DNA is 
tightly associated with histone like protein VII (pVII) to form the core (Russell, 2009). 
Terminal protein (pTP), which plays a role in initiating viral genome replication, 
covalently binds to the ends of the viral genome (Russell, 2009). Structural proteins 
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hexon, penton base, pVIII, pVI, IIIa and non-structural protein 100K and 52K proteins 
are common to all adenoviruses. However, significant differences were found in proteins 
encoded by Early (E) region 1, E3 and E4 region among members of different adenovirus 
genera (Davison et al., 2000; Kovacs and Benko, 2009; Pitcovski et al., 1998). 
So far, more than 100 adenovirus members have been identified, which can infect a 
broad range of mammal, birds, reptile, amphibian and fish hosts (International Committee 
on Taxonomy of Viruses, 2012). One of the salient contributions of adenovirus research 
to the modern biology is the discovery of the splicing mechanism and the existence of 
introns (Berget et al., 1977). 
 
1.1.1 Adenovirus classification 
Adenoviridae family is composed of five genera: Mastadenovirus, Aviadenovirus, 
Atadenovirus, Siadenovirus and Ichtadenovirus based on phylogenetic distance, genome 
organization, host range, and cross-neutralization (Davison et al., 2003) as shown in Fig 
1.1. 
Members of Mastadenovirus genus only infect mammals (Davison et al., 2003).  
The genomes of Mastadenoviruses range from 30,536 (Morrison et al., 1997) to 37,860 
bp (Roy et al., 2009) with relatively long and complex ITRs. The longest ITR of 368 bp 
has been identified in BAdV-10 (Dan et al., 2001). Adenovirus proteins pV and pIX are 
only encoded by genomes of Mastadenovriuses. Protein pV is a core protein which 
bridges the core and the capsid via the binding of capsid protein (Chatterjee et al., 1985) 
and the viral genome DNA (Chatterjee et al., 1986).  Protein pIX is a minor structural 
protein which not only stabilizes the capsid by binding to adjacent hexons (Boulanger et 
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al., 1979) as shown in Fig 1.2, but also acts as a transcription factor and in nuclear 
reorganization (Rosa-Calatrava et al., 2001).  
Members of Aviadenovirus genus infect only birds, including chicken (Chiocca et 
al., 1996), falcon (Schrenzel et al., 2005), goose (Zsak and Kisary, 1984) and turkey 
(Kajan et al., 2010). Although their genomes are relatively large and range from 43,804 
bp (Chiocca et al., 1996) to 45,667 bp (Griffin and Nagy, 2011), their ITRs are relatively 
short and present in the same locations as Mastadenoviruses. Each vertex of 
aviadenovirus capsid contains two fiber proteins, no matter the virus encodes two fiber 
genes like Fowl Adenovirus 1 (Griffin and Nagy, 2011) or only one gene like Duck 
Adenovirus 2 (Marek et al., 2014). The E1, E3, and E4 regions are missing in 
aviadenoviruses genomes. Instead, at the left and the right ends of the genome, it is rich 
in open reading frames (Chiocca et al., 1996), which are predicted to encode proteins to 
make up the functions of E1, E3 and E4 regions (Chiocca et al., 1996). 
Members of Atadenovirus can infect a broad range of hosts, including mammals 
(Benko et al., 2002), birds (Hess et al., 1997) and scaled reptiles (Benko et al., 2002). 
Atadenoviruse genomes range between 29,576 (Vrati et al., 1995) and 33,213 bp (Hess et 
al., 1997) in length with high AT content and relatively small ITRs between 46 (Vrati et 
al., 1995) and 118 (Benko et al., 2002). Similar to aviadenoviruses, the members of 
Atadenovirus genome does not encode proteins pV and pIX (Benko et al., 2002; Hess et 
al., 1997; Vrati et al., 1995). There are several unique proteins encoded by atadenovirus 
genomes, such as a structural protein p32K, which is encoded by the left side of the viral 
genome (Benko et al., 2002; Hess et al., 1997; Vrati et al., 1995). 
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Figure 1.1 Phylogenetic analysis of members in Adenoviridae family base on hexon 
amino acids sequence distance matrix analysis. Abbreviations of simian adenoviruses: rh, 
rhesus macaque; cy, cynomolgus macaque; go, gorilla; ch, chimpanzee; bo, bonobo. 
Adapted from (Davison et al., 2003), with permission to use. 
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Figure 1.2 Structure of adenovirus virion. Adapted from (Russell, 2009), with permission 
to use. 
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Members of Siadenovirus genus infect reptiles (Kovacs and Benko, 2009) , frogs 
(Davison et al., 2000)  and turkey (Pitcovski et al., 1998). So far, only three adenoviruses 
namely Raptor Adenovirus 1 (RAdV-1) (Kovacs and Benko, 2009), Frog Adenovirus 1 
(FrAdV-1) (Davison et al., 2000) and Turkey Adenovirus 3 (TAdV-3) (Pitcovski et al., 
1998)  are included in this genus. These siadenoviruses contain smallest genomes ranging 
from 26,163 bp to 26,282 bp, as well as the shortest ITRs, from 29 to 39 bp (Davison et 
al., 2000; Kovacs and Benko, 2009; Pitcovski et al., 1998). The unique feature of 
members of Siadenovirus is the encoding of Sialidase enzyme (Davison et al., 2000). 
Unlike Mastadenoviruses, E1, E3 and E4 early regions and genes of pV, pIX are missing 
from their genomes, and replaced with 5 potential novel protein encoding ORFs (Davison 
et al., 2000; Kovacs and Benko, 2009; Pitcovski et al., 1998).  
After the phylogenic analysis of the first fish adenovirus isolated from white 
sturgeon in 2003, a new genus, Ichtadenovirus, was added in adenoviridae family 
(Davison et al., 2003). The White Sturgeon Adenovirus 1 (WSAdV-1) is the only number 
of Ichtadenovirus genus. The genome of Ichtadenovirus is 48,396 bp, which is the 
longest in all known adenovirus members. Although positional homologue of fiber gene 
is not deleted in WSAdV-1, a fiber homologue encoded by an ORF at the left end 
(Davison et al., 2003) of the genome has been reported.  
 
1.1.2 Human adenovirus 
Human adenovirus (HAdV), which belongs to Mastadenovirus genus was first 
isolated in early 1950s from human adenoids (Rowe et al., 1953). So far, 67 serotypes 
have been identified, and they are grouped in 7 subgroups (A-G) (Ghebremedhin, 2014; 
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Rosen, 1960). The fiber induced red blood cell agglutination can be inhibited by the 
antisera of the viruses from the same subgroup, but not other subgroups. 
 
1.1.2.1 Human adenovirus pathogenesis 
Human adenoviruses most often infect the upper respiratory tract and can be 
asymptomatic or cause mild fevers, gastroenteritis and conjunctivitis. About 5% of acute 
upper respiratory infection in children under 4-year-old are because of human adenovirus 
type 4 and 7. Adenoviral infection also causes lower respiratory infection, but it is not as 
common as the upper respiratory infection (Murtagh et al., 1993). Eye infection of 
serotype 8, 19 or 37 may cause epidemic keratoconjunctivitis, while infection of serotype 
3, 7 or 11 may cause conjunctivitis (Kitamura, 2001). HAdV-40 and 41 are also 
responsible for gastroenteritis in children (Wilhelmi et al., 2003). Moreover, HAdV-36 
has been identified to cause obesity (Gabbert et al., 2010).  
Two fatal cases caused by adenovirus infection were reported by the US military 
recruitment department (Potter et al., 2012). Acute respiratory disease (ARD) is usually 
caused by infection of HAdV-4, 7 and 2. Adenoviral infections cause much severe 
symptoms in immunecompromised hosts, like patients with severe combined 
immunodeficiency (SCID) (Al-Herz and Moussa, 2012) or acquired immunodeficiency 
syndromes (AIDS) (Adeyemi et al., 2008) and organ receivers (Klein et al., 2015). 
Although infection of human adenovirus type 12 causes malignant tumors in newborn 
hamster at the injection site (Trentin et al., 1962), the oncogenic potential of human 
adenovirus for humans have not been reported (Mackey et al., 1976). 
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1.1.2.2 Human adenovirus structure 
Human adenoviruses are members of Mastadenovirus (International Committee on 
Taxonomy of Viruses, 2012). The adenovirus virion is composed of 13 structural proteins 
and a linear double stranded DNA of 26-48 kb (Russell, 2009) as shown in Fig 1.2 Of 
these structural proteins, there are 7 capsid proteins, which are part of the capsid, and 6 
core proteins, which connect the capsid and viral DNA or bind to viral DNA to form a 
nucleosome-like structure (Mackey et al., 1976). Hexon, penton and fiber are the major 
capsid proteins. Each capsid contains 240 trimeric hexons and 12 pentons (van Oostrum 
and Burnett, 1985). Each hexon is surrounded by 6 hexon proteins or 5 hexon proteins 
and 1 penton protein, and each penton is surrounded by 5 hexon proteins. Proteins IIIa, 
VI, VIII and IX are minor capsid proteins that play roles in stabilizing the virion structure 
via interaction with the major capsid proteins (Russell, 2009). 
The adenovirus core contains the viral genome core proteins IVa2, V, VII, terminal 
protein (TP), Mu (X) and virus encoded protease (San Martin, 2012). Protein VII and V 
are the most abundant core proteins of adenovirus. In the mature virions, pVII functions 
as a histone like structure around which viral DNA is wrapped (Daniell et al., 1981).  pV 
mediates the transportation of the viral genome from the cytoplasm to the nucleus 
(Wodrich et al., 2006). Because of its interaction with viral DNA, it may play a role in 
viral DNA replication and transcription, as well as the viral DNA encapsidation (Haruki 
et al., 2006; Spector, 2007). Although pV seems to be dispensable in human adenovirus 
replication (Ugai et al., 2007), it still acts to bridge between the viral core and capsid by 
interaction with viral DNA and capsid proteins. Since pV has been proved to associated 
with cellular protein p32, it is possible that pV helps adenovirus hijack the cellular routes 
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to reach the nucleus (Matthews and Russell, 1998a). Because of the capability to 
redistribute nucleolar proteins B23 and nucleolin from the nucleolus to the cytoplasm, pV 
might play some unknown function in the nucleolus (Matthews, 2001). For other core 
proteins, IVa2 is involved in activation of late transcription and viral DNA encapsidation 
(Ostapchuk et al., 2005; Tyler et al., 2007); protease activates viral protein precursors by 
cleaving them (Mangel et al., 2003); Mu plays a role in condensing viral prechromatin 
(Lee et al., 2004) and pTP binds at the end of viral DNA and primes viral DNA 
replication (Webster et al., 1997). 
 
1.1.2.3 Genome organization 
Adenovirus genome contains two DNA replication origin sites. In several hundreds 
base pairs in left side of the adenoviral DNA, its also contains a packaging sequence, 
which directs the viral genome into the empty capsid (Hearing et al., 1987). The viral 
genome carries four early transcription regions (E1-E4), two intermediate genes (IVa2 
and pIX) and one major late unit that is transcribed and alternatively sliced into five 
groups of late mRNA (L1-5) as shown in Fig 1.3. All of these genes are transcribed by 
RNA polymerase II (Mishoe et al., 1984). In addition, human adenovirus also carries 
viral associated RNAs (VA RNAs), which are transcribed by RNA polymerase III (Kidd 
et al., 1995). E1, E3 and major late unit are transcribed from the forward strand, while E2, 
E4 and IVa2 are transcribed from the reverse strand (Chroboczek et al., 1992). 
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Figure 1.3 Schematic representation of the adenoviral genome. Thick black boxes 
represent DNA sequences of ITR or MLP. Early, intermediate and late regions are 
depicted in red, blue and black, respectively. ITR: inverted terminal repeat; ψ: packaging 
sequence; MLP: major late promoter. Adapted from (Wold and Toth, 2013), with 
permission to use. 
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1.1.2.4 Replication cycle 
The adenovirus replication cycle can be divided into five stages: adsoption and 
entry, activation of early genes, DNA replication, activation of late genes, assembly and 
release. 
 
1.1.2.4.1 Adsoption and entry 
Adenovirus infection is initiated by the attachment of virus to the cells, which is 
mediated by fiber protein. The fiber protein of different adenoviruses can bind different 
cellular proteins exposed on the cells membrane as receptors. The most popular one is 
coxsakievirus and adenovirus receptor (CAR) (Bergelson et al., 1997), which is used by 
human adenovirus subgroup A, C, D, E and F (Roelvink et al., 1998). In addition to CAR, 
other cellular proteins used as receptors by human adenoviruses including: heparin 
sulphate glycosaminoglycans, cluster of differentiation (CD) 46, CD80, CD86 and sialic 
acid (Zhang and Bergelson, 2005). Since some adenoviruses cannot enter some cells to 
which they are capable to bind, it is possible that another protein-protein interaction is 
involved in adenovirus internalization (Silver and Anderson, 1988). The interaction 
between penton arginine-glycine-aspartic acid (RGD) sequence and integrin has been 
proved to be critical for both adenovirus internalization and endosome escape 
(Shayakhmetov et al., 2005). It is postulated that the fiber-receptor interaction is just 
facilitating the RGD-integrin interaction by bring the virion to the cell surface. 
The RGD-integrin interaction triggers adenovirus internalization via receptor-
mediated endocytosis (Varga et al., 1991). The purified penton not fiber has been shown 
to quickly penetrate the cell membrane in cell culture (Wickham et al., 1993). The 
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interaction between RGD motif and integrin activates the lipid kinase 
phosphotidylinosito-3-OH kinase, which is involved in the rearrangement of actin 
cytoskeleton (Li et al., 1998). Moreover, adenovirus internalization also requires dynamin, 
which is associated with the regulation of clathrin-mediated endocytosis (Wang et al., 
1998). 
After internalization of the cell, adenovirus uses two steps to escape the endosome: 
1, viral uncoating to become smaller; and 2, disruption of the endosome membrane to 
pass through. Once in the endosome, the virus starts to stimulate the cell to acidify the 
cytosol to respond to the infection, which helps adenovirus disassembly. The vertex part, 
which contains penton base and fiber protein are firstly detached from the capsid. Then, 
the protein IIIa that bridges hexon and penton is lost, followed by removal of hexon, pVI, 
pVIII and pIX (Greber et al., 1993). Since both pVI and pVIII connect capsid and core, 
the removal of these proteins prepares for release of pVII and viral DNA complex. After 
partial disassembly, pVI is cleaved by the viral protease, and then attaches to endosome 
membrane causing membrane disruption and adenovirus escape (Wiethoff et al., 2005). 
Moreover, pVI is also involved in the activation of 23K proteinase (Ding et al., 1996) and 
cytoplasm to nucleus transportation of hexon (Kelkar et al., 2006). 
After escaping from endosomes, partially disassembled adenovirus must inject its 
viral DNA into the nucleus to start the replication, but firstly it has to get access to the 
nucleus. To achieve this, the partial disassembled adenovirus is associated with 
cytoplasmic dynein and transported to microtubule organization center (MTOC), which is 
adjacent to the nucleus (Kelkar et al., 2006). Once it reaches MTOC, the adenovirus must 
detach from the MTOC and attach to the nuclear pore complex (NPC). After being 
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transported to the nucleus by pVI, hexon binds to the NPC, which gives access to nucleus 
to pVII-DNA complex (Kelkar et al., 2006). Finally, the viral genome is injected into the 
nucleus via NPC and starts transcription and DNA replication. 
 
1.1.2.4.2 Expression of early genes 
Once inside the nucleus, adenovirus DNA starts to express its early regions, which 
encode mostly non-structural proteins that facilitate viral replication. Adenoviruses 
express early proteins to fulfill three main goals. The first is to establish the environment 
optimal for viral replication by inducing the host cell to enter S phase, in which host cell 
prepares for DNA replication. Proteins involved in this process are E1A, E1B and E4 
regions proteins. The second is to activate the transcription of E2 region genes, which are 
required for viral DNA replication. The third is to antagonize the host immune system so 
that adenovirus can finish replication before the infected cell is eliminated by the host 
immune response. Products encoded by E3 and VA RNA genes are associated with this 
process. 
E1A region is first to be transcribed and produce proteins after the viral DNA 
enters the nucleus. E1A encodes two mRNAs by alternative splicing, 12S and 13S, with 
co-terminal 5’ and 3’ ends (Frisch and Mymryk, 2002). Three conserved regions (CR1, 2 
and 3) were identified in E1A proteins of a variety of human adenovirus serotypes. E1A 
proteins are capable to immortalize primary cells, as well as induce tumors in newborn 
rodents with E1B proteins (Ben-Israel and Kleinberger, 2002). Instead of directly binding 
to DNA, E1A proteins interact with key cellular regulatory proteins and transcription 
factors to control cell cycle and gene expression (Avvakumov et al., 2002). 
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To regulate the cell cycle, E1A interacts with pRB to disrupt the pRB-E2F (E2 
promoter factor) complex and free E2F. The pRB inhibits E2F transcriptional activation 
by forming a complex with it, while CR1 and CR2 regions of E1A proteins bind to pRB, 
dissociating it from E2F (Ikeda and Nevins, 1993). Free E2F activates both viral and 
cellular genes dramatically regulating the cell cycle. E1A proteins also inhibit other cell 
cycle control proteins, like the cyclin-dependent kinase inhibitor p21 (Chattopadhyay et 
al., 2001). E1A proteins have also been reported to regulate chromatin structure by 
interacting with host factors, such as TRRAP/GCN5 (Lang and Hearing, 2003), pCAF 
and p300/CBP  (Chakravarti et al., 1999; Hamamori et al., 1999). Chromatin remodeling 
may increase DNA and transcription factor binding, thereby increasing expression of 
genes regulating cell cycle. Moreover, E1A proteins may regulate target gene expression 
by directly interaction with cellular transcription factors like CBF1 (Ansieau et al., 2001) 
and SUR2 (Stevens et al., 2002). 
Cells respond to E1A induced cell cycle deregulation by accumulating tumor 
suppressor p53 protein (Lowe and Ruley, 1993). The cell signaling pathways activated by 
p53 induce apoptosis of the infected cell to prevent viral replication. In adenovirus-
infected cells, E1B transcriptional unit encodes two proteins, E1B-55K and E1B-19K, 
which are involved in preventing apoptosis. The E1B-55K inhibits p53-dependent 
apoptosis by directly binding to and degrading p53 (Li et al., 2011b). To degrade p53, 
E1B-55K forms a complex with another viral protein E4orf6 and other cellular proteins, 
which act as ubiquitin ligase (Sarnow et al., 1984). In addition, p53 accumulated in the 
infected cell is ubiquinated and degraded (Querido et al., 2001). Moreover, E1B-55K can 
bind and repress p53 to inhibit activation of pro-apoptosis genes (Ben-Israel and 
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Kleinberger, 2002), which results in accumulation of inactive p53. The E1B-19K blocks 
cell programmed death by mimicking cellular anti-apoptotic protein MCL1 (White, 2001). 
Pro-apoptotic proteins BAK and BAX form a complex and bind to mitochondria 
membrane to induce apoptosis (Cuconati et al., 2003). MCL1 directly binds to BAK and 
BAX complex to inhibit its pro-apoptotic activity. In adenovirus-infected cells, E1B-19K 
mimics MLC1 to bind BAK and BAX complex and inhibits its pro-apoptotic activity 
(Cuconati et al., 2003). 
The E2 unit encodes three products: DNA binding protein (DBP), terminal protein 
(pTP) and DNA polymerase (pol), and all of them contribute to viral DNA replication (de 
Jong et al., 2003).  Although, adenovirus replicates in the nucleus, adenovirus encodes its 
own DNA polymerase. Precursor terminal protein (pTP) binds to the 5’ end of each 
strand and serves as a primer to initiate the viral DNA replication (Mysiak et al., 2004). 
DBP forms a complex with pTP and viral DNA polymerase to initiate the DNA 
replication, and it also plays a role in elongation by unwinding the template (van 
Breukelen et al., 2003). 
The E3 region encodes 4 proteins, include: E3-gp19K, 10.4K, 14.5K and 14.7K. 
They all help human adenovirus to evade the host immune defense (Horwitz, 2004). E3-
gp19K modulates major histocompatibility complex (MHC) class I in two ways. Firstly, 
E3-gp19K binds and retains MHC class I in the endoplasmic reticulum (ER), therefore, it 
cannot be transported to the cell membrane and present peptides to cytotoxic T 
lymphocytes (Burgert et al., 1987). Secondly, E3-gp19K also plays a role in inhibiting 
the assembly of MHC class I and peptides thus reduces the antigen presentation (Bennett 
et al., 1999). E3-10.4K and 14.5K bind to each other to form receptor internalization and 
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degradation (RID) complex, which clears chemokine receptors from cell surface and 
mediates their lysosome transportation and degradation to inhibit chemokine induced 
apoptosis (Shisler et al., 1997). E3-14.7K not only inhibits tumor necrosis factor (TNF)-α 
induced apoptosis, but also decreases the secretion of TNF-α induced arachidonic acid, 
which is a inflammatory intermediate (Zilli et al., 1992). 
E4 transcriptional unit encodes several proteins such as orf1, orf3, orf6, orf4 and 
orf6/7with different functions. E4orf1 has been shown to induce mammary tumor in rat 
by directly binding to tumor suppressor zonulae occludentes (ZO) protein (Javier et al., 
1991). Both E4orf3 and E4orf6 facilitate viral mRNA maturation, transport, stability and 
cytoplasmic accumulation, and thus increase production of the late viral proteins 
(Imperiale et al., 1995). Additionally, both of them also function to regulate viral DNA 
replication (Bridge and Ketner, 1989). E4orf6/7 protein plays a role in facilitating E1A 
proteins to activate other viral or cellular genes by directly binding to E2F (Schaley et al., 
2000). E4orf4 has been reported to decrease both E1A and E4 production via protein 
phosphatase 2A (Muller et al., 1992), which limits the cytotoxic effects and ensures 
maximum productivity. 
 
1.1.2.4.3 Viral DNA replication 
As the accumulation of E2 encoded proteins occurs, adenovirus DNA replication 
initiates from the ITRs, which act as replication origins (Hay, 1985). Initiation of 
adenovirus DNA replication requires a protein complex composed of several viral and 
cellular proteins (Hoeben and Uil, 2013). The three E2 encoded proteins are present in 
this complex. The pTP is a 80-kD protein covalently binds to 5’ end of the viral genome, 
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and plays a role in initiation of viral DNA replication (de Jong et al., 2003). Adenovirus 
encoded DNA polymerase is synthesized as a 140-kD protein and has distinct 
characteristics from any other eukaryotic DNA polymerase (Field et al., 1984). In 
addition to the 5’ to 3’ polymerase activity, it also contains 3’ to 5’ exonuclease activity 
indicating its proofreading activity (Field et al., 1984). Two cellular factors, nuclear 
factor I (NFI) and NFIII are recruited in the DNA replication complex. The NFI stabilizes 
the DNA pol-pTP complex at the origin by directly interacting with DNA pol (Mul et al., 
1990). NFI also binds to ITRs, which is facilitated by E2 encoded protein, DBP (Stuiver 
and van der Vliet, 1990). 
Adenoviral replication is initiated with the formation of an ester bond between the 
deoxycytidine monophosphate (dCMP) α-phosphoryl group and the β-OH of a serine in 
pTP (Lichy et al., 1981). After pTP-dCMP complex formation, 3’-OH group starts to 
serve to the new strand synthesis by DNA pol. Two E2-encoded proteins, DNA pol and 
DBP, and a cellular factor NFII are required for DNA elongation. DBP binds to single 
stranded DNA tightly in a sequence independent pattern and serves as DNA helicase to 
unwind the double stranded template in DNA replication (Lindenbaum et al., 1986). NFII 
functions as a topoisomerase, and is postulated to overcome the long DNA problem after 
extensive replication (Nagata et al., 1983). 
 
1.1.2.4.4 Expression of intermediate genes 
Two viral structural proteins, IVa2 and pIX, are known as delayed-early or 
intermediate proteins since they are expressed at the same time as the viral DNA 
replication starts. IVa2 is present in both empty capsid and mature virus particles (Zhang 
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and Imperiale, 2003). IVa2 also functions to regulate major late promoter (MLP) activity 
(Lutz and Kedinger, 1996; Lutz et al., 1997), regulate empty capsid formation and viral 
DNA encapsidation by binding to DNA packaging sequence (Zhang and Imperiale, 2003). 
pIX  is involved in holding adjacent hexon proteins and plays  a role in adenovirus 
replication and MLP activation (Lutz et al., 1997). In addition, pIX accumulation induces 
formation of specific nuclear domains in infected cells, which probably inhibits the 
antiviral activity of ND10 and contributes to optimal viral replication (Rosa-Calatrava et 
al., 2003). Since pIX is present on the virion surface, it has been used as a target for 
addition of ligands for altering adenovirus tropism (Dmitriev et al., 2002). 
 
1.1.2.4.5 Expression of late genes and viral assembly 
After the onset of DNA replication, adenovirus starts to express late genes. All late 
genes are encoded by major late transcription unit (MLTU) and grouped into 5 late (L) 
regions L1-L5 (Fraser et al., 1979). The MLTU encodes a single pre-mRNA, which is 
spliced and polyadenylated into approximately 20 mature mRNAs. These mRNAs 
primarily encode viral structural proteins and scaffolding proteins facilitating virion 
assembly (Iwamoto et al., 1986). 
After DNA replication, the expression of MLTU provides adequate amount of late 
proteins for virion assembly. Hexon trimerizes in the cytoplasm soon after translation, 
even though virions assembles in the nucleus (Cepko and Sharp, 1983). After being 
translocated to the nucleus, the hexon trimmers start to associate with penton base and 
other minor proteins to form the capsid (Wodrich et al., 2003). After the formation of the 
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empty capsid, the viral DNA genome is transported to the capsid to complete genome 
encapsidation (Edvardsson et al., 1976). 
A number of viral proteins are required for genome encapsidation. IVa2 is required 
for capsid formation by directly binding to DNA packaging sequence (Zhang and 
Imperiale, 2003).  L1-52/55K gene mutant virus produces only empty capsid and partially 
filled virions, suggesting that this protein is required for genome encapsidation (Gustin 
and Imperiale, 1998). Intriguingly, IVa2 and L1-52/55K protein form a complex, which 
binds to the packaging sequence and helps in viral DNA encapsidation (Perez-Romero et 
al., 2005). Moreover, L4 encoded 33K protein is also involved in viral DNA 
encapsidation since the 33K mutant virus cannot assemble into mature virus particles 
(Finnen et al., 2001). 
The left end of the viral DNA between ITR and ATG of E1A protein contains the 
DNA packaging sequences; 7 sequence element repeats (A1-A7) with different functional 
relevance (Hearing et al., 1987). Before virion assembly is complete, several structural 
proteins are cleaved by virus-coded protease to produce mature virus particles (Mangel et 
al., 2003). At approximately 30 hours post-infection, virus particle are released from the 
lysed cell. Although mechanisms involved in the release of adenovirus from cells is not 
clear, E3 encoded 11.6 K protein or adenovirus death protein (ADP) has been suggested 
to play a role in this process (Tollefson et al., 1996a). Although ADP is encoded by the 
E3 region, it is transcribed by the MLP not the E3 promoter (Tollefson et al., 1996b). 
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1.1.3 Bovine adenovirus-3 
1.1.3.1 Classification of bovine adenoviruses 
Bovine adenovirus (BAdV) was first isolated from a healthy cow, though they 
usually cause mild gastrointestinal or respiratory disease (Lehmkuhl et al., 1975). So far 
eleven BAdV serotypes have been identified (Lehmkuhl and Hobbs, 2008). Based on the 
difference of phylogenetic proximity, these eleven identified BAdV serotypes are 
subdivided into four subgroups (group A-D) and classified into two genera, 
Mastadenovirus and Atiadenovirus. Subgrope A (BAdV-1), B (BAdV-3) and C (BAdV-
10) belongs to Mastadenovirus, while subgroup D (BAdV-4, 5, 6, 7, 8 and strain Rus) 
belongs to Atadenovirus (Harrach, 2000; Lehmkuhl and Hobbs, 2008). Since the 
Mastadenovirus serotypes are classified as their own species, they are more 
phylogenetically close to ovine adenovirus rather than to each other, while the 
Atadenovirus serotypes are more phylogenetically close related to each other. 
  
1.1.3.2 Characteristics of BAdV-3 
BAdV-3 virus particle is an icosahedral particle of 75 nm in diameter containing a 
linear double stranded DNA genome of 34,446 base pairs in its non-enveloped capsid 
(Reddy et al., 1998). BAdV-3 was first isolated in 1960s from the conjunctiva of an 
apparently healthy cow in Great Britain (Darbyshire et al., 1965). BAdV-3 infected 
calves show mild or no clinic symptoms, although this virus has been isolated from cows 
with respiratory or enteric diseases (Mattson et al., 1988). 
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1.1.3.3 Genome organization of BAdV-3 
The G/C content of BAdV-3 genome is 54%, which is very close to HAdV-12 
genome and 20% more than the G/C content of ovine adenovirus genome (Reddy et al., 
1998; Vrati et al., 1996). Like other adenoviruses, the BAdV-3 genome is divided into 
early regions, intermediate regions and late regions (Fig 1.2), which are predicted to 
encode 33 proteins (Reddy et al., 1999a; Reddy et al., 1998). BAdV-3 genome is flanked 
by 195 bases ITRs with G/C content of 84%, which is unusually high compared to other 
adenoviruses (Reddy et al., 1998). Although the BAdV-3 genome packaging sequence is 
located at the left end of the adenovirus DNA as other adenoviruses, a part of the E1A 
open reading frame is shown to be essential for BAdV-3 genome packaging (Xing and 
Tikoo, 2007; Xing et al., 2003). Moreover, there are no TATA or CAAT boxes between 
the left ITR and E1A open reading frame, suggesting that the left ITR contains the E1A 
promoter (Xing and Tikoo, 2006). The transcription map of BAdV-3 is shown in Fig 1.4.  
 
1.1.3.3.1 Early genes 
The E1A proteins of early regions are first to be transcribed. Because of different 
splicing, E1A produces several transcripts, which encode three relatively small proteins 
termed 211R, 115R and 100R with the same N-terminus (Reddy et al., 1999a). As E1A-
221R is rich in proline and glutamic acid residues, the observed molecular weight is more 
than the predicted molecular weight in sodium dodecyl sulphate polyacrylamide gels 
(SDS-PAGE) (Reddy et al., 1999a). Both 211R and 115R are encoded from transcripts  
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Figure 1.4 Transcription map of BAdV-3. Transcript locations and directions are 
indicated by arrows. Adapted from (Reddy et al., 1998), with permission to use. 
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with the same open reading frames but have different downstream splicing. These two 
E1A encoded proteins are expressed at 24 hours post-infection, while the 100R was 
observed from 12 hours to 36 hours post-infection. HAdV-5 genes can be activated by 
BAdV-3 E1A product, indicating that they are homologous in functions (Zheng et al., 
1994). Moreover, BAdV-3 E1A transcripts have unusually long 5’-untranslated region, 
the function of which is not known (Reddy et al., 1999a). The E1B regions transcribe two 
different mRNAs, coding 420R and 157R, which are homologous to HAdV-5 E1B-19K 
and 55K (Zheng et al., 1994), respectively. Phosphorylation has been reported on 
serine/threonine of E1A and E1B-157R serine/threonine and tyrosine residues of E1B-
420R (van Olphen et al., 2002). Unlike HAdV-2 (Berk and Sharp, 1978), BAdV-3 E1A 
and E1B share the same promoter and polyadenylation sites (Reddy et al., 1998). 
Like human adenoviruses, BAdV-3 E2 region encodes proteins that contribute to 
viral DNA replication. The only protein encoded by E2A is DBP, which is a 
multifunctional protein and involved in diverse processes (Chase and Williams, 1986). 
BAdV-3 DBP is 423 amino acids in length, which is shorter than HAdV DBPs 
(Kitchingman, 1985). Like in other adenoviruses, the DBP of BAdV-3 contains a variable 
N-terminus and a conserved C-terminus (Tucker et al., 1994). Although the variable N-
terminus is not essential for HAdV replication, it determines the host range (Anderson 
and Klessig, 1984). The conserved C-terminus is involved in DNA binding, DNA 
replication and activation of MLP (Kitchingman, 1985). HAdV DBPs contain two zinc 
atom-binding motifs, which maintain the protein three-dimensional structure and function 
via binding to zinc atoms (Tucker et al., 1994). The BAdV-3 DBP contains a number of 
threonine and serine residues at the N-terminus that may act as the phosphorylation sites.  
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Like HAdV DBPs, BAdV-3 DBP contains motifs rich in basic amino acid, 
including 29PRKK32, 35RKRR38, and 53KRAK56, which are potential nuclear localization 
signals (NLS) (Reddy et al., 1998). Adenovirus DNA Pol and precursor terminal protein 
(pTP) are coded from E2B region. As in HAdV-2, BAdV-3 transcripts coding DNA Pol 
and pTP are 3’ co-terminal (Reddy et al., 1998). BAdV-3 DNA Pol and pTP are 1023 and 
649 amino acids long, respectively (Baxi et al., 1998), and share 59-60% and 58-60% 
amino acid identity, respectively, to their counterparts of other members in 
Mastadenovirus genus. 
The E3 region of BAdV-3 is 1.4 kb, which is relatively small compare to other 
adenoviruses including HAdV-5 (Davison et al., 2003), and produces transcripts 
encoding four proteins of 284, 121, 86 and 82 amino acids (Idamakanti et al., 1999). The 
284R, which is unique in BAdV-3, is a glycoprotein. The 121R shows limited homology 
to HAdV-5 E3-14.7 kDa protein (Mittal et al., 1993).  It is expressed as 14.5 kDa protein 
in BAdV-3 infected cells (Idamakanti et al., 1999) and involved in inhibition of TNF-α 
mediated apoptosis (Gooding et al., 1988; Gooding et al., 1990; Horton et al., 1991). Like 
HAdV-5 (Morin et al., 1987), the E3 region is dispensable for the replication of BAdV-3 
in cultured cells. 
Like HAdV-5 (Bridge and Ketner, 1989), the E4 region is located at the right end 
of the BAdV-3 genome (Reddy et al., 1998). Alternative splicing of E4 transcript 
generates several transcripts, which encode five open reading frames (ORFs) (1-5) 
(Reddy et al., 1998). ORF 1, ORF2 and ORF4 are 143, 69 and 143 amino acids long, 
respectively, and show no homologue to E4 ORFs of HAdV-5 (Bridge and Ketner, 1989). 
However, ORF3 and ORF5 are proteins of 268 and 219 amino acids, respectively, and 
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they show some homology with HAdV-5 E4orf6 proteins (Baxi et al., 2001). None of 
these ORFs appear essential for replication of BAdV-3 in tissue culture cells or cotton 
rats (Baxi et al., 2001).  
HAdV-2 expresses two copies of non-coding RNAs, termed viral associated (VA) 
RNA, which are transcribed by RNA polymerase III (Ma and Mathews, 1996). They 
inhibit the phosphorylation of eukaryotic initiation factor 2 (eIF2) by binding to protein 
kinase R (PKR) (Sano et al., 2006), which facilitate viral protein expression. However, no 
VA RNAs have been identified in BAdV-3 genome so far (Reddy et al., 1998). VA RNA 
genes are located between 52/55K and pTP genes in HAdV, while there is no enough 
space for them in BAdV-3 genome since 52/55K protein is adjacent to pTP unless VA 
RNA genes overlap both 52/55K and pTP genes. It is possible that BAdV-3 VA RNA 
genes are probably located at different locations from HAdV-2. Alternatively, it is also 
possible that BAdV-3 uses other mechanisms to antagonize PKR rather than expressing 
VA RNAs (Reddy et al., 1998). 
 
1.1.3.3.2 Intermediate genes 
Like HAdV-2 (van Oostrum and Burnett, 1985), BAdV-3 expresses two 
intermediate (delayed-early) proteins IVa2 and IX. Protein IVa2 gene is located 
downstream of DNA Pol and pTP genes on the complementary strand. Unlike HAdV-2 
(Berk and Sharp, 1978), BAdV-3 IVa2 transcripts do not share the 3’-terminus with both 
DNA Pol and pTP transcripts (Reddy et al., 1998). BAdV-3 protein IVa2 is a structural 
protein with 376 amino acids, which is shorter than IVa2 proteins of other adenoviruses, 
sharing 29-69% of homology with its counterparts (Reddy et al., 1998). BAdV-3 protein 
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IX gene is located downstream of E1A and E1B regions and encodes a 125 amino acids 
structural protein showing 16-28% sequence identity with protein pIX encoded by other 
members of Mastadenovirus (Zheng et al., 1999). 
 
1.1.3.3.3 Late genes 
 The late (L) proteins of BAdV-3 are encoded by different mRNAs that are 
generated form a single transcript of MLTU by alternative splicing. Unlike HAdV-5 late 
region (Fraser et al., 1982), BAdV-3 MLTU can be divided into seven late regions (L1-
L7) based on mRNAs sharing the same poly(A) signal (Reddy et al., 1998). BAdV-3 
MLP contains a TATA box, inverted CAAT box, USF binding site and initiator element 
(Reddy et al., 1998). Like HAdV-2 tripartite leader (TPL) (Chow et al., 1977). BAdV-3 
MLP also transcribes a TPL of 205nt composed of three leaders with 40nt, 78nt and 87nt 
in length respectively (Reddy et al., 1998). 
Unlike HAdV-2 (Kreivi et al., 1991), the L1 region of BAdV-3 encodes four 
proteins namely 52K, IIIa, III and pVII since their transcripts share the same poly(A) 
signal. BAdV-3 52K is a non-structural protein of 331 amino acids showing 61% amino 
acids sequence identity to HAdV-2 52/55K (Reddy et al., 1998). It is localized in the 
nucleus in both transfected and infected cells, and three basic residues 105RKR107 seems 
essential for 52K nuclear transportation (Paterson et al., 2012). 52K can interact with 
importin α3, suggesting that the classical importin α/β dependent nuclear transport 
pathway mediates 52K nuclear trafficking (Paterson, 2010; Paterson et al., 2012). 52 K 
was also detected to redistribute NFB-binding protein (NFBP), which is involved in 
ribosomal RNA (rRNA) processing, from the nucleolus to the nucleoplasm (Paterson, 
 27 
2010; Paterson et al., 2012). pIIIa is a structural protein bridging the hexon trimmers to 
stablize the capsid in HAdV-2 (Vellinga et al., 2005). BAdV-3 pIIIa is a 568 amino acids 
protein with a putative viral protease cleavage site at 19 residues from the carbon-
terminus, and showing 25-57% amino acids identities to other adenovirus pIIIa proteins 
(Reddy et al., 1998). Penton base protein comprises the vertexes of the capsid and plays 
an important role in virus internalization (Zubieta et al., 2005). BAdV-3 penton base 
protein has 482 residues and share 44-64% homology to penton base proteins of other 
adenoviruses (Reddy et al., 1998). BAdV-3 penton base protein contains a MDA motif 
rather than RGD motif found in HAdV penton, and interacts with αvβ3 and αvβ5 to trigger 
endocytosis for virus internalization (Wickham et al., 1993). To form the penton, BAdV-
3 penton base protein also interacts with fiber protein at the conserved fiber-interaction 
domain (Caillet-Boudin, 1989). BAdV-3 pVII is a core protein of 171 amino acids in 
length and shares 53% sequence identity to HAdV-2 pVII protein (Reddy et al., 1998). 
BAdV-3 pVII contains a mitochondria localization signal (MLS), which directs pVII 
mitochondria localization (Anand et al., 2014). pVII mitochondria localization inhibits 
apoptosis by maintaining mitochondria membrane potential (MMP), retention of 
mitochondria Ca2+ and increasing ATP production (Anand et al., 2014). 
Unlike HAdV-2 (Davison et al., 2003), the L2 region of BAdV-3 encodes only 
protein V (pV), a protein unique to Mastadenoviruses (Bahr et al., 2003). BAdV-3 pV is 
423 amino acids long and shows animo acids sequence identities of 28-40% to other 
Mastadenovirus pV proteins (Reddy et al., 1998). Moreover, pV is rich of basic amino 
acids residues, which indicates pV may localized in nucleus (Reddy et al., 1998). 
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Unlike HAdV-2 (Anderson et al., 1989), the L3 region of BAdV-3 encodes pX 
precursor (Anderson et al., 1989). BAdV-3 pX precursor protein is 80 amino acids long 
and shares 54% sequence identity to HAdV-2 pX (Reddy et al., 1998). Similar to HAdV-
2 pX (Anderson et al., 1989), it contains a conserved sequence, which may act as a 
bipartite NLS for protein, and two predicted viral protease cleavage site (Reddy et al., 
1998). 
Unlike HAdV-5 (Hayes et al., 1990), the L4 region of BAdV-3 encodes only pVI 
protein (Reddy et al., 1998). BAdV-3 pVI is a structural protein with 263 amino acids 
and shares 32% homology to HAdV-2 pVI. In addition to being assembled in the capsid, 
pVI also mediates the disruption of endosome membrane and pVI precursor transports 
hexon from cytoplasm to nucleus (Kauffman and Ginsberg, 1976). BAdV-3 pVI protein  
contains two putative protease cleavage sites at both N- and C-terminus of protein 
(Reddy et al., 1998). 
Unlike HAdV-2 (Chroboczek et al., 1992), the L5 region of BAdV-3 encodes 
hexon and protease (Reddy et al., 1998). BAdV-3 hexon is a 910 amino acids protein, 
showing 65% sequence identity to HAdV-2 hexon. Although there are some differences 
in external loops between BAdV-3 and HAdV-3 hexon proteins, the difference did not 
influence the structure of hexon proteins (Athappilly et al., 1994; Hu et al., 1984). BAdV-
3 protease is 204 amino acids long, and showing 65% sequence identity to HAdV-2 
protease. In BAdV-3, protease cleaves structural proteins pIIIa, pVI, pVII, pVIII, pX, and 
pTP precursors before virus assembly (Reddy et al., 1998). 
Unlike HAdV-2 L4 region, which encodes only 100K and 33K (Oosterom-Dragon 
and Anderson, 1983), the L6 region of BAdV-3 encodes non-structural proteins 100K, 
 29 
33K and 22K, and a structural protein pVIII (Kulshreshtha et al., 2004). The BAdV-3 
100K protein is 850 amino acids long, and showing 52% sequence identity with HAdV-2 
100K. It functions to facilitate hexon trimerization (Oosterom-Dragon and Ginsberg, 
1981). Moreover, BAdV-3 100K contains two putative protease cleavage sites, and the 
cleaved C-terminus product is localized in the nucleolus, although the cleavage of 100K 
is not essential for viral replication (Makadiya et al., 2015). 100K interacts with viral 
protein 33K and cellular protein dynein light chain (DYNLT) 1, while co-expression of 
100K with 33K or DYNLT1 did not alter the cellular localization of 100K (Makadiya, 
2013). In BAdV-3, 33K and 22K share the same N-terminus while differs in C-terminus 
because of splicing (Kulshreshtha et al., 2015). BAdV-3 33K interacts with 100K and pV, 
and functions to transactivate MLP (Kulshreshtha and Tikoo, 2008). 100K was also 
found to interact with cellular protein bovine presenilin-1-associated 
protein/mitochondrial carrier homolog 1 (BoPSAP/BoMtch1), and colocalize in the 
mitochondria with BoPSAP (Kulshreshtha, 2009). BAdV-3 pVIII is the only structural 
protein encoded by L6 region. It is 216 amino acids in length, and showing 52% 
sequence identity with HAdV-2 pVIII (Reddy et al., 1998). Two proteases cleavage sites 
have been identified in BAdV-3 pVIII, and after cleavage, the 8 kD C-terminus is 
assembled into the virions (Ayalew et al., 2014). pVIII can abolish translation of capped 
mRNA via its interaction with cellular protein DEAD box (DDX) 3, and knockdown of 
DDX3 significantly reduces the BAdV-3 viral yield and expression of viral late proteins 
(Ayalew, 2014). 
The fiber protein is coded by BAdV-3 L7 region rather than L5 region in HAdV-2 
(Reddy et al., 1998). BAdV-3 fiber protein is 976 amino acids long and shows 23.7% 
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amino acids identity to HAdV-3 fiber protein. The speculated motif interacting with 
penton is highly conserved in both HAdV-2 and BAdV-3 (Caillet-Boudin, 1989). 
Replacing its knob region of BAdV-3 fiber with HAdV-5 knob region can alter its 
tropism (Wu and Tikoo, 2004).  
 
1.1.3.4 BAdV-3 as vectors for vaccination 
With the development of DNA editing, genomics and immunology, it has become 
possible to manipulate viruses to use them as vaccine delivery vehicles (Draper and 
Heeney, 2010). Adenovirus is one of the few viruses being developed and evaluated as 
vaccine delivery vehicles (Wold and Toth, 2013). Although human adenoviruses are 
widely evaluated for delivery of vaccine antigens of HIV (Herath et al., 2015), influenza 
viruses (Coughlan et al., 2015), rabies (Shen et al., 2012), dengue (Raviprakash et al., 
2008), middle east respiratory syndrome coronavirus (MERS-CoV) (Kim et al., 2014) 
and Ebola virus (Ledgerwood et al., 2015) to human and animals, safety concerns and 
efficiency of vaccination has hindered its widespread use (Fausther-Bovendo and 
Kobinger, 2014).  Currently, non-human adenoviruses such as chimpanzee adenovirus-
7/63 (Kobinger et al., 2006; Nebie et al., 2014), bovine adenovirus-3 (Mittal et al., 1995; 
Reddy et al., 1999b; Singh et al., 2008), porcine adenovirus-3/5 (Hammond et al., 2001; 
Tuboly and Nagy, 2001) and canine adenovirus-2/3 (Tordo et al., 2008; Wright et al., 
2013), ovine adenovirus-7 (Tang et al., 2012), and fowl adenovirus-9 (Deng et al., 2013) 
are being evaluated as vaccine delivery vehicles both in humans (Kobinger et al., 2006; 
Nebie et al., 2014) and animals (Tang et al., 2012).  
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A number of properties of BAdV-3 including high titers, low virulence, easy 
manipulation, stability and safety make it a vector of choice for developing BAdV-3 
based vaccines for humans (Singh et al., 2008; Wu and Tikoo, 2004) and animals (Mittal 
et al., 1995; Reddy et al., 1999b; Singh et al., 2008). E1A 286R or E1B 55 kDa are 
essential for BAdV-3 replication since their deletion renders BAdV-3 replication-
defective in cultured cells (van Olphen et al., 2002). Thus, the replication-defective 
BAdV-3 vectors are generated by the deletion of E1A region, therefore E1 deleted 
vectored vaccines are thought to be safer than replication-competent vectored vaccines 
(Ayalew et al., 2015). However, deletion of a small region of E1B (Zhou et al., 2001) or 
the E3 region (Reddy et al., 2000; Zakhartchouk et al., 1998) does not alter the 
replication of BAdV-3 in cultured cells. Thus, replication-competent vectors are 
generated by deletion of E1B (Zhou et al., 2001) and \ or E3 (Reddy et al., 2000; 
Zakhartchouk et al., 1998). Several BAdV-3 vectored vaccines based on insertion of 
foreign antigenic genes, such as bovine herpes virus (BHV)-1 gD (Zakhartchouk et al., 
1998), bovine viral diarrhea virus (BVDV) E2 (Baxi et al., 2000) and bovine coronavirus 
(BCV) HE (Reddy et al., 2000), into the E3 deleted region have been developed and 
evaluated in cotton rats (Zakhartchouk et al., 1998). In addition, the E4 region has been 
identified as an insertion region for foreign ORFs (Baxi et al., 1999; Baxi et al., 2001). 
The C-terminal 1.3 kb or N-terminal 1.5 kb fragment can be deleted from E4 region 
without influencing BAdV-3 replication (Baxi et al., 1999; Baxi et al., 2001) and 
suggested that foreign ORFs can be inserted at these positions to increase BAdV-3 
vectors capacity (Baxi et al., 1999; Baxi et al., 2001). Protecting animals from multiple 
antigens is feasible for BAdV-3 vectors since they can express multiple antigenic foreign 
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genes. Two antigens BHV-1 gD and bovine respiratory syncytial virus (BRSV) gG are 
inserted into a BAdV-3 based vector that induces production of protective antibodies 
against both BHV-1 and BRSV in cotton rats (Brownlie et al., 2015).  
BAdV-3 structural proteins can be modified to expand the tropism of the BAdV-3 
based vectored vaccines. Two viral proteins are the potential targets for tropism 
modification. Firstly, fiber protein is a major capsid proteins used by BAdV-3 for cellular 
receptor binding (Wu and Tikoo, 2004). The replacement of BAdV-3 fiber knob region 
with that of HAdV-5 increases the BAdV-3 vector transduction efficiency significantly in 
non-bovine cells, which are transduced by the unmodified BAdV-3 vectors with low 
efficiency (Wu and Tikoo, 2004). Secondly, pIX is a minor protein that exposed on the 
BAdV-3 virion surface that provides its potential for tropism modification. Insertion of 
RGD motif into the C-terminus of pIX enhances fiber-independent tropism of BAdV-3 
(Zakhartchouk et al., 2004). Tropism alterations of BAdV-3 vectored vaccines not only 
improve vaccine delivery efficiency, but also broaden the range of target animals 
(Ayalew et al., 2015). 
 
1.1.3.5 Protein-protein interaction in adenoviruses 
Proteins play indispensible roles in different steps of adenovirus replication, 
including attachment, internalization, DNA replication, protein expression and vial 
particle assembly. Many of these viral proteins perform their function by interacting with 
other viral \ cellular proteins (Arnberg, 2009). A variety of assays have been developed to 
detect these protein-protein interactions, such as co-immunoprecipitation (Co-IP) 
(Takahashi, 2015), bimolecular fluorescent complementation (BiFC) (Hu et al., 2002; 
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Kong et al., 2015), pull down assay (Fonseca and Solano, 2013; Wang et al., 2014b), 
yeast two hybrid (Maruta et al., 2016), strep protein interaction experiment (SPINE) 
(Herzberg et al., 2007), quantitative immunoprecipitation combined with knock-down 
(QUICK) (Selbach and Mann, 2006), label transfer (Liu et al., 2007), phage display 
(Sidhu et al., 2003), photo-reactive amino acid analogs (Hetu et al., 2008), tandem 
affinity purification (Rohila et al., 2006), chemical cross-linking (Tang and Bruce, 2009), 
proximity ligation assay (Soderberg et al., 2006). Moreover, recently methods based on 
Machine-learning-based computational approaches have been developed and utilized for 
prediction of protein-protein interaction sites (Liu et al., 2015). 
 
1.1.3.5.1 Protein-protein interactions in adenovirus attachment and interanlization 
Adenovirus infection starts with an interaction between fiber knob and cellular 
receptors, which is followed by the interaction of penton base RGD or LDV motifs with 
integrin on the cell membrane (Arnberg, 2009). Although there is no RGD or LDV motifs 
present in BAdV-3 penton base, the LDV motif seems to be replaced by MDV motif, 
which may interact with α4β1 intergrin (Komoriya et al., 1991; Reddy et al., 1998). After 
endosomal escape, partially uncoated adenovirus is transported to the nucleus along the 
MTOC, which is possibly mediated by an interaction between viral pV and cellular p32 
protein. Cellular protein p32 can shuttle between mitochondria and the nucleus; therefore 
adenovirus may hijack this route to reach the nucleus after escape from the endosome 
(Matthews and Russell, 1998a). Since knockdown of Nup214 reduced adenovirus 
genome entry into the nucleus, it has been suggested that the entry of the adenovirus 
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genome into the nucleus is mediated by the interaction between hexon and nucleoporin 
Nup214 (Cassany et al., 2015).  
 
1.1.3.5.2 Protein-protein interactions of adenovirus early proteins 
After entry of adenovirus genome in the nucleus, it starts to express E1A proteins 
(Curtois and Berk, 1984). E1A reprograms the cell cycle and gene expression by directly 
binding to key cellular regulatory proteins and transcription factors (Avvakumov et al., 
2002). As described prviously (1.1.2.4.2), E1A products can regulate the cell cycle by 
interacting with pRB to disrupt pRB-E2F complex and release E2F, a trans-activator of 
genes involved in the cell cycle (Ikeda and Nevins, 1993). Ib addition, chromatin can be 
remodelled by the by E1A protein by interacting with TRRAP/GCN5 (Lang and Hearing, 
2003), pCAF and p300/CBP (Chakravarti et al., 1999; Hamamori et al., 1999). Finally, 
E1A proteins regulate target protein expression by protein-protein interaction with 
CCBF1 and SUR2 (Ansieau et al., 2001).  
The two E1B proteins are involved in inhibition of apoptosis. E1B-55K directly 
binds to tumor suppressor p53 to degrade it (Ben-Israel and Kleinberger, 2002) or  it also 
forms a complex with other proteins including an ubiquitin ligase to degrade p53 
(Sarnow et al., 1984). The interaction of E1B-19K with BAK and BAX can disrupt BAK 
and BAX complex binding to the mitochondria membrane therefore inhibits its pro-
apoptosis activity (Cuconati et al., 2003).  
The E2 region proteins are involved in viral DNA replication. DBP, pTP and DNA 
pol are complexed by interacting with each other to initiate the DNA replication, 
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maintain the elongation and mediate the termination of the DNA replication (Mysiak et 
al., 2004; van Breukelen et al., 2003).  
The protein-protein interaction between E3-gp19K and MHC class I helps to retain 
MHC class I in the ER, therefore it cannot migrate to cell surface and present antigens to 
cytotoxic T lymphocytes (CTLs) (Burgert et al., 1987). The RID complex formed by the 
interaction of E3-10.4K and 14.5K removes the chemokine receptors on the cell surface 
and mediates their degradation and hence inhibits chemokine induced cell apoptosis 
(Shisler et al., 1997). 
E4 region encoded proteins are involved in modulation of cell cycle, transcription, 
DNA repair and cell signalling via protein-protein interactions (Weitzman, 2005). The 
interaction of E4-orf1 and cellular protein Discs Large 1 (Dlg1) promotes cell survival 
and viral replication by activating phosphatidylinositol 3-kinase (PI3K) (Kong et al., 
2014). E4-orf3 promotes viral replication by interacting with cellular proteins 
transcription intermediary factor (TIF) 1α, TIF1β and TIF1γ and relocating them to 
nuclear track structures (Vink et al., 2012). Unlike other E4 proteins, E4-orf4 induces 
apoptosis and down regulates adenovirus early protein expression (Muller et al., 1992) by 
interacting with ATP dependent chromatin-remodeling factor ACF, which is composed 
of an Acf1 regulatory subunit and a sucrose non-fermenting-2h (SNF2h) ATPase 
(Brestovitsky et al., 2011). Moreover, the interaction of E4orf4 and PP2A inhibits the 
activity of ACF and enhances the chromatin activity of WSTF-SNF2h (Brestovitsky et al., 
2011). E4-orf6 interaction with E1B-55K not only shuts off cellular protein translation 
but also degrades tumor suppressor p53 by ubiquitination (Evans and Hearing, 2003).  
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1.1.3.5.3 Protein-protein interactions of adenovirus intermediate proteins 
The intermediate protein IVa2 is involved in viral capsid assembly (Zhang and 
Imperiale, 2003), viral DNA encapsidation (Zhang et al., 2001) and activation of the 
major late promoter. In HAdV-5 infected cells, IVa2 interacts with L1 protein 52/55K to 
facilitate the viral DNA packaging (Zhang and Imperiale, 2003). Recently, IVa2 was 
found to function as a packaging ATPase and interact with another viral protein 33K, 
which is important for viral DNA packaging (Ahi et al., 2015). In another study, IVa2 
forms a complex with L4-22K and attaches to the DNA packaging sequence to direct 
viral DNA packaging (Pardo-Mateos and Young, 2004; Yang and Maluf, 2012).  
Moreover, IVa2 interacts with pVIII in porcine adenovirus-3 (PAdV-3) infected VIDO 
R1 cells, although the purpose is not clear (Singh et al., 2005). 
Adenovirus pIX is a structural protein, which plays an important role in the 
stabilization of the capsid by interacting with the C-terminus of hexon (Parks, 2005). 
Moreover, pIX also functions as a transcription activator and causes virus-induced 
nuclear reorganization by interacting with the major late promoter (Rosa-Calatrava et al., 
2001). In another study, pIX has shown to colocalize and associate with promyelocytic 
leukemia protein (PML), which is a major component of nuclear structure nuclear 
domain 10 (ND10) and involved with an antiviral response (Chee et al., 2003). The 
interaction of pIX with PML probably leads to the sequestration of PML and inhibition of 
its antiviral activity (Parks, 2005). 
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1.1.3.5.4 Protein-protein interactions of adenovirus late proteins 
The HAdV-5 L1-52/55K mediates viral DNA packaging via its interaction with 
IVa2 (Perez-Romero et al., 2005). L1-52/55K was also detected to serve as the packaging 
scaffold protein in viral assembly (Mangel and San Martin, 2014). Recently, it has been 
demonstrated that L1-52/55K interacts with the core and capsid components and is 
present in empty capsid but not in mature viral particles (Perez-Berna et al., 2014). In the 
maturation process of adenovirus particles, the L1-52/55K molecules are cleaved by the 
viral protease and transported out from the capsid (Perez-Berna et al., 2014). The other 
L1 protein IIIa is a structural protein that interacts with hexon to stabilize the viral capsid 
(Ma and Hearing, 2011). In addition, IIIa interacts with L1-52/55K to improve viral DNA 
packaging, and the interaction has been detected both in vivo and in vitro (Ma and 
Hearing, 2011). 
The HAdV-5 L2 pVII is a core protein that binds to the viral DNA non-specifically 
(Zhang and Arcos, 2005).  In viral DNA nuclear import, pVII interacts with nuclear 
transport factors importin alpha, importin beta, importin 7 and transportin via its three 
nuclear localization signals (Wodrich et al., 2006). The use of multiple nuclear import 
pathways by pVII is thought to improve the efficiency of viral genome nuclear import 
(Wodrich et al., 2006). Moreover, pVII also functions in viral DNA encapsidation by 
interacting with two viral DNA packaging proteins IVa2 and L1-52/55K (Zhang and 
Arcos, 2005). Another HAdV-5 L2 protein pV bridges the capsid and core via interaction 
with capsid component pVI (Matthews and Russell, 1998b) and core components pVII 
(Harpst et al., 1977).  pV also interacts with cellular protein p32, which shuttles between 
the mitochondria and nucleus, and this interaction may mediate adenovirus transportation 
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form the cytoplasm to the nucleus (Matthews and Russell, 1998a). In addition, pV has 
been detected to interact with nucleolar protein B23. This interaction not only 
redistributes nucleolar protein nucleolin from the nucleus to the cytoplasm but is also 
involved in core protein dissociation (Samad et al., 2007). The L2 penton base protein 
also functions as a structural protein and plays an important role in adenovirus 
internalization (Varga et al., 1991) . The interaction between the penton base RGD motif 
and integrins triggers clathrin-mediated endocytosis, which facilitates adenovirus cellular 
entry (Varga et al., 1991). In addition, the penton protein also interacts with a highly 
conserved fiber-interacting motif (HSRLSNLLGIRKR) to form the penton (Caillet-
Boudin, 1989). 
The HAdV-5 L3 pVI interacts with other viral components to stabilize the viral 
particle (Chatterjee et al., 1985; Matthews and Russell, 1998b). It also plays a role in 
viral endosomal release and capsid assembly. pVI can interacts with the newly 
synthesized hexon (another L3 protein) and facilitates its import to the nucleus where 
viral assembly occurs (Wodrich et al., 2003).  
The HAdV-5 L4 protein 100K interacts with eukaryotic initiation factor 4G 
(eIF4G) to form a complex involved in ribosome shunting to improves late viral protein 
translation (Xi et al., 2004). In addition, 100K also functions in viral capsid assembly of 
hexon. The 100K serves as a chaperone for hexon protein folding and trimerization by 
interaction with globular domain of hexon protein, and mediates its nuclear import in 
insect cells (Hong et al., 2005). 100K can interact with granzyme, a serine proteases 
released by cytotoxic T cells or natural killer cells to induce programmed cell death, to 
inhibit its activity against viral replication (Andrade et al., 2003). The HAdV-5 L4 33K 
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protein interacts with viral packaging proteins, such as L1-52/55K, IVa2 (Ahi et al., 
2013), IIIa (Wu et al., 2013) and 22K (Wohl and Hearing, 2008). These interactions are 
thought to be involved in viral assembly (Wu et al., 2013).  
The only protein encoded by the HAdV-5 L5 region is fiber, which interacts with 
penton base to form penton (Caillet-Boudin, 1989). Moreover, adenovirus infections start 
with the interaction between fiber knob and the cellular receptors, such as coxsackie virus 
and adenovirus receptor (Tomko et al., 1997), Heparan sulfate glycosaminoglycans (HS-
GAGs) (Dechecchi et al., 2001), CD46 (Stevenson et al., 1995), CD80 and CD86 (Short 
et al., 2004), and sialic acid (Arnberg et al., 2002). 
 
1.2 PROTEIN NUCLEOCYTOPLASMIC TRANSPORT 
The nucleus is the repository of genetic material and control center of eukaryotic 
cells. Important processes like DNA replication, RNA transcription and processing take 
place in the nucleus (Cooper GC, 2006). The nuclear envelope separates the genetic 
materials in the nucleus from the cytoplasm, which provides eukaryotic cells 
opportunities to regulate protein expression at the levels of transcription and post-
transcription. By controlling the nuclear transport of transcription factors, eukaryotic cells 
regulate gene expression at the transcriptional level (Cooper GC, 2006). On the other 
hand, eukaryotic cells regulate gene expression at post-transcription level by alternative 
splicing, which does not happen in prokaryotic cells (Cooper GC, 2006). 
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1.2.1 Nuclear pore complex 
The nuclear pore complex is the only channel through which cellular materials can 
travel between the cytoplasm and the nucleus (Tonini et al., 1999). The RNAs are 
synthesized in the nucleus, and must be transported to the cytoplasm for translation 
leading to protein expression (Cooper GC, 2006). Similarly, proteins are synthesized in 
the cytoplasm, and need to be transported to the nucleus to perform certain functions 
(Cooper GC, 2006). Thus, the NPC plays a fundamental role in eukaryotic cells by 
regulating the transport of molecules between the cytoplasm and the nucleus (Tonini et 
al., 1999). 
 
1.2.1.1 Nucleoporin 
Nucleoporins (Nups) are a family of proteins that comprise the NPC and regulate 
the transportation of macromolecules between the cytoplasm and the nucleus. 
Nucleoporins contain some conserved FG (phenylalanine-glycine) motifs, which serve as 
binding sites for the transport factors (Bayliss et al., 2000). FG repeats consist of several 
tandem repeats, having hydrophobic cores with hydrophilic spacers. The two most 
common FG motifs are GLFG and FxFG (x represents small amino acid residues, like 
alanine, glycine and serine) (Bayliss et al., 2000). Multiple copies of these FG motifs are 
present in nucleoporins, for example Nup116p and Nsp1p contain 33 GLFG and 19 
FxFG, respectively (Bayliss et al., 2000), which bind directly to soluble transport factors 
(Finlay and Forbes, 1990). Protein nuclear import can be blocked by Mab414 (Davis and 
Blobel, 1986), which directly interacts with FxFG motifs, and RNA nuclear export can be 
blocked by anti-Nup98 antibody (Powers et al., 1997). Intriguingly, purified Nup153 
 41 
FxFG motifs can inhibit the nuclear transport mediated by importins due to its 
recognition and interaction with classic nuclear localization signals (NLSs), while it has 
no effect to the nuclear import mediated by transportin, which binds to a different NLS 
(Shah and Forbes, 1998). In addition to FG motifs, some nucleoporins also contain 
coiled-coils, which are probably involved in interacting with other nucleoporins for NPC 
assembly (Bayliss et al., 2000). 
Nucleoporins are assembled into functional sub-complexes prior to the construction 
of NPC (Krull et al., 2004). Of the known nucleoporins (Harel et al., 2003), the Nup107-
160 sub-complex is the most extensively studied. Nine nucleoporins present in Nup107-
Nup160 sub-complex include: Sec13, Seh1, Nup37, Nup43, Nup85, Nup96, Nup107, 
Nup133 and Nup160, and knocking out of any of these nine leads to the nuclear envelope 
devoid of NPC (Harel et al., 2003). This sub-complex plays a role in NPC assembly and 
facilitates the anchoring of Nup153 at the face of the envelope. The Nup93 sub-complex 
is composed of Nup35/53, Nup188, Nup155, Nup205 and anchors NPC on the nuclear 
envelope via an interaction with the cellular protein Ndc1. The interaction of Nup93 with 
Ncl1 seems to be essential for the assembly of NPC (Mansfeld et al., 2006). 
 
1.2.1.2 Structure of nuclear pore complex 
The nuclear pore is a large protein complex composed of three components, 
including the cytoplasmic ring and filaments, the nuclear ring and bucket, and the central 
cylinder (Stoffler et al., 1999) (Fig 1.5). More than 30 different types of nucleoporins are 
present in the NPCs in eight or multiples of eight copies due to the eight-fold symmetry 
of NPC structure (Stoffler et al., 1999). Recent studies have shown that the NPC is 
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approximately 50 nm thick with an outside diameter of 80-120 nm and an inner diameter 
of approximately 40 nm (Bui et al., 2013). 
As shown in Fig 1.5, the NPC is composed of an assembly of eight spokes that 
surrounds a central channel, which spans the outer and the inner membranes of the 
nuclear envelope (Wente and Rout, 2010). Spokes, which are comprised of the Nup93 
sub-complex in vertebrates, connects the rings at the cytoplasmic and the nuclear surfaces 
(Wente and Rout, 2010) . The ring-spoke assembly is anchored on the site of fusion 
between the outer and the inner membrane of the nuclear envelope (Wente and Rout, 
2010) . While some nucleoporins protrude into the cytoplasm to form cytoplasmic 
filaments, some nucleoporins extend into the nucleoplasm to form the nuclear bucket 
(Kabachinski and Schwartz, 2015). Moreover, the nucleoporins with FG motifs are 
located in the central channel to provide the transport-binding sites (Wente and Rout, 
2010). 
 
1.2.2 Protein selective import 
Small proteins with molecular weight less than approximately 40 kDa can freely 
pass through the nuclear envelope in either direction (Patel et al., 2007), although 
proteins larger than 60 kDa have been proved to diffuse through the NPC (Wang, 2007). 
Large proteins, however, pass through the NPC by an active process in which proteins are 
transported via interactions with transport factors in a specific direction. Proteins that can 
be transported through the NPC contain specific amino acids sequence termed nuclear 
localization signal (NLS) or nuclear export signal (NES), which can be recognized and  
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Figure 1.5 Schematic diagram of nuclear pore complex structure. Adapted from 
(Strambio-De-Castillia et al., 2010; Wente and Rout, 2010), with permission to use. 
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bound by transport factors to mediate active transportation (Kabachinski and Schwartz, 
2015). 
The NLS is a motif rich in basic amino acids arginine (R) and lysine (K), and the 
best described among them is the classical NLS (cNLS), which is monopartite with a 
consensus sequence of (K/R) 4-6 (Dingwall and Laskey, 1991). The first cNLS was 
identified in simian virus 40 (SV40) large-T antigen (Kalderon et al., 1984). The NLS of 
large-T antigen was defined as a seven amino acids sequence (PKKKRKV), where all 
lysine residues appeared to be essential for the protein nuclear transport (Kalderon et al., 
1984). A different type of NLS  (KRPAATKKAGQAKKKK), which is composed of two 
basic domains and a ten amino acids spacer that tolerates site mutations, was identified in 
nucleoplasmin (Robbins et al., 1991). Since it contains two separate domains, it was 
called bipartite NLS. Though most NLSs are rich in basic amino acids residues, some 
NLSs do not ressemble the consensus sequence. While NLS activity in some proteins 
may be realized by their 3 dimensional structure (Boulikas, 1993), others may use 
different factors for their transportation (Lee et al., 2006a). Some proteins contain amino 
acids sequences that mediate their nuclear export, termed nuclear export signals that are 
rich in leucine residues (Fornerod et al., 1997).  
Protein nucleocytoplasmic transport is a complex process that starts with the 
interaction of NLS/NES containing target protein with nuclear transport factors. As 
shown in Fig 1.6, in the importin-α/β mediated nuclear import, importin-β can bind to the 
NLS of the target protein directly or by using importin-α as an adaptor. After the 
formation of transport factor-cargo complex, it binds to the cytoplasmic filament, and 
move toward the nucleus by sequential binding to specific nucleoporins inside the NPC. 
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In the nucleus, the importin-cargo complex is disrupted by the interaction of importin-β 
with Ran-GTP to release the cargo protein in the nucleus. The importin-Ran-GTP 
complex is recycled by being transported back to the cytoplasm where importins 
participate the next round of protein nuclear import (Wente and Rout, 2010). Nuclear 
export is a similar process where the binding of NES by exportins and the Ran-GTP form 
the nuclear export complex that is composed of cargo protein, exportins and Ran-GTP. 
After the translocation of the complex through the NPC to the cytoplasm, the hydrolysis 
of GTP to GDP disrupts the complex and leads to the release of the cargo protein into the 
cytoplasm (Wente and Rout, 2010). 
 
1.2.3 Nuclear transport receptor 
The NLSs/NESs are recognized and bound by karyopherin proteins that serve as 
nuclear transport receptors. The karyopherin protein family are subdivided into importins 
and exportins depending on their function in nuclear import or nuclear export, 
respectively. Importin-α recognizes and binds to classical NLSs and serves as the bridge 
between importin-β and cargo protein, while importin-β recognizes non-classical NLSs, 
such as PY-NLS that is rich of proline and tyrosine (Lee et al., 2006a). Nuclear transport 
receptors also contain domains that bind to nucleoporins and Ran-GTP (Bednenko et al., 
2003; Kutay et al., 1997).  
The Ran is a small GTPase that interacts with the transport receptor-cargo complex 
and regulates nuclear transport (Steggerda and Paschal, 2002). In the nucleus, the 
importin-cargo complex is disrupted by a conformational change in importin-β induced 
by the binding of Ran-GTP. The importin-Ran-GTP complex is then transported back to 
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Figure 1.6 Importin α/β mediated protein nuclear transportation. Adapted from (Flather 
and Semler, 2015; Kuersten et al., 2001), with permission to use. 
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the cytoplasm through the NPC. The Ran-GTP is hydrolyzed in the cytoplasm by Ran-
GTP-activating protein (Ran GAP) to Ran-GDP (Hutten et al., 2008), which causes the 
release of importins so that they can participate the next round of nuclear import. The 
newly generated Ran-GDP is transported back to the nucleus by NTF2, and then Ran-
GDP is transformed to Ran-GTP by Ran guanine nucleotide exchange factor Ran GEF 
(Macara, 2001). 
 
1.3 NUCLEOLUS 
The nucleolus is a prominent body in the nucleus. It is present in the nucleus during 
the interphase but not at the stage of mitosis. The nucleolus serves as a site for ribosome 
RNA transcription, processing and ribosome subunits biosynthesis (Sirri et al., 2008). Its 
size increases during ribosome synthesis (Altmann and Leblond, 1982; Kononowicz and 
Janick, 1988). 
 
1.3.1 Structure and functions of the nucleolus 
The nucleolus is a solid structure with deceptive appearance under the light or 
electron microscope. In eukaryotic cells, the nucleolus consists of three main blocks with 
different functions, including: fibrillar center (FC), dense fibrillar component (DFC) and 
granular component (GC), which functions as sites for ribosomal RNA (rRNA) 
transcription, processing and ribosome assembly, respectively (Caudron-Herger et al., 
2015).  
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1.3.1.1 Structure of the nucleolus 
The nucleolus is a structure composed of granules and fibrils. The low contrast 
areas of the fibrils are called FCs. The FCs contain rDNA as well as factors for rDNA 
transcription (Thiry, 1992), such as DNA polymerase I subunits, upstream binding factors 
(UBF) and DNA topoisomerase I (Thiry and Goessens, 1991). However, the rDNA 
transcription is detected at the interface between FCs and DFCs rather than in the FCs 
(Hozak et al., 1994). After the transcription, the pre-rRNA transcripts need to be 
processed to generate functional rRNAs (Casafont et al., 2007). DFCs are featured with 
densely packed filamentous materials. It contains nascent pre-rRNA transcripts, which 
are still attached to the rDNA and pre-rRNA transcripts complex with some proteins and 
small nucleolar RNAs (snoRNA) (Azum-Gelade et al., 1994; Nazar, 2004; Qiu et al., 
2008). The third block designated GC is featured with the presence of the granules, which 
are possibly pre-60S subunits at different stages of the assembly and the maturation 
process (Falini et al., 2007). The GC is the site for 60S ribosome subunits assembly 
because of the presence of proteins for the 5.8S and 28S rRNAs processing (Gadal et al., 
2002). Many other proteins involved in ribosome biosynthesis have been detected in the 
GC, such as B23 (nucleophosmin) (Falini et al., 2007), Nop52 (Yoshikawa et al., 2015), 
Bop1 (Rohrmoser et al., 2007), and ribosome RNA processing 1B (RRP1B) (Chamousset 
et al., 2010). It also has been reported that RRP1B containing complexes play functions 
at the middle and the late stages of 60S assembly (Chamousset et al., 2010). 
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1.3.1.2 Non-traditional Functions of Nucleolus 
Only 30% of the nucleolar proteins are involved in ribosome biosynthesis and 
suggests that the nucleolus may engage in functions other than ribosome biosynthesis 
(Ahmad et al., 2009). Recently, reports suggested that nucleolus might be involved in cell 
cycle regulation, p53 activity regulation and signal recognition particle (SRP) assembly. 
 
1.3.1.2.1 Role of nucleolus in regulating tumor suppressor p53 
Though p53 is involved in apoptosis induction and cell cycle regulation to respond 
the cell stress, the main function of the cellular protein p53 is to suppress tumor 
formation (Zilfou and Lowe, 2009). Some nucleolar proteins are found to regulate p53 
activities, which suggests the nucleous is involved in cell cycle regulation via p53 (Rubbi 
and Milner, 2003). The cellular protein murine double minute 2 (Mdm2), which is 
considered the major negative regulator of p53, can induce p53 degradation via its E3 
ubiquitin ligase activity to keep p53 at a stable level (Bouska and Eischen, 2009). 
The expression of another nucleolar protein ARF is inhibited in many different 
kinds of tumor cells suggesting that it also plays a role in tumor suppression (Maggi et 
al., 2014). ARF activates Mdm2 E3 ubiquitin ligase to inhibit the ribosome biosynthesis 
of tumor cells. One possible explanation is that AFR directly binds to Mdm2 to sequester 
it in the nucleolus; thereby stabilizing p53 because of the absence of Mdm2 (Tao and 
Levine, 1999). In addition to binding to Mdm2 alone, the ARF also interacts with a 
complex of p53 and Mdm2 to inhibit p53 ubiquitination and degradation (Kamijo et al., 
1998). In addition to the p53-denpendent AFR function, the antitumor activity of ARF 
also shows in p53-independent manner (Weber et al., 2000a). 
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The nucleophosmin (NPM) also known as B23, is one of the most abundant 
nucleolar proteins. It is a multifunctional protein involved in ribosome biosynthesis, pre-
rRNA splicing (Savkur and Olson, 1998) and RNase activity regulation (Herrera et al., 
1995). It is also involved regulating p53 oncogenesis by inhibiting (Li et al., 2004) and 
activating p53 activity (Grisendi et al., 2006). Overexpression of B23 inhibits the cell 
proliferation by directly binding to and activating p53 (Colombo et al., 2002). In addition, 
B23 stabilizes ARF by sequestering it in the nucleolus and ARF cannot be transported to 
the nucleolus without B23 (Colombo et al., 2005). On the other hand, tumor cells express 
higher levels of B23 than normal cells, which suggests B23 may be associated with 
oncogenesis and cell proliferation (Zhang, 2004). The activity of p53 is also inhibited by 
the interaction between B23 and ARF, which sequesters ARF in the nucleolus, thus not 
letting ARF stabilize and activate p53 (Colombo et al., 2005). 
Some ribosome proteins (Harpst et al., 1977 ) are also associated with the 
regulation of p53 activity (Dai and Lu, 2004; Dai et al., 2004; Lohrum et al., 2003). If 
ribosome biosynthesis is disrupted, RPs will be released from the nucleolus and directly 
interact with Mdm2 to prevent the Mdm2 mediated p53 degradation (Zhou et al., 2012). 
For example, p53 induced cell cycle arrest can be induced by dysfunction of proteins 
associated with pre-rRNA transcription, such as Wrd36 (Zhang et al., 2008), WDR12 
(Holzel et al., 2005) and Bop1 (Pestov et al., 2001). In addition, some drugs, like 
actinomycin D, can also disrupt the ribosome biosynthesis (Martinez-Ramon, 1979). Pre-
rRNA transcription can be inhibited by actinomycin D via the inhibition of RNA 
polymerase I activity, which facilitates the release of RPs and p53 mediated cell cycle 
arrest (Ginisty et al., 1999). NPs including RPL5, RPL11 and RPL23 antagonize Mdm2 
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activity by directly binding to it and inhibiting its E3 ubiquitin ligase activity (Dai and 
Lu, 2004; Dai et al., 2004; Lohrum et al., 2003). The RPS7, which is substrate of Mdm2 
E3 ubiquitin ligase, also binds to and inactivates Mdm2 (Zhu et al., 2009).  
 
1.3.1.2.2 Role of nucleolus in cell cycle regulation 
The nucleolar protein nucleostemin is involved in maintaining the continuous 
proliferation of cancer cells and stem cells, and has been found in the nucleoli of the 
neural stem cells and the embryonic stem cells (Tsai and McKay, 2002). Nucleostemin is 
member of the GTP binding protein family, with the GTP free form localized in the 
nucleoplasm while the GTP bound form is localized in the nucleolus. Deletion of 
nucleostemin causes cell cycle arrest at either G1/S or S/G2 phases in different tumor 
cells (Beekman et al., 2006). Overexpression of nucleostemin induces active cell 
proliferation in low nucleostemin expressing cells; while cell cycle was arrested at G1/S 
phase in high nucleostemin expressing cells (Dai et al., 2008). Besides regulating the cell 
cycle, nucleostemin is also involved in pre-rRNA processing since the splicing of 32S 
pre-rRNA to 28S rRNA is delayed after the knockout of nucelostemin (Romanova et al., 
2009). 
The function of nucleostemin in cell cycle regulation is achieved by its interaction 
with other proteins. The interaction of nucleostemin with Mdm2 stabilizes Mdm2 and 
improves its E3 ubiquitin ligase activity and sequesters it in the nucleoplasm to inhibit 
p53 activity (Meng et al., 2008). The interactions between Mdm2 and RPL5 or RPL11 
can be detected after the deletion of nucleostemin, which induces the stabilization and 
activation of p53 (Dai et al., 2008). In summary, the function of the nucleolus in cell 
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cycle regulation depends on the nucleolar protein nucleostemin, which inhibits p53 
activity by binding to and stabilizing Mdm2. 
 
1.3.1.2.3 Role of nucleolus in Signal recognition particle assembly 
Signal recognition particle (SRP) is a family of cytoplasmic RNA-protein 
complexes (RNP) that recognize and target membrane and secretory proteins in the 
endoplasmic reticulum (Janda et al., 2010). The SRP recognizes and binds to the signal 
peptide of a nascent protein to arrest the synthesis of the polypeptide, and then the protein 
is transported to the ER by the subsequent co-translational translocation (Shan and 
Walter, 2005). The SRP is a complex composed if 6 proteins, SRP9, SRP14, DRP16, 
SRP54, SRP64 and SRP72, and SRP RNA transcribed by RNA polymerase III (Walter 
and Johnson, 1994). Micrococcal nuclease cleaves SRP into the two domains and S 
domain. Alu domain is composed of SRP9 and SRP14; while S domain consists of the 
other 4 SRP proteins (Walter and Johnson, 1994). Different SRP proteins play different 
roles (Egea et al., 2008). For example, SRP 54 recognizes the peptide signal (Egea et al., 
2008), and SRP 68/72 are involved in the nascent protein translocation (Iakhiaeva et al., 
2009). The nucleolar localization of SRP components supports that the nucleolus is 
involved in the SRP assembly. The SRP RNA nucleolar localization has been 
demonstrated by situ hybridization and microinjection (Jacobson and Pederson, 1998). 
The S domain proteins SRP9 and SRP14 are localized only in the nucleolus (Andersen et 
al., 2002). Three Alu domain proteins ARP19, ARP68 and ARP72 are found in the 
nucleolus, the nucleoplasm and the cytoplasm, while the SRP54 is localized only in the 
cytoplasm (Politz et al., 2000). The nucleolar localization of SRP components suggests 
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that the nucleolus is partially involved in SRP assembly. Moreover, it is also likely that 
the nucleolus provides a potential site for SRP RNA processing since the nucleolar 
localization of SRP and the presence of RNA processing machinery in the nucleolus. 
 
1.3.2 Ribosome biosynthesis 
The most important function of the nucleolus is that it acts as a factory for ribosome 
assembly (Cmarko et al., 2008). In the nucleolus, rDNA is transcribed to a 47S pre-
rRNA; and then nascent pre-rRNA is processed to form mature rRNAs 5.8S, 18S and 
28S. Finally, the mature rRNAs bind to ribosome proteins to form 40S and 60S ribosomal 
subunits (Fig1.7) (Woolford and Baserga, 2013). 
 
1.3.2.1 rRNA transcription 
In eukaryotic cells, the ribosome contains four different kinds of rRNAs, including 
5S, 5.8S, 18S and 28S. Among them, 18S rRNA belongs to 40S small ribosome subunit, 
and the other three rRNAs belong to 60S large ribosome subunit. The 5.8S, 18S and 28S 
arise from the pre-47S rRNA transcript (Lafontaine, 2015). Transcription of pre-47S 
rRNA occurs in the nucleolus and is catalyzed by RNA polymerase I (Engel et al., 2013), 
while transcription of 5S rRNA is catalyzed by RNA polymerase III and occurs in the 
nucleoplasm (Costanzo et al., 2001). In addition to RNA polymerase I, the complex for 
rDNA transcription also contains TATA binding protein (TBP), upstream binding factor 
(UPF), several transcription activating factors (Gorski et al., 2007) and the transcription 
terminator (Bartsch et al., 1988). 
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Figure 1.7 The process of eukaryotic ribosome biosynthesis. Adapted from (Lafontaine, 
2015), with permission to use. 
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The higher eukaryotic cells contain rRNA genes in multiple copies to transcribe 
large amount of rRNA molecules. The human genome contains approximately 200 copies 
of gene that transcribes 5.8s, 18S and 28S rRNAs, and about 2000 copies of gene that 
encode 5S rRNA (Conrad-Webb and Butow, 1995). In human cells, five different 
chromosomes (13, 14, 15, 21 and 22) contain clusters of 5.8s, 18S and 28S rRNAs genes 
organized in tandem arrays, while there is only one tandem array of 5S rRNA gene on 
chromosome 1 (Henderson et al., 1972). The 5.8s, 18S, and 28S rRNA genes consists of 
a non-transcribed spacer and a transcribed sequence. The non-transcribed spacers are 
sites for the promoters and the terminators that are indispensable for RNA polymerase I 
transcription (Hillis and Dixon, 1991).  
  
1.3.2.2 rRNA processing 
In addition to 5.8S, 18S and 28S rRNAs, the nascent pre-rRNA 47S also contains 
spacer regions called external transcribed spacers (ETSs) and internal transcribed spacers 
(ITSs) (Kent et al., 2009). The ETSs are localized at both the 5’ and the 3’ ends of the 
47S pre-rRNA and the ITSs are present between 5.8S, 18S and 28S rRNAs (Kent et al., 
2009).  The transcription of pre-rRNA 47S is followed by different post-transcriptional 
manipulations, which splice and modify the pre-rRNA 47S into mature rRNAs for 
ribosome assembly. The pre-rRNA splicing starts with the removal of the 3’-ETS and 
cleavage within the 5’-ETS, followed by the cleavages to the ITSs to generae mature 
rRNAs (Fig 1.8). Besides splicing, a substantial amount of modifications at some ribose 
residues and bases are essential for rRNA maturation (Decatur and Fournier, 2002). Two 
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main types of modification occur; methylation of specific ribose residues and bases, and 
conversion of uridines to pseudouridines (Decatur and Fournier, 2002).  
Both pre-rRNA splicing and modification require nucleolar proteins and RNAs. A 
number of small nucleolar RNAs and more than 150 nucleolar proteins are involved in 
pre-rRNA processing (Nazar, 2004). Single snoRNAs complexes with approximately 10 
nucleolar proteins to form small nucleolar RNA proteins (snoRNP). Together multiple 
snoRNPs for a pre-mRNA spliceosome like complex with the pre-rRNAs to facilitate its 
processing (Fayet-Lebaron et al., 2009). U3 is one of the snoRNAs associated with pre-
rRNA splicing. It is the most abundant snoRNA in the nucleolus and involved in the 
cleavage within the 5’-ETS (Pleiss et al., 2007). In addition, snoRNA U22 is involved in 
maturation of 18S rRNA (Tycowski et al., 1994) and U8 is associated with the cleavages 
that generate the mature 5.8 and 28S rRNAs (Peculis, 1997). SnoRNAs also serve as 
guide RNA for pre-RNA base modifications. These snoRNAs guides contain an 
approximately 15-mer sequence that is complementary to pre-RNA and mediate 
snoRNPs binding to the modification sites (Kishore et al., 2013). Therefore, the snoRNAs 
functions as guide RNAs to direct enzymes responsible for pseudouridylation and 
methylation to correct modification sites on pre-RNA molecules by base paring (Kishore 
et al., 2013).  
 
1.3.2.3 Ribosome assembly 
The ribosome that assembles in the nucleolus, consists of 5S, 5.8S, 18S, 28S 
rRNAs and different types of ribosomal proteins. Its formation involves the assembly of 
nucleolus-synthesized rRNAs with both ribosomal proteins and another nuclear-  
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Figure 1.8 Pre-ribosomal RNA processing pathways in eukaryotic cells. Adapted from 
(Lafontaine, 2015), with permission to use. 
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synthesized rRNA 5S. These ribosomal protein genes are transcribed by RNA 
polymerase II. After translation of mRNAs in the cytoplasm, the ribosomal proteins are 
transported to the nucleolus and assemble with the rRNAs to form pre-ribosomal 
complexes. Another ribosome component, 5S rRNA, which is transcribed by RNA 
polymerase III outside of the nucleolus, is transported to the nucleolus and assembled 
into the ribosome (Ciganda and Williams, 2011).  
More than 200 assembly factors are spatially and temporally involved in ribosome 
assembly (Strunk et al., 2011), which starts while transcription is still in progress. Before 
pre-RNAs cleavage, more than half of the ribosomal proteins have been associated with 
them. For 5S rRNAs and the remaining ribosome proteins, they are incorporated into the 
assembling complexes during pre-RNAs cleavage (Calvino et al., 2015). The two 
ribosome subunits, 40S and 60S, are assembled separately. In higher eukaryotic cells, 
small 40S subunits are composed of 18S rRNAs and 45 additional proteins (Rabl et al., 
2011; Taylor et al., 2009). The assembly of 40S subunits is a stepwise process, in which 
several sub-ribosomal complexes can be detected (Krogan et al., 2004). The first purified 
sub-ribosomal complex is composed of 35S pre-rRNA, some ribosomal proteins, U3 
snoRNP and a number of non-ribosomal proteins (Grandi et al., 2002), suggesting that 
40S subunits assembly starts before pre-rRNAs processing. The pre-40S subunits change 
dramatically after the cleavage of pre-35S rRNAs mediated by U3 snoRNP, including the 
disassociation of non-ribosomal proteins and the recruitment of other ribosomal proteins 
(Schafer et al., 2003). The pre-40S particles are then transported to the cytoplasm where 
they become functional subunits after the maturation of 18S rRNAs (Fatica et al., 2003; 
Vanrobays et al., 2003). The assembly of 60S subunit is also a multistep process like 40S. 
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The 27SA and 28SB pre-rRNAs, ribosomal and non-ribosomal proteins were detected in 
the first purified pre-60S particles (Kressler et al., 2008); while no snoRNP was detected 
indicating that formation of an earlier pre-particle exists. The processing of pre-rRNAs in 
pre-60S particles is companied by the incorporation of ribosomal proteins and exchanges 
of non-ribosomal proteins (Kressler et al., 2008). Subsequently, the pre-60S particles are 
transported to the cytoplasm, followed by the release of non-ribosomal proteins such as 
Arx1 (Kressler et al., 2010), and the final processing of 5.8S rRNAs (Ansel et al., 2008; 
Gabel and Ruvkun, 2008). 
 
1.4 ADENOVIRUS pV 
Mastadenovirus members express two unique proteins, pV and pIX (Davison et al., 
2003). In HAdV-2, pV is encoded by the L2 region with other two late proteins, pVII and 
penton base protein (Davison et al., 2003). The HAdV-2 pV is essential for viral 
replication in primary cells, but not cancer cells (Ugai et al., 2012). As a structural 
protein, pV bridges the capsid and DNA core to stabilize the virion. Recently, the C-
terminus of pV has been shown to interact with pVI in the interior of adenovirus particle 
(Reddy and Nemerow, 2014). The pV also interacts with pVIII C-terminus. Therefore, 
these three proteins can form a ternary complex to glue the peripentonal hexons and 
connect them with adjacent group of nine hexons. Moreover, the basic amino acids rich 
N-terminus of pV may interact with the adenoviral genome to bridge the viral core with 
the capsid (Reddy and Nemerow, 2014). The interaction of pV and pVI also provide an 
insight of the pVI release into the endosome leading to the disruption of endosome 
membrane and release of partially disassembled adenovirus particle into the cytoplasm. 
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Figure 1.9 Amino acid homology of HAdV-5 and BAdV-3 pV. AAD09725.1 is the gene 
bank accession of BAdV-3 pV, and AP_000172.1 is the gene bank accession of HAdV-5 
pV. 
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In addition to acting as a structural protein, pV also interacts with cellular protein 
p32, which shuttles between the mitochondria and the nucleus. This interaction may 
mediate transport of partially uncoated adenovirus from the cytoplasm to the nucleus 
(Matthews and Russell, 1998a). In addition, pV has been detected to interact with 
nucleolar protein B23 and nucleolin. This interaction not only redistributes B23 and 
nucleolin from the nucleolus to the cytoplasm but also helps in dissociation of core 
proteins (Samad et al., 2007).  
Unlike HAdV-2 (Davison et al., 2003), the L2 region of BAdV-3 encodes only 
protein pV. BAdV-3 pV is 423 amino acids long and shows amino acids sequence 
identities of 40% to HAdV-5 pV protein (Reddy et al., 1998) (Fig 1.9). Moreover, pV is 
rich in basic amino acids residues, which indicates pV may be localized in the nucleus 
(Reddy et al., 1998). So far, BAdV-3 pV was shown to interact with another viral non 
structural protein 33K (Kulshreshtha et al., 2004). 
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2.0 HYPOTHESIS AND OBJECTIVES 
2.1 RATIONALE FOR HYPOTHESIS 
BAdV-3 has been studied and developed as a vector for vaccination and gene 
therapy because of the advantages it owns, such as low virulence, easy manipulation, 
growth to high titers in cultured cells and broad tropism. It is also a promising vector for 
human vaccination and gene therapy because the pre-existing human adenovirus 
immunity extensively influences the efficiency of human adenovirus-based vectored 
vaccines. Though the BAdV-3 genomic organization is similar to other mastadenovirus 
members, some distinct features have been observed, such as the cell receptor used for 
attachment, major late transcription unit organization and the absence of the viral-
associated RNAs. 
Unlike human adenovirus 5, which expresses penton, pVII, pV and pX, the L2 
region of BAdV-3 encodes only protein pV.  pV is a structural protein that bridges the 
capsid and viral genome to stabilize the viral particle. However, in addition to its role as a 
structural protein, pV may also play other functions in viral replication via its interaction 
with cellular proteins. It is possibly involved in viral transport from the cytoplasm to 
nucleus because it interacts with the mitochondria-nucleus shuttle protein p32. Moreover, 
pV redistributes nucleolar proteins B23 and nucleolin from the nucleolus to nucleoplasm 
and cytoplasm, suggesting pV may regulate nucleolar functions via interactions with 
nucleolar proteins.  
Viral protein interactions with other viral proteins or cellular proteins play 
indispensable roles in all steps of BAdV-3 replication. Identifying viral/cellular protein-
protein interactions and elucidating their mechanisms would be important to understand 
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BAdV-3 biology as well as the development of more efficient vaccine delivery vectors. 
BAdV-3 assembly occurs in the nucleus, while structural protein pV is located to the 
nucleolus in both transfected and infected cells.  
 
2.2 HYPOTHESIS 
We hypothesize that pV may interact with other viral or cellular proteins and plays 
additional biological functions in BAdV-3 replication rather than just being a structural 
protein.  
 
2.3 OBJECTIVES 
The specific goals of this project are: 
1)  To characterize pV expression, nuclear/nucleolar localization and determine the 
biological functions of pV nucleolar localization signals in BAdV-3 replication. 
2)  To elucidate the biological significance of pV in viral replication by isolating and 
analyzing pV deleted BAdV-3. 
3)  To identify viral/cellular proteins that interact with pV and study the biological 
functions of these interactions.  
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3.0 NUCLEOLAR LOCALIZATION OF BOVINE ADENOVIRUS pV AND ITS 
CONTRIBUTION TO VIRAL REPLICATION 
3.1 INTRODUCTION 
Bovine adenovirus BAdV-3, a member of the Mastadenovirus genus is a non-
enveloped icosahedral particle which contains a double stranded DNA genome of 34,446 
bp organized into early, intermediate, and late regions (Reddy et al., 1998). Despite 
similarity in genome organization with human adenovirus (HAdV)-5, BAdV-3 appears to 
possess certain distinct features (Bangari and Mittal, 2006; Idamakanti et al., 1999; 
Reddy et al., 1998; Xing and Tikoo, 2006, 2007; Xing et al., 2003) including organization 
of late (L) transcriptional unit into seven (L1-L7) regions in contrast to HAdV-5 (Reddy 
et al., 1998).  
The L2 region of HAdV-5 encodes a minor capsid protein named pV, which 
appears to associate with the viral genome and bridge the core and the capsid proteins 
(Chatterjee et al., 1985; Lehmberg et al., 1999; Matthews and Russell, 1998a; Vayda et 
al., 1983). pV appears to be essential for virus replication in primary cells but not in 
cancerous cells (Ugai et al., 2007). Protein V mainly localizes to the nucleolus utilizing a 
transportin dependent pathway (Hindley et al., 2007) and over expression of pV 
redistributes nucleolin and nucleophosmin to the cytoplasm (Matthews, 2001).   
The nuclear localization of a protein is a well-characterized process regulated by 
nuclear pore complexes (NPCs) and requiring active transport mechanisms and specific 
nuclear localization signal (NLS) sequences on the transported protein. Unlike the 
nucleus, the nucleolus is a membrane-free subnuclear structure involved in ribosome 
biogenesis, cell cycle regulation, cellular stress response, apoptosis and viral replication 
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(Salvetti and Greco, 2014). Nucleolar localization depends on the interactions of 
nucleolar constituents with specific protein sequences namely nucleolar localization 
signals (NoLS) usually rich in arginine and lysine (Reed et al., 2006). NoLS binds to 
nucleolar proteins or rRNA and acts as nucleolar retention signal (Zakhartchouk et al., 
2004) rather than a NoLS (Reed et al., 2006).  
Recently, we reported the characterization of late structural\non structural BAdV-3 
proteins and demonstrated that BAdV-3 52K (Paterson et al., 2012) and pVIII (Ayalew et 
al., 2014) utilize the importin / pathway to localize to the nucleus in infected cells, 
BAdV-3 33K utilizes both importin / and transportin 3 pathways for localization to the 
nucleus in infected cells (Kulshreshtha et al., 2014). 
The L2 region of the late transcription unit of BAdV-3 encodes pV, which is 
collinear with pV of HAdV-5 (Reddy et al., 1998). A recent report suggested that pV 
interacts with 33K in BAdV-3 infected cells (Kulshreshtha and Tikoo, 2008). Although 
homologs of pV have been identified in other members of Mastadenovirus genus, BAdV-
3 pV show 28%-41% amino acid identity with pV proteins of other Mastadenoviruses. 
Since it does not show significant similarity with pV encoded by other members of 
Mastadenovirus, we sought to characterize this protein in detail. Here, we report the 
characterization and identification of signals mediating nucleolar localization of BAdV-3 
pV, and demonstrate that nucleolar localization of pV is required for BAdV-3 replication.  
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3.2 MATERIALS AND METHODS 
3.2.1 Cells and viruses  
Madin Darby bovine kidney (MDBK), cotton rat lung (CRL) cells, VIDO DT1 
cells (CRL cells expressing endonuclease I-SceI) and CRL.pV (CRL cells expressing 
BAdV-3 pV) (Zhao and Tikoo, manuscript in preparation) cells were cultivated in 
minimal essential medium (MEM) (Sigma) supplemented with 10% heat-inactivated fetal 
bovine serum (FBS) (Invitrogen). Vero cells and HEK293T cells were propagated in 
Dulbecco’s modified eagle’s medium (DMEM) supplied with 10% FBS. BAV304a 
(BAdV-3 E3 region was replaced by a EYFP gene) and mutant BAdV-3s were cultivated 
in MDBK or CRL.pV cells.   
 
3.2.2 Antibodies 
The production and characterization of antisera raised against BAdV-3 DBP (Zhou 
et al., 2001), fiber (Wu and Tikoo, 2004) and 100K (Makadiya et al., 2015) have been 
described. Anti-hexon serum detects a protein of 98 kDa in BAdV-3 infected cells 
(Kulshreshtha et al., 2004). Anti-pVII serum detects two proteins of 22 and 20 kDa in 
BAdV-3 infected cells (Paterson, 2010). Anti-pX recognizes a protein of 25 kDa in 
BAdV-3 infected cells. 
To produce BAdV-3 pV specific sera, two peptides representing amino acid 1-24 
(XZ1) and amino acids 180-212 (XZ2) were synthesized by Genscript. Rabbits were 
immunized with individual (500 μg / rabbit) peptide conjugated to keyhole limpet 
haemocyanin emulsified with Freund’s complete adjuvant (Sigma) followed by two 
injections of ovalbumin conjugated individual peptide (300 μg/rabbit) in Freund’s 
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incomplete adjuvant (Sigma) three weeks apart. Sera were collected ten days after third 
injection and tested for specificity by Western blotting. Commercial antibodies used in 
this report are listed as follows:  
RPA194 Antibody (C-1) (Santa Cruz Biotechnology)  
Anti-β-actin monoclonal antibody (Sigma-Aldrich) 
Alexa Fluor 488-conjugated goat anti-rabbit IgG (Jackson Immunoresearch) 
TRITC-conjugated goat anti-mouse IgG (Jackson Immunoresearch) 
TRITC-conjugated goat anti-rabbit IgG (Jackson Immunoresearch) 
Alexa Fluor 647-conjugated goat anti-rabbit IgG (Invitrogen) 
Alexa Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen) 
 IRDye800 conjugated goat anti-mouse antibody (Rockland) 
 
3.3.3 Construction of plasmids  
Constriction of plasmids used in this section was depicted in the Appendix A. 
 
3.2.4 Isolation of pV nucleolar localization signal deleted BAdV-3 mutants 
To isolate mutant BAdV-3s, we constructed full-length BAdV-3 plasmids 
containing mutant BAdV-3 genomic DNAs as described (Chartier et al., 1996).  
a)  Plasmid pUC304a.pVd1. A 972 bp DNA fragment was amplified by PCR using 
primers M-F and d(21-50)-F1-R (Table 3.1), and plasmid pcV DNA as a template. 
Similarly, an 1134-bp DNA fragment was amplified by PCR using primers d(21-50) F2-F 
and pV-XhoI-R (Table 3.1), and plasmid pcV DNA as a template. In the third PCR, these 
two PCR fragments were annealed and used as DNA template to amplify a 2068-bp DNA 
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fragment by overlapping PCR using primers M-F and pV-XhoI-R (Table 3.1). A 1171-bp 
EcoRI-XhoI DNA fragment of the final PCR product (2068 bp) was isolated and ligated 
to EcoRI-XhoI digested plasmid pcDNA3 to create plasmid pcV.d1. A 528-bp EcoRI-
NheI DNA fragment of plasmid pcV.d1 was isolated and ligated to EcoRI-NheI digested 
pMCS.pV to create plasmid pMCS.pVd1.  
At last, a 6.2-kb EcoRV-Bst1107I fragment of plasmid pMCS.pVd1 was isolated 
and recombined with SbfI digested plasmid pUC304a.dV DNA in Escherichia coli 
BJ5183 (Chartier et al., 1996) to generate plasmid pUC304a.pVd1.  
b) Plasmid pUC304a.pVm123. A 986-bp DNA fragment was amplified by PCR using 
primers M-F and M12-F1-R (Table 3.1) and plasmid pcV DNA as a template. Similarly, 
a 1025-bp DNA fragment was amplified by PCR using primers M12-F2-F and pV-XhoI-
R (Table 3.1), and plasmid pcV DNA as a template. In the third PCR, two fragments 
were annealed and used to amplify a 2159-bp DNA fragment by overlapping PCR using 
primers M-F and pV-XhoI-R (Table 3.1). At last, a 1261-bp EcoRI-XhoI DNA fragment 
of the PCR product (2159 bp) was isolated and ligated to EcoRI-XhoI digested plasmid 
pcDNA3 to generate plasmid pcDNA3-pV-m12. 
To create pcV.m123, a 1059-bp DNA fragment was amplified by PCR using 
primers M-F and M3-F1-R (Table 3.1), and plasmid pcDNA3-pV-m12 as a template. An 
1141-bp DNA fragment was amplified by PCR using primers M3-F2-F and pV-XhoI-R 
(Table 3.1), and plasmid pcDNA3-pV-M12 DNA as a template. In the third PCR, these 
two DNA fragments were annealed and used to amplify a 2159-bp DNA fragment by 
overlapping PCR using primers M-F and pV-XhoI-R (Table 3.1). Finally, a 1261-bp 
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DNA fragment of the PCR product (2159-bp) was isolated and ligated to EcoRI-XhoI 
digested plasmid pcDNA3 to generate plasmid pcV.m123. 
A 618-bp EcoRI-NheI fragment of plasmid pcV.m123 was isolated and ligated to 
EcoRI-NheI digested plasmid pMCS.pV to create plasmid pMCS.pVm123. The SbfI 
digested plasmid pUC304a.dV was recombined with a 6.3-kb EcoRV-Bst1107I DNA 
fragment of plasmid pMCS.pVm123 in Escherichia coli BJ5183 (Chartier et al., 1996) 
creating plasmid pUC304a.pVm123. 
c) Plasmid pUC304a.pVd3 and pUC304a.pVd1d3. An 1171-bp fragment was amplified 
by PCR using primers pV-EcoRI-F and F1-R (Table 3.1), and plasmid pMCS.pV DNA as 
a template. Similarly, a 661-bp fragment was amplified by PCR using primers pV-d(380-
389) F2-F and dV-F2-R (Table 3.1), and plasmid pMCS.pV DNA as the template. In the 
third PCR, two PCR fragments were annealed and used to amplify a 1790-bp DNA 
fragment by overlapping PCR using primers pV-EcoRI-F and dV-F2-R (Table 3.1). At 
last, a 650-bp SacI-HpaI fragment of PCR product (1790-bp) was isolated and ligated to 
SacI-HpaI digested plasmid pMCS.pV and pMCS.pVd1 to create plasmid pMCS.pVd3 
and pMCS.pVd1d3, respectively.    
The SbfI digested plasmid pUC304a.dV was recombined with a 6.2-kb EcoRV-
Bst1107I fragment of plasmid pMCS.pVd3 or plasmid pMCS.pVd1d3 in Escherichia coli 
BJ5183 (Chartier et al., 1996) to generate plasmid pUC304a.pVd3 and plasmid 
pUC304a.pVd1d3, respectively. 
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Table 3.1 List of primers used for PCR. 
Name Sequence 
M-F                          5’- TCTGCTCTGA TGCCGCATAGTTAAGCC 
d(21-50)-F1-R          5’- CGCTTTCTAGAGCCGCGGTAAATCTCAGGCGCCACGA 
TGTC 
d(21-50)-F2-F          5’-TCGTGGCGCCTGAGATTTACCGCGGCTCTAGAAAGCGGG  
CCTTG  
pV-XhoI-R               5’-AATACTCGAGAGCGCTTAACGGCGGAGCCGGGTTAC-3 
M12-F1-R               5’-CTGCAGCAGCTGCTGCGGGTGCAGCTCCTGCGTAAATCTC  
AGGCGCCACGATG 
M12-F2-F 5’-CGCAGGAGCTGCACCCGCAGCAGCTGCTGCAGCACCGTA  
TGCTGTGAAG 
M3-F1-R 5’-TTTCTAGAGCCGCGAGCAGCTGCTGCCTCCGCCTTTACTA 
AAGGCTTCTC 
M3-F2-F 5’-TTAGTAAAGGCGGAGGCAGCAGCTGCTCGCGGCTCTAG 
AAAGCG GGCCTTG 
pV-EcoRI-F           5’-GGAGCC GAATTCATGGCCTCCTCTCGGTTGATTAAAGAAG 
pV-d(380-
389) F1-R 
5’-CAGCGCTGAGGCGGGGAGTCGCGACTGCAGGCAGGC 
GCACAC 
pV-d(380-
389) F2-F   
5’-GTGTGCGCCTGCCTGCAGTCGCGACTCCCCGCCTCAGCG 
CTG 
dV-F2-R 5’-GTCC-ATGGCGTGTTAACAAGCTGTG 
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3.2.5 Western blotting 
Protein in purified recombinant BAdV-3s or infected cells were separated by 10% 
SDS-PAGE, transferred to nitrocellulose membrane and probed by Western blot using 
protein specific antisera and alkaline phosphatase (AP)-conjugated goat anti-rabbit IgG 
(Sigma) or Alexa Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen). 
 
3.2.6 Immunofluorescence microscopy 
Cells infected with BAV304a or mutant BAdV-3, or transfected with plasmid 
DNAs were fixed with 3.7% paraformaldehyde for 15 min and permeabilised with PBS 
supplied with 0.5% Triton X-100. Cells were then blocked with 5% goat serum and 
stained with protein specific sera and fluorophor conjugated goat anti-rabbit antibody 
(Jackson Immunoresearch). Finally, cells were mounted by mounting buffer (Vector 
Laboratories Inc.) with DAPI and imagined under confocal microscope TCS SP5 (Leica).  
 
3.2.7 GST-pull down assay 
GST fusion proteins (Importin α1, α3, α5, α7, β1 or transportin-1) were purified 
from plasmids transfected E.coli BL21 by glutathione sephorose beads (GE Healthcare).  
[35S] Methionine-labeled pV was synthesized and labeled by TNT T7 Quick 
Coupled Transcription/Translation System (Invitrogen). After incubation of GST fusion 
proteins and [35S] methionine-labeled pV overnight, the samples were separated by 10% 
SDS-PAGE. After exposure, the phosphor screen was scanned and analyzed by 
Molecular Imager FX (Bio-Rad). 
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3.2.8 Isolation of mutant BAdV-3s 
Monolayers of VIDO DT1 (CRL cells expressing I-SceI recombinase) cells or CRL.pV 
(CRL cells expressing BAdV-3 pV) cells in six-well plate were transfected with 5-7.5 ug 
of individual plasmid DNA with Lipofectamine 2000 (Invitrogen). At 4 hrs post-
transfection, the media were replaced with fresh MEM containing 2% FBS. Transfected 
cells showing cytopathic effect (CPE) were harvested, freeze-thawed three times and 
propagated in MDBK cells. 
 
3.2.9 CsCl gradient centrifugation 
Monolayers of MDBK or CRL.pV (CRL cells expressing BAdV-3 pV) cells in T-
150 flasks were infected with wild type or mutant BAdV-3s at a multiplicity of infection 
of 5. At 48 h post-infection, the cells were collected and resuspended in 5ml medium. 
After freeze thawing three times, the cell lysates were subjected to CsCl density gradient 
centrifugation at 35 000 rpm for 1 hr at 4C. The bands containing viruses were collected, 
and subjected to a second centrifugation at 35 000 rpm for 16 hrs at 4C. At last, the virus 
band was collected, dialyzed three times to remove the trace amount of cesium chloride 
and stored in small aliquots at -80C. 
 
3.2.10 Virus single cycle growth curve 
Monolayers of MDBK cells in 24-well plates were infected with wild type or 
mutant BAdV-3s at a MOI of 1. At indicated time points post infection, the infected 
cells were harvested, lysed by freeze-thawing three times to release the virus into 
medium, and then used to determine virus titers by TCID50 in CRL.pV cells. 
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3.2.11 Protein expression analysis 
Monolayers of MDBK in six-well plate were infected with BAV304a or mutant 
BAdV-3s at MOI of 1. At 24h post-infection, infected cells were harvested and probed 
by Western blot using protein-specific rabbit antisera and mouse anti-β-actin as primary 
antibodies (Sigma), Alexa Fluor 680 goat anti-rabbit (Invitrogen) and IRDye 800 goat 
anti-mouse (Rockland), respectively, as secondary antibodies. At last, the membranes 
were imagined and analyzed by using the Odyssey® CLx Imaging System (LI-COR). 
 
3.2.12 Virus thermostability assay 
To determine the thermostability of BAV304a and mutant BAdV-3s, 105 purified 
infectious viral particles were incubated at different temperatures (-80C, -20C, 4C, 
25C and 37C) for three days in PBS containing 10% glycerol. To assess the different 
dynamics of viral inactivation, 105 infectious purified viral particles were incubated at 
different temperatures (-80C, 4C and 37C) for 0, 1, 3 and 7 days in PBS containing 
10% glycerol. At last, TCID50 was used to titrate the remaining infectivity. 
 
3.2.13 Transmission electron microscopy 
Monolayers of MDBK cells were infected with BAV304a or BAV.pVd1d3 at MOI 
of 5. At 48 h post-infection, the cells were harvested and fixed with 2.5% glutaraldehyde 
in 0.1 M PBS, followed by post-fixation in 1% OsO4 and dehydration in a graded ethanol 
series and propylene oxide. Dehydrated cells were infiltrated in mixtures of propylene 
oxide and EMbed-812 embedding medium, and then polymerized in embedding capsules 
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at 60C for 24-48 h. At last, the pellet was sectioned with a Reichert ultracut microtome, 
each section was stained with 2% uranyl acetate and viewed on a Philips CM10 TEM. 
 
3.3 RESULTS 
3.3.1 Expression of pV during BAdV-3 infection 
To characterize BAdV-3 pV, peptides ZX1 (1MASSRLIKEEMLDIVAPEIY 
KRKR24) and peptide ZX2 (180SRKRGVGKVEPTIQVLASKKRRMA212) were 
synthesized and used to generate anti-pV sera designated as XZ1 and XZ2 sera, 
respectively. The specificity of the sera was analyzed by Western blot using BAdV-3 
infected MDBK cells. As seen in Fig 3.1A, both XZ1 serum and XZ2 serum detected a 
protein of 55 kDa in BAdV-3 infected cells. No such protein could be detected in mock-
infected cells using XZ1 or XZ2 sera or BAdV-3 infected cells using pre-bleed sera. The 
protein could be detected at 24-48 hrs post infection (panel B lanes 6-8) but not at 12 hrs 
post infection (panel B lane 5).  Similarly, anti-pV pooled sera detected a 55 kDa protein 
in HEK293T cells transfected with plasmid pcDNA3-pV (pcV) (Fig 3.1C, lanes 3-4) 
DNA. No such protein could be detected in plasmid pcDNA3 DNA transfected cells (Fig 
3.1C, lane 5).  
 
3.3.2 Subcellular localization of pV 
To determine the subcellular localization of pV, CRL cells were transfected with 
plasmid pDsRed.B23 (Gomez Corredor and Archambault, 2009) and infected with 
BAdV-3 at 48 hrs post-transfection. At 24 hrs post-infection, the cells were analyzed by 
indirect immunofluorescence assay using anti-pV serum.  As seen in Fig 3.1D, pV co-
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localized predominantly with nucleolar protein B23 fused to DsRed (pDsRed.B23) 
suggesting that pV localizes in the nucleolus of the infected cells. To determine if 
nucleolar localization is dependent on other viral proteins, we determined the localization 
of pV in Vero cells co-transfected with plasmid pcV and pDsRed.B23 DNAs by 
florescence microscopy. As seen in Fig 3.1D, pV co-localizes predominantly with 
nucleolar marker B23 fused to DsRed in the nucleolus of the co-transfected cells. 
 
3.3.3 Identification of pV nucleolar localization signal 
Bioinformatic analysis of pV protein sequence using motif prediction algorithms by 
such as “PredictProtein”predicted that the amino acids 21KRKRPRRERAAPYAVKQ 
EEKPLVKAERKIK50, 190RKRGVGKVEPTIQVLASKKRR210 and 380RRRRRRRTRR 
389 of BAdV-3 pV may act as potential nuclear localization signals (NLSs) (Fig 3.2A). To 
determine if these domains act as NLS, we constructed plasmids expressing mutant pV 
containing specific NLS domain deletions (Fig 3.2B).  Vero cells co-transfected with 
plasmid pDsRed.B23 DNA and individual plasmid DNA expressing mutant pV protein 
were analyzed with immunofluorescence assay at 48 hrs post transfection. As seen in Fig 
3.2C, the mutant pV containing deletion of amino acid 21-50 (V.d1) localized both in the 
nucleus and the nucleolus of the transfected cells. Similarly, mutant pV containing 
deletion of amino acid 380-389 (V.d3) localized both in the nucleus and the nucleolus of 
the transfected cells. However, mutant pV containing deletion of amino acid 190-210 
(V.d2) localized in the nucleolus of the transfected cells. Interestingly, mutant pV 
containing a deletion of amino acids 21-50 and 190-210 (v.d1d2) or deletion of amino 
acids 190-210 and 380-389(V.d2d3) could be detected in the nucleus and  
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Figure 3.1 Expression of pV. Proteins from BAdV-3 infected MDBK cells A,B) and 
indicated plasmid DNA transfected cells C) (lane 2 and 3) or mock infected/transfected 
cells were harvested at different time points, separated by SDS-PAGE and transferred to 
nitrocellulose membrane. The separated proteins were probed by Western blot using anti-
pV serum. The position of the molecular weight marker (lane M) in kD was used for 
sizing the protein bands.  D) CRL cells were transfected with plasmid pDsRed.B23 DNA 
and infected by BAdV-3 (panels a-d) or co-transfected with plasmid pcV and 
pDsRed.B23 DNAs  (panels e-h) and fixed at 24 hours post-infection\transfection. The 
DsRed.B23 was visualized by direct fluorescence microscopy (panels b,f). BAdV-3 pV 
was visualized by indirect immunofluorescence microscopy (panels c,g) using anti-pV 
antiserum and Alexa Fluor 488-conjugated goat anti-rabbit IgG. The nuclei were stained 
with DAPI.  
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Figure 3.2 Analysis of BAdV-3 pV nucleolar localization signals. A) Schematic 
representation of BAdV-3 pV. The thick black line represents BAdV-3 pV. The numbers 
below represent amino acids of pV. Potential nuclear localization signal (NLS) and 
nucleolar localization sequences (NoLS1 and NoLS2) are depicted. The name of the 
plasmid is depicted on the right. B) Schematic diagram represents mutant pV. Thick 
black lines represent pV gene, thin black lines represent the deleted regions. The name of 
the plasmid is depicted on the right. C) Sub cellular localization of pV mutants. Vero 
cells were transfected with those plasmids expressing pV and mutant pV genes 
individually and fixed with 4% formaldehyde at 48h post-transfection. BAdV-3 pV was 
visualized by indirect immunofluorescence using anti-pV antiserum and Alexa Fluor 488-
conjugated goat anti-rabbit IgG (Jackson Immunoresearch). Nuclei were stained with 
DAPI and nucleoli were visualized with indirect immunostaining by using RPA194 
Antibody (C-1) (Santa Cruz Biotechnology) and TRITC-conjugated goat anti-mouse IgG 
(Jackson Immunoresearch).  
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nucleolus of the transfected cells. In contrast, mutant pV containing the deletion of amino 
acids 21-50 and 380-389 (pV.d1d3), or deletion of amino acids 21-50,190-210 and 380-
389 (V.d1d2d3) localized predominantly in the nucleus of the transfected cells. 
Earlier, Weber et al (Weber et al., 2000b) suggested that the basic amino acid rich 
sequence K/R-K/R-X-K/R, wherein X stands for any amino acids, may play a role in 
protein nucleolar localization. Our analysis of NoLS1 (amino acid 20-50) and NoLS2 
(amino acid 380-389) sequence identified three motifs  (21KRKR24, 26RRER29 and 
47RKIK50) in NoLS1, which have the potential to act as NoLS (Fig 3.3A). To determine 
the role of each motif (m1, m2, m3) in nucleolar localization, we constructed a panel of 
plasmids expressing mutant pV proteins (amino acid 380-389 deleted) in which the basic 
residues of identified potential NoLS motifs were replaced with glycine\alanine residues 
(Fig 3.3A). Vero cells were co-transfected with plasmid pDsRed.B23 and individual 
plasmid DNA expressing mutant pV protein, and analyzed with immunofluorescence 
assay using anti-pV sera. As seen in Fig 3.3B, pV is predominantly localized in the 
nucleolus of cells transfected with plasmids expressing mutant pV containing amino acid 
substitution in single motif (V.m1d3, V.m2d3, V.m3d3,) or double motif (V.m1m2d3, 
V.m2m3d3, V.m1m3d3). In contrast, pV is predominantly localized in the nucleus of the 
cells transfected with plasmid expressing mutant pV containing basic amino acid 
substitution in all three potential NoLS (V.m1m2m3d3). To confirm the nucleolar 
retention function of BAdV-3 pV amino acids 21-50 and 380-389, DNA fragments 
encoding amino acids 21-50 and 380-389 were fused in-frame with enhanced yellow 
fluorescent protein (EYFP) gene to create plasmids pNoLS1.EY and pNoLS2.EY 
expressing fusion proteins (Fig 3.3C). Vero cells co-transfected with plasmid 
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pDsRed.B23 DNA and either plasmid pNoLS1.EY DNA or plasmid pNoLS2.EY DNA 
were analyzed by confocal microscopy at 48 hrs post transfection. As seen in Fig 3.3D, 
EYFP was detected both in the nucleus and the cytoplasm of the transfected cells as 
EYFP could diffuse passively in the nucleus due to its small size (26 kDa). In contrast, 
NoLS1 (amino acids 21-50) and NoLS2 (amino acids 380-389) were able to direct the 
heterologous protein (EYFP) predominantly to the nucleus and the nucleolus of the 
transfected cells.  
 
3.3.4 Identification of pV nuclear localization signal 
To determine the nuclear localization signal(s) of BAdV-3 pV, we constructed 
plasmids expressing mutant BAdV-3 pV containing truncations and \ or internal deletions 
(Fig 3.4A).  Vero cells were transfected with individual recombinant plasmid DNA. At 
48 hrs post transfection, transfected cells were analyzed by indirect immunofluorescence 
using anti-pV sera. As seen in Fig 3.4B, mutant pV containing deletions of amino acids 
191-423 (V.d4, V.d5, V.d6 and V.d7) appear to be localized in the nucleus of the 
transfected cells. Moreover, mutant pV containing deletion of amino acid 21-50 and 190-
423 (V.d8) also localized to the nucleus of the transfected cells. As expected, V.d4, V.d5 
and V.d7 (contain one or both identified NoLS) localized to the nucleolus of the 
transfected cells, while V.d6 (absence of identified NoLS1 and 2) localized to the nucleus 
of the transfected cells. In contrast, analysis of mutant V.d9 (containing deletion of amino 
acids 21-50+101-210+380-423), V.d10 (containing deletion of amino acid 2-100+190-
210+380-423) and V.d11 (containing deletion of amino acids 21-50+81-120+190-210 
+380-423) suggested that amino acids 21-50, 81-120, 190-210 and 380-423 might  
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Figure 3.3 Mutation analysis of pV NoLS1. A) Schematic representation of BAdV-3 
pV depicting the amino acid sequence of NoLS1. The thick line represents BAdV-3 pV 
gene. The thin line represents deleted region. The basic residue rich motifs (m1, m2, m3) 
are shown in different font size or indicated by small black bar. The numbers above 
represent amino acid of BAdV-3 pV. The name of the plasmids is depicted on the right of 
the panel. B) Sub cellular localization of pV mutants. Vero cells were co-transfected with 
plasmid pDsRed.B23 and individual indicated plasmid DNAs. At 48h post-transfection, 
cells were fixed with 4% formaldehyde. BAdV-3 pV NoLS1 mutant proteins were 
visualized by indirect immunofluorescence microscopy using anti-pV antiserum and 
Alexa Fluor 488-conjugated goat anti-rabbit IgG (Jackson Immunoresearch). The 
DsRed.B23 was visualized by direct fluorescence microscopy. Nuclei were stained with 
DAPI. C) Schematic representation of fusion protein containing BAdV-3 pV NoLSs. The 
white box represents BAdV-3 pV nucleolar localization signals amino acids 21-50 or 
380-389. The black box represents the EYFP gene. The numbers above represent amino 
acids of BAdV-3 pV. D) Sub cellular localization of fusion protein NoLS-EY. Vero cells 
were co-transfected with individual indicated plasmid expressing fusion proteins and 
pDsRed.B23 DNAs, and fixed with 4% formaldehyde at 48h post-transfection. The 
DsRed.B23 (panel c, g, k) and EYFP (panel b, f, j) were visualized by direct fluorescence 
microscopy. Nuclei were stained with DAPI (panel a, e, i).  
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contain nuclear localization signal(s) motifs, which may have redundant function. To 
further determine the importance of these sequences in nuclear localization of pV, we 
constructed plasmids (Fig 3.4C) containing deletion of three of the four regions of pV 
containing potential NLS.  Vero cells were transfected with individual plasmid DNAs 
and subcellular localization of mutant pVs were analyzed at 48 hrs post transfection by 
indirect immunofluorescence using anti-pV sera. As seen in Fig 3.4D, mutant pV 
containing amino acids 81-120 (V.d12), 190-210 (V.d13) or amino acid 380-423 (V.d14) 
localized to nucleus\nucleolus. In contrast, mutant pV containing amino acid 21-50 
(V.d15) localized predominantly in the cytoplasm of the transfected cell. 
To examine if pV NoLSs can serve as NLSs, plasmids expressing pV.d16 
(containing deletion of amino acids 81-120+190-210+390-423) (Fig 3.4C) and NoLS1-
GFPβGal (Fig 3.4E) were constructed and used to transfect Vero cells. As shown in Fig 
3.4D and F, pV.d16 and NoLS1-GFPβGal were localized in nucleus and cytoplasm, 
respectively. 
 
3.3.5 Interaction of pV with importins 
Members of the importin super family play an important role in nuclear transport of 
proteins. Since transport of some adenovirus proteins requires importins (Kohler et al., 
1999; Kulshreshtha et al., 2014; Paterson et al., 2012; Wodrich et al., 2006), we 
performed a GST pull down assay using purified GST-fusion proteins of importin 1, 
importin 3, importin 5, impotin 7 or importin 1 individually immobilized on 
glutathione-sepharose beads with radiolabelled in vitro synthesized BAdV-3 pV. As seen 
in Fig 3.5A, GST-importin α3 was able to bind pV (lane 5) as similar protein was  
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Figure 3.4 Analysis of BAdV-3 pV nuclear localization signals. A, C) Schematic 
representation of pV mutants. The thick black line represents BAdV-3 pV gene. Thin 
black line represents the deleted regions. The numbers above represent amino acids of 
BAdV-3 pV. The name of the plasmid is depicted on the right. B, D) Sub cellular 
localization of pV mutants. Vero cells were transfected with individual indicated plasmid 
DNA and fixed with 4% formaldehyde at 48h post-transfection. BAdV-3 pV mutants 
were visualized by immunofluorescence using anti-pV antiserum and TRITC-conjugated 
goat anti-rabbit IgG (Jackson Immunoresearch). Nuclei were stained with DAPI. E) 
Schematic representation of GFP-βGal fusion protein containing BAdV-3 pV NoLS1. 
The white box represents BAdV-3 pV NoLS1 amino acids 21-50. The black box 
represents the fusion protein GFP-βGal. The numbers above represent amino acids of 
BAdV-3 pV. The name of the plasmid is depicted on the right. F) Sub cellular 
localization of fusion protein NoLs1-GFP-βGal. Vero cells were transfected with those 
plasmids individually, and fixed with 4% formaldehyde at 48h post-transfection. The 
GFP-βGal visualized with direct fluorescence microscopy. Nuclei were stained with 
DAPI. 
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observed in input protein control (lane 1). No radiolabelled pV was observed when 
purified GST alone (lane 7) or GST fusions of importin 1 (lane 2), importin 7 (lane 3), 
importin 5 (lane 4) or importin 1 (lane 6) bound to glutathione-sepharose beads were 
used in pull down assays. 
Like pV (Fig 3.5C,D), GST-importin 3 bound to glutathione-sepharose was able 
to bind radiolabeled pV.d18 (deletion of amino acids 190-210 and 380-423), pV.d19 
(deletion of amino acids 81-120 and 190-210) and pV.d17 (deletion of amino acids 81-
120 and 380-423) albeit with less intensity. However, no such interaction was observed 
when GST-importin 3 fusion bound to glutathione-sepharose was used to pull down 
pV.d15 containing deletion of amino acids 81-120, 190-210 and 380-423. Intriguingly, 
two additional bands were detected in the pV.d15 only lane. 
Recently, we demonstrated that BAdV-3 33K interacts with transportin-3 
(Kulshreshtha et al., 2014). To determine if pV binds to transportin-3 (Hindley et al., 
2007; Kulshreshtha et al., 2014), GST pull down assay was performed using GST alone 
or GST-Transportin fusion protein and in vitro [35S] methionine labeled pV. As seen in 
Fig 3.5B, a protein could be observed in input protein control (lane 1). However, no 
similar protein could be detected bound to GST-TRN-SR2 (transportin-3) fusion protein 
(Lane 2) or GST alone (lane 3). 
 
3.3.6 Construction of BAdV-3s expressing mutant pV proteins 
To determine if the potential NoLSs are required for efficient replication of BAdV-
3, we constructed full length plasmid genomic clones expressing mutant pV containing  
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Figure 3.5 In vitro interaction of pV with transport receptors. A) In vitro interaction 
of pV with importin α3. In vitro synthesized and [35S]-labelled BAdV-3 pV was 
incubated with purified GST fusion proteins (GST fused with importin α1, α3, α5, α7, β1, 
or transportin 3) or GST alone and pulled down with glutathione sepharose beads (GE 
Healthcare). B) Schematic representation of pV mutants. The thick black line represents 
BAdV-3 pV gene. Thin broken line represents the deleted regions. The numbers above 
represent amino acids of BAdV-3 pV. The name of the plasmid is depicted on the right. 
C) In vitro interaction of pV mutants with importin α3. In vitro synthesized and [35S]-
labelled BAdV-3 pV mutants were incubated with purified GST-α3 or GST alone and 
pulled down with glutathione sepharose beads. Samples form (A) and (C) were separated 
by 10% SDS-PAGE and exposed to a phosphor screen. The exposed phosphor screen was 
visualized by Molecular Imager FX (Bio-Rad). 5% of the input radiolabelled pV mutants 
were used as control.  
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deletion of potential NoLSs and \ or substitutions of basic residues with alanine\glycine 
of potential NoLS1 (Fig 3.6A). Monolayer of VIDO DT1 (cotton rat lung cells 
expressing I-Sce1 recombinase) cells were transfected with 5-7.5 μg of individual 
plasmid DNAs. The cytopathic effects appeared between 9-15 days (Fig 3.6B). However, 
repeated transfection of VIDO DT1 (cotton rat lung cells expressing I-SceI recombinase) 
cells with plasmid pUC304a.pVd1d3 did not produce any cytopathic effects. Moreover, 
reinfection of fresh VIDO DT1 (cotton rat lung cells expressing I-SceI recombinase) with 
supernatants of infected cell lysates containing mutant viruses (Fig 3.6A) named 
BAV.pVd1 (deletion of amino acid 21-50), BAV.pVm123 (containing substitutions of 
basic residues of all three motifs of amino acids 21-50) and BAV.pVd3 (containing 
deletion of amino acids 380-389) produced infectious virions. In contrast, reinfection of 
fresh VIDO DT1 (cotton rat lung cells expressing I-SceI recombinase) with supernatant 
of cell lysates potentially containing mutant BAV.pVd1d3 (containing deletion of amino 
acid 21-50 and amino acid 380-389) did not produce any infectious virion (Data not 
shown). To produce mutant BAV.pVd1d3, CRL.PV cells (CRL cells expressing BAdV-3 
pV) were transfected with 5-7.5 μg of PacI digested plasmid pUC304a.pVd1d3 DNA. 
The cytopathic effects were observed in 13 days (Fig 3.6B). To purify the mutant viruses, 
the MDBK cells infected individually with BAV.pVd1, BAV.pVm123 or BAV.pVd3  
(Fig 3.6A) or CRL.PV cells infected with BAV.pVd1d3 were collected, freeze-thawed 
and purified by CsCl density gradient purification. 
The presence of the desired mutations was confirmed by DNA sequencing and 
restriction enzyme digestion of virion DNAs. Since an additional XbaI recognition site 
was introduced into mutant BAV.pVd1 or BAV.pVm123 genomes, the viral genomes 
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were digested with XbaI. As seen in Fig 3.6C, BAV.pVd1 (Lane 1) and BAV.pVm123 
(lane 3) genomes had a band of 2.4 kb, which was missing in BAV304a (lane 2). Similar 
analysis of XbaI digested BAVd1d3 (lane 9) genome detected an expected band of 2.4 
kb, but not in BAV304a (lane 8). Since an additional PstI recognition site was introduced 
to the viral genome BAV.pVd3, the viral genome was digested with PstI. As seen in Fig 
3.6C, a 3.2 kb band was detected in BAV304a (lane 5) but not in BAV.pVd3 (lane 4). 
Similar analysis of PstI digested BAV.pVd1d3 genome detected an expected band of 3.2 
kb in BAV304a (lane 6) but not in BAV.pVd1d3 (lane 7). 
The ability of the mutant BAdV-3s to express pV protein was analyzed by Western 
blot analysis of proteins from the lysates of virus infected cells. As seen in Fig 3.6E, 
protein bands of expected molecular weight could be detected in lysates of CRL cells 
infected with mutant BAV.pVd1, BAV.pVm123, BAV.pVd3 or BAV.pVd1d3. The 
ability of mutant BAV.pVd1d3 to express pV protein was analyzed in both CRL and 
CRL.pV (CRL expressing BAdV-3 pV) cells. As expected, two proteins of 55 kDa 
(representing wild-type pV expressed in CRL.pV cells) and 53 kDa (representing mutant 
pV expressed in BAV.pVd1d3) were detected in lysates of CRL.pV cells infected with 
BAV.pVd1d3, while only the 53 kDa band was detected in CRL cells infected with 
BAV.pVd1d3. 
 
3.3.7 Sub cellular localization of mutant pV protein in recombinant BAdV-3 
infected cells 
To determine the effect of deletions or amino acid substitutions on nucleolar 
localization of pV, CRL cells were transfected with plasmid pDsRed.B23 DNA. At 48 
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hrs post transfection, the cells were infected with BAV304a or individual mutant BAdV-
3s. At 24 hrs post infection, the cells were analyzed by immunofluorescence using anti-
pV sera. As seen in Fig 3.6F, pV appears localized mainly in the nucleoli of BAV304a or 
BAV.pVd1 infected cells. Similarly, pV appears localized predominantly in the nucleoli 
of BAV.pVm123 infected cells. In contrast, pV appears localized in the nucleus of 
BAV.pVd3 or BAV.pVd1d3 infected cells.  
 
3.3.8 Growth kinetics of viruses 
To examine if the deletion\mutation of pV nucleolar localization signals affects 
BAdV-3 replication, we compared the ability of the mutant viruses and BAV304a to 
grow on MDBK cells. The virus infected cells were harvested at indicated time points 
post infection, freeze-thawed 3-5 times and cell lysates were used to determine the virus 
titers by TCID50 assay. As seen in Fig 3.6D, at 48 hrs, virus titer of mutant BAVpVd1, 
BAV.pVm123, BAV.pVd3 appeared 0.6 to 1.0 log less compared to BAV304a. In 
contrast, mutant BAV.pVd1d3 did not replicate in MDBK cells.  
 
3.3.9 Analysis of gene expression in mutant virus-infected cells 
 Since the deletion\mutation of pV NoLS influences the viral growth kinetics, we 
investigated the effects of pV NoLS deletion /mutations on the expression of early and 
late proteins in mutant BAdV-3 infected cells by Western blot using protein specific 
antisera. As seen in Fig 3.7A, anti-DBP serum, anti-pVII serum, anti-pV serum, anti-pX 
serum, anti-hexon serum and anti-100K serum detected proteins of expected  
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Figure 3.6 L2 pV. A) Schematic representation of BAdV-3 Genomes. Dotted box 
represents BAdV-3 genome, and thich black line represents pV sequence. The thin line 
depicts deleted regions. The arrows represent the direction of transcription. The amino 
acid numbers of pV are shown. The substituted amino acids (alanines\glycines) of NoLS1 
are underlines and shown in italics. E3 (early region 3); nucleolar localization signal 
(NoLS1, NoLs2); CMV (human cytomegalovirus immediate early promoter); EYFP 
(enhanced yellow fluorescent protein). B) Fluorescent microscopy.  The VIDO DT1 or 
CRL.PV cells transfected with indicated plasmid DNAs were observed for appearance of 
green fluorescent cells and cytopathic effects. The numbers represent the day the 
observation was made after transfection. C) Restriction enzyme analysis of recombinant 
BAdV-3 genome. The DNAs were extracted from MDBK or CRL.PV cells infected with 
BAV304a (lanes 2, 5, 6, and 8), BAV.pVd1 (lane 1), BAV.pVm123 (lane 3), BAV.pVd3 
(lane 4), and BAV.pVd1d3 (lanes 7 and 9) as described previously (Farina et al., 2001), 
digested with XbaI (lanes 1, 2, 3, 8, and 9) or Pst1 (lanes 4, 5, 6, and 7) and analyzed by 
agarose gel electrophoresis. D) Virus titer. Monolayers of MDBK cells were infected 
with BAV304a or recombinant BAdV-3s. At different time points post infection, the cells 
were freeze-thawed and titrated on CRL.PV cells as described. Values represent averages 
of two independent repeats and error bars indicate the standard deviations. E) Western 
Blot. Proteins from lysates of CRL or CRL.pV cells infected with BAV304a, BAV.pVd1, 
BAV.pVm123, BAV.pVd3 and BAV.pVd1d3 were separated by 10% SDS-PAGE, 
transferred to nitrocellulose membrane and probed by Western blot using anti-pV serum. 
The membrane was visualized by Odyssey® CLx Imaging System (LI-COR). F) Confocal 
microscopy. CRL cells were transfected with plasmid pDsRed.B23 DNA and infected 
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with indicated mutant BAdV-3s. Infected cells were fixed at 48 hrs post-infection. The 
DsRed.B23 was visualized by direct fluorescence microscopy. BAdV-3 pV was 
visualized by indirect immunofluorescence microscopy using anti-pV serum and Alexa 
Fluor 647-conjugated goat anti-rabbit IgG. The nuclei were stained with DAPI.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 98 
molecular weights both in BAV304a and mutant virus infected cells. Densitometer 
analysis of protein production (Fig 3.7B) showed no significant differences in the 
expression of DBP, pX in any mutant BAdV-3 infected cells compared to BAV304a 
infected cells. Similarly, there was no dramatic change in the expression of pVII in 
mutant infected cells compared to BAV304a infected cells. However, expression of 
hexon and 100K was significantly reduced in BAV.pVd1d3 infected cells compared to 
BAV304a infected cells. Moreover, the expression of pV was severely reduced in mutant 
BAVd1d3 infected cells compared to BAV304a, BAV.pVd1, BAV.pVm123, and 
BAV.pVd3 infected cells. 
 
3.3.10 Structural protein incorporation assay 
To determine if the decreased late protein express influences the structural protein 
incorporation, structural proteins in purified virus were separated by 10% SDS-PAGE, 
transferred to nitrocellulose membrane and probed with Western blot by anti-hexon 
(Kulshreshtha et al., 2004), anti-fiber (Wu and Tikoo, 2004), anti-pVII (Paterson, 2010), 
anti-pV and anti-pVIII (Ayalew, 2014) antisera. As shown in Fig 3.8, there was no 
detectable difference between hexon, fiber, pVII and pVIII expression among these 
recombinant BAdV-3s. However, the expression of pV mutants was different. Firstly, 
different sized pV mutants were detected from different recombinant BAdV-3s, 
indicating the deletion or mutation of pV NoLS(s). Secondly, different pV expression 
patterns shown in BAV.pVd1d3 purified from CRL and CRL.pV cells. Two pV bands 
were detected in BAV.pVd1d3 purified from CRL.pV cells, while only the lower one was 
detected in the BAV.pVd1d3 purified from CRL cells. 
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Figure 3.7 Analysis of gene expression in mutant BAdV-3 infected cells. A) Proteins 
from lysates of MDBK cells infected with indicated mutant BAdV-3s were separated by 
10% SDS-PAGE, transferred to nitrocellulose and probed with protein specific antisera 
and Alexa Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen). β-actin was used 
as a loading control and was detected using anti-β-actin monoclonal antibody (Sigma-
Aldrich) and IRDye800 Conjugated goat anti-mouse antibody (Rockland). Protein names 
are depicted on the right of the panel. E (Early), L(Late), DBP (DNA binding protein). B) 
The values were analyzed by using Odyssey® CLx Imaging System (LI-COR). Values 
represent averages of two independent repeats and error bars indicate the standard 
deviations. 
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Figure 3.8 Structural protein incorporation assay. Structural proteins from the 
purified BAV304a (lane 1), BAV.pVd1 (lane 2), BAV.pVd1 (lane 3), BAV.pVd3 (lane4) 
or BAV.pVd1d3 (lane 5) grown in CRL cells and BAV.pV BAV.pVd1d3 (lane 6) grown 
in CRL.pV cells were separated by 10% SDS-PAGE, transferred to nitrocellulose and 
probed by Western blot using protein specific antisera. Protein bands were visualized by 
Odyssey® CLx Imaging System (LI-COR). Protein names are depicted on the right of the 
panel. 
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3.3.11 Analysis of BAdV-3 capsid assembly.  
Since expression of BAdV-3 proteins  (hexon, 100, and pV) was significantly 
reduced in NoLSs deleted BAdV-3 (BAV.pVd1d3), viral capsid assembly was analyzed 
initially in BAV.pVd1d3 and BAV304a infected MDBK cells. Capsid formation was 
analyzed in BAV.pVd1d3 infected cells by TEM.  As seen in Fig 3.9A, although capsid 
formation was observed in BAV.pVd1d3 infected cells, many of the capsids were lightly 
stained. Moreover, there were fewer amounts of capsids observed in BAV.pVd1d3 
infected cells than BAV304a infected cells. 
Viral capsid assembly was analyzed by using BAV.pVd1d3 and BAV304a viral 
paricles purified from MDBK cells. The infected cells were harvested, freeze-thawed, 
and the virions were purified using CsCl gradients. As seen in Fig 3.9B, few mature 
virions were present in purified BAV.pVd1d3. Moreover, the amount of mature virions 
present in purified BAV.pVd1d3 was significantly lower than the amount detected in 
BAV304a infected cells.   
 
3.3.12 Thermostability of recombinant BAdV-3s 
Deletions and mutations in viral genome are always associated with thermo 
vulnerability (Ugai et al., 2007). To examine if the deletion or mutation of pV NoLSs 
leads to the decrease of BAdV-3 thermostability, wild-type and recombinant BAdV-3s 
were treated as described above (Ugai et al., 2007). As seen in Fig 3.10A, there is no titer 
difference when the temperature was under 25C. However, when viruses were incubated 
at 37C, the titers dropped significantly, especially for BAV.pVd1d3 and BAV.pVm123.  
To assess the different dynamics of viral inactivation, wild-type and recombinant BAdV-
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3s were treated at -80C, 4C or 37C for 0, 1, 3 or 7 days. As seen in Fig 3.10B-F, after 
seven days incubation at -80C or 4C, there was no detectable change in all these five 
BAdV-3s. However, after seven days incubation at 37C, BAV304a, BAV.pVm123 and 
BAV.pVd1d3 lost all their infectivity, while for the single NoLS deleted recombinant 
viruses BAV.pVd3 and BAV.pVd1, ~103 infectious VP were still remaining. 
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Figure 3.9 Transmission electron microscopic analysis. A) Viral assembly in infected 
cells. Uninfected MDBK cells (Panel 1, 2), MDBK cells infected with BAV.pVd1d2 
(Panel 3, 4) or BAV304a (Panel 5, 6). The arrows depict higher magnification (60 000x) 
of the areas in the red boxes. B) Negative staining of purified BAV304a (Panel 1, 2) and 
BAV.pVd1d2 (Panel 3, 4). The arrows depict higher magnification (120 000x) of the 
areas in the red boxes. 
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Figure 3.10 Thermostability of the recombinant BAdV-3s. A) Thermostability assay 
of the recombinant BAdV-3s. 105 TCID50 of BAV304a, BAV.pVm123, BAV.pVd1 or 
BAV.pVd3 virions purified from CRL cells or 105 TCID50 of BAV.pVd1d3 virions 
purified from CRL.pV cells were incubated at -80C, 20C, 4C, 25C or 37C for 3 days, 
and the residual viral infectivity was determined with TCID50 on CRL.pV cells. Values 
represent averages of two independent repeats and error bars indicate the standard 
deviations. B, C, D, E, F) 105 TCID50 of BAV304a, BAV.pVm123, BAV.pVd1 or 
BAV.pVd3 virions purified from CRL cell or 105 TCID50 of BAV.pVd1d3 virions 
purified from CRL.pV cells were incubated at -80C, 4C or 37C for 0, 1, 3 or 7 days. 
The residual viral infectivity was determined with TCID50 using CRL.pV cells. Values 
represent averages of two independent repeats and error bars indicate the standard 
deviations. 
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3.4 DISCUSSION 
Although adenovirus protein homologs are encoded by members of 
Mastadenovirus genus, recent reports have demonstrated the differences in the sub 
cellular localization and function of homologous adenovirus proteins (Blanchette et al., 
2013; Cheng et al., 2013; Stracker et al., 2005). Recently, we reported that 100K protein 
encoded by HAdV-5 and BAdV-3 differ in sub cellular localization and protein function 
(Makadiya et al., 2015). Adenovirus pV is a Mastadenovirus genus specific minor core 
protein, which localizes to both the nucleus and the nucleolus in infected cells (Matthews, 
2001). Although transportin appears necessary for the nucleolar localization of pV 
(Hindley et al., 2007), the molecular mechanism involved in the nucleolar localization is 
not known. The present study was designed to characterize BAdV-3 pV protein, 
investigate the mechanism of nucleolar localization and determine its role in virus 
replication.   
The BAdV-3 pV is predicted to encode a protein of 423 amino acids, which is 
expressed as 55 kDa protein, appears between 12-24 hrs post infection and could be 
detected till 48 hrs post BAdV-3 infection. pV is almost exclusively detected in the 
nucleolus of the BAdV-3 infected or transfected cells in the absence of any other viral 
proteins.  
Proteins localizing to nucleolus also localize to the nucleus and thus may contain 
either overlapping NLS \ NoLS (Cheng et al., 2002; Sheng et al., 2004) or separate non-
overlapping signals for localizing to both the nucleus and the nucleolus (Cros et al., 2005; 
Ladd and Cooper, 2004). Amino acid sequence analysis of BAdV-3 pV predicted three 
clusters of arginine-lysine rich sequences in both N-terminus (amino acid 21-50), central 
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domain (amino acid 190-210) and C-terminus (amino acid 380-389) of pV with potential 
to act as NLS.  
However, deletion analysis identified N-terminal amino acids 21-50 (NoLS1) and 
C-terminal amino acid 380-389 (NoLS2) as NoLS, both containing basic residues that 
can function as NoLS. Both NoLS1 and NoLS2 amino acids were sufficient to direct 
nucleolar import of EYFP, a non-nucleolar protein. This is consistent with the earlier 
report, suggesting that NoLS are rich in basic amino acids and are predominantly 
localized near N or C-terminus of the protein (Scott et al., 2010). Deletion of a potential 
NoLS did not reduce the nucleolar localization of pV suggesting that NoLS1 and NoLs2 
function is redundant. Interestingly, three arginine and lysine rich motifs of NoLs1 also 
appear to have redundant function as mutation of any arginine lysine rich motif of NoLs1 
did not abrogate the nucleolar localization of BAdV-3 pV. Interestingly, deletion of both 
abrogated the nucleolar localization of pV. However, deletion of potential NoLS did not 
alter the nuclear localization of pV. Moreover, V.d15 (Fig 3.4C) containing amino acid 
21-50 (NoLS1) localized predominantly in the cytoplasm of the transfected cells (Fig 
3.4D) and the fusion protein GFPβGal (Fig 3.4E) containing amino acid 21-50 showed no 
nuclear and nucleolar localization (Fig 3.4F). Unlike EYFP, a 26 kDa protein can diffuse 
between the cytoplasm and the nucleus, GFPβGal is too big to diffuse through the NPC 
(Paterson, 2010). These results suggest that the NoLS1 does not contain nuclear 
localization signal(s) required for pV to localize to the nucleus. In contrast, V.d16 (Fig 
3.4C) containing amino acids 21-50 (NoLS1) and 380-389 (NoLS2) located in the 
nucleus and nucleolus (Fig 3.4D), suggesting that amino acids 380-389 can mediate 
V.d16 both nuclear and nucleolar localization. Although human adenovirus 2 pV can 
 108 
redistribute B23 from the nucleolus to cytoplasm (Matthews, 2001), in this study, B23 
was used as a nucleolar marker and no B23 redistribution by pV was observed both in the 
infected and transfected cells. This is probably because of the low identity between 
BAdV-3 and HAdV-2 pV (40.9%) (Reddy et al., 1998). 
The nucleolar transport usually require binding of nucleolar constituents to specific 
protein sequences namely nucleolar localization signal (NoLS), which helps to retain the 
protein in the nucleolus. Though, there is no consensus in known NoLS sequences, NoLS 
are usually rich in lysine and arginine residues, which may interact with nucleolar RNAs 
or other nucleolar proteins (Olson and Dundr, 2005) for their retention in the nucleolus 
by a charge dependent mechanism (Musinova et al., 2015). While many nucleolar 
proteins contain RNA binding motifs (Hiscox, 2007) and are retained by binding to 
nucleolar RNAs, nucleophosmin protein contains acidic regions which bind to positively 
charged amino acids in putative nuclear proteins and retain them in the nucleolus (Adachi 
et al., 1993; Valdez et al., 1994). Though NoLS1 and NoLS2 do not contain a specific 
amino acid sequence, both are rich in positively charged residues. Since no specific 
NoLS sequence pattern could be defined in pV, the abundance of positively charged 
residues appears to mediate translocation of pV from nucleus to nucleolus suggesting that 
nucleolar retention is due to electrostatic interactions.  
Unlike nucleolar transport, nuclear import requires active transport mechanisms, 
which are dependent on energy, soluble factors and functional nuclear pore complex 
(Nigg, 1997). Most of the proteins imported into the nucleus contain nuclear localization 
signals (Boulikas, 1993; Kosugi et al., 2009), which interact with importin α/β and/or 
transportins in the cytoplasm and are transported through nuclear pore complex into the 
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nucleus. Though bioinformatic analysis predicted 190-210 to act as potential NLS, 
deletion analysis identified three regions including amino acid 80-120, 190-210 and 380-
423, which can act as NLS. Deletion of all three motifs is required to abolish the nuclear 
localization and binding of pV to importin 3 suggesting that each motif is functionally 
redundant.  Separate or overlapping redundant NLSs have been identified in viral 
proteins including polyomavirus large T antigen (Howes et al., 1996; Richardson et al., 
1986), influenza virus NS1 protein (Melen et al., 2007), adeno-associated virus 2 
assembly activating protein (Earley et al., 2015) and in BAdV-3 33K (Kulshreshtha et al., 
2014). It is possible that BAdV-3 pV NLS redundancy may help promote efficient 
interaction with nuclear transport system leading to an effective nuclear transport. 
Support for this comes from the fact that increased binding of pV to importin 3 could be 
observed in the presence of all three NLS regions (Fig 3.5C,D). Two additional bands 
were detected in the in vitro synthesized pV.d15. It is possible that the deletion of amino 
acids 81-120, 190-210 and 380-389 induces the leaky scan, which renders 40S ribosomal 
subunit bypass the first AUG sometimes and starts translation at the second AUG.  
A number of viral proteins, including HAdV-5 pVII, use multiple nuclear import 
pathways (Wodrich et al., 2006). Recently, we also have demonstrated that nuclear 
import of BAdV-3 33K involves recognition of overlapping NLS motifs located in 40 
amino acid long conserved region of BAdV-3 33K by importin 5 and transportin-3 
(Kulshreshtha et al., 2014). Though transportin-3 has been shown to be required for 
HAdV-5 pV nucleolar transport, our data suggest that the nuclear import of pV appears to 
be mediated only by importin α3 of importin α/β pathway and requires amino acids 81-
120, 190-210, and 380-423. 
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Although deletion of NoLS2 affects the efficient production of progeny virus, both 
NoLS1 and NoLS2 do not appear essential for the production of viable virus suggesting 
that each NoLS motif may be functionally redundant. In contrast, deletion of both NoLS1 
and NoLS2 prevented the production of viable virus suggesting that nucleolar 
localization of pV is essential for the production of viable virus. Since nucleolar 
delocalization of pV appeared lethal for production of progeny virus in MDBK cells, this 
phenotype could be due to defect in any step of the viral replication including viral 
protein expression, DNA replication and\or virus assembly. The early protein expression 
in BAV.pVd1d3 appeared comparable to BAV304a suggesting that the loss of growth is 
potentially due to an event occurring late in infection. Analysis of late protein expression 
revealed that the nucleolar delocalization of pV altered the expression of some late viral 
proteins namely hexon, 100K and pV in BAV.pVd1d3 infected cells compared to 
BAV304a infected cells. Moreover, progeny virus could be detected in BAV.pVd1d3 
infected MDBK cells suggesting that pV NoLSs are not required for assembly of empty 
capsids and immature virions. Western blot analysis of CsCl purified BAV.pVd1d3 virus 
grown in CRL cells could not detect difference in pV incorporation, indicating that pV 
NoLSs are not essential for pV incorporating into the virus particles. 
Earlier reports have suggested that trimerization and nuclear transport of hexon by 
100K is required for formation of capsid (Hong et al., 2005; Xi et al., 2005). In the 
protein expression assay (Fig 3.7), the expression of both 100K and hexon was decreased 
in NoLSs deleted BAdV-3 infected cells. Thus, one explanation of the impaired viral 
assembly is the reduced expression of hexon, as well as its decreased trimeration and 
nuclear transport because of the decreased expression of 100K. Moreover, in another 
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study, the interactions of 33K with pV or 100K were detected (Kulshreshtha and Tikoo, 
2008). We also found that pV can interact with 100K and 33K (Zhao and Tikoo, 
unpublished data). Therefore, one may speculate that pV may form a complex with 100K 
and 33K to manipulate not only 100K functions but also 33K functions. 33K has been 
proved to regulate the major late promoter (Ali et al., 2007), capsid assembly and capsid 
DNA interaction (Finnen et al., 2001; Kulshreshtha and Tikoo, 2008). Therefore, it is 
possible that pV may improve the viral capsid assembly via its interaction with 33K, 
while future work need to be done to prove this speculation.  
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4.0 TRANSITION FROM SECTION 3.0 TO SECTION 5.0 
Nucleolar localization signals of pV have been proved to be essential for BAdV-3 
replication. Deletion of pV NoLSs blocks pV nucleolar retention, thereby abrogating pV 
function in nucleolus in viral replication. In addition to this, pV may also play other 
functions in viral replication. To elucidate the other functions of pV may play, the 
following chapter was performed. In this chapter, pV was deleted from BAdV-3 genome 
to construct pV deleted BAdV-3 (BAV.dV) by using homologous recombination. Then, 
pV functions were examined by comparing the differences between BAdV-3 and 
BAV.dV in different stages of viral replication. 
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5.0 DELETION OF pV AFFEACTS ITEGRITY OF CAPSID CAUSING DEFECT 
IN THE INFECTIVITY OF BOVINE ADENOVIRUS-3  
5.1 INTRODUCTION 
Adenoviruses are non-enveloped icosahedral particles of 70 to 100 nM in diameter 
(Horne et al., 1959), which infect mammals, birds (Chiocca et al., 1996), reptiles (Benko 
et al., 2002), frogs (Davison et al., 2000) and fish (Kovacs et al., 2003). Members of 
Mastadenovirus genus including human adenovirus (HAdV) infect mammals and encode 
unique proteins including pIX and pV (Davison et al., 2003). Earlier reports suggested 
that HAdV-5 pV acts as a bridge between the core and the capsid proteins in mature 
virions (Chatterjee et al., 1985; Lehmberg et al., 1999; Matthews and Russell, 1998a). 
Additional investigations have revealed that pV promotes viral assembly through 
nucleophosmin 1 (Ugai et al., 2012) and  is essential for virus replication in primary but 
not in cancer cells (Ugai et al., 2007). 
Bovine adenovirus 3 (BAdV-3) is non-enveloped icosahedral virus of 75 nm in 
diameter (Thompson et al., 1981), which contains a genome of 34,446 bp long and 
organized into early (E), intermediate (I) and late (L) regions (Reddy et al., 1998). 
Previously, we reported that the core protein pVII encoded by L1 region of BAdV-3 
localizes to the mitochondria using a mitochondrial localization signal, and interferes 
with apoptosis by altering some mitochondrial functions in infected cells (Anand et al., 
2014). Recently, we reported that conserved regions of pVIII encoded by L6 region 
contain motifs involved in nuclear localization or packaging in mature virions (Ayalew et 
al., 2014). Similarly, conserved leucines (Kulshreshtha et al., 2015) and conserved 
arginines (Kulshreshtha et al., 2014) of 33K protein encoded by L6 region appeared 
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important in binding and the activation of major late promoter, and in nuclear transport of 
33K and BAdV-3 replication, respectively. 
Though positional homologs are encoded by HAdV-5 and BAdV-3, the structure 
and function of the homologous proteins may always not be similar (Anand et al., 2014; 
Kulshreshtha et al., 2004; Li et al., 2009; Reddy et al., 1998). Recently, we demonstrated 
that unlike HAdV-5, bovine adenovirus-3 protease cleaves 100K protein, which is 
required for the nuclear transport in the infected cells but not for the virus replication 
(Makadiya et al., 2015).  
The L2 region of BAdV-3, a member of Mastadenovirus genus, encodes pV protein 
of 423 amino acids, which shows 40.9% homology to pV encoded by HAdV-2 (Reddy et 
al., 1998). Recently, we have demonstrated that pV is detected as a) 55 kDa protein in 
CsCl gradient purified BAdV-3 virions or in BAdV-3 infected cells, and b) is localized 
predominantly in the nucleolus of the virus infected cells, which is required for the 
replication of BAdV-3 (Zhao and Tikoo, 2016, manuscript in preparation). Here, we 
report the role of pV in the replication of BAdV-3 in the infected cells. 
 
5.2 MATERIALS AND METHODS 
5.2.1 Cells and viruses  
Madin Darby bovine kidney (MDBK), CRL (Cotton rat lung) cells (Papp et al., 
1997), VIDO-DT1 (CRLcells expressing I-SceI) and CRL.pV cells (described below) 
were cultivated in minimal essential medium (MEM) (Sigma) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS, Invitrogen). The HEK293T cells (ATCC® 
CRL-3216TM) were cultivated in Dulbecco’s minimal essential medium (DMEM) 
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(Sigma) with 10% FBS. BAV304a was propagated in MDBK cells, and BAV.dV was 
propagated in CRL.pV cells. 
 
5.2.2 Antibodies 
Production and characterization of anti-DBP (Kulshreshtha et al., 2004), which 
detect a protein of 48 and 102 kDa in BAdV-3 infected cells, respectively, has been 
described. The anti-pX serum detects a protein of 25 kDa, anti-hexon serum detects a 
protein of 103 kDa and anti-pVII serum detects proteins of 22 and 20 kDa (Paterson, 
2010) in BAdV-3 infected cells. Production and characterization of anti-pV sera, which 
recognize a protein of 55 kDa in BAdV-3 infected cells will be described elsewhere 
(Zhao and Tikoo, 2016, manuscript in preparation). TRITC conjugated goat anti-rabbit 
IgG (Jackson Immunoresearch), Alexa Fluor 680 conjugated goat anti-rabbit antibody 
(Invitrogen), anti-β-actin monoclonal antibody (Sigma-Aldrich) and IRDye800 
conjugated goat anti-mouse antibody (Rockland) were purchased. 
 
5.2.3 Construction of plasmid pUC304A.dV 
A 6.4-kb EcoRV-Bst1107I DNA fragment of plasmid pUC304A+ (E3 deleted 
BAdV-3 containing CMV.EYFP inserted in E3 region), was isolated and ligated to a 2.1-
kb EcoRV-Bst1107I fragment of plasmid pMCS1 (Thanbichler et al., 2007) creating 
plasmid pMCS.pV. To delete pV from pMSC.pV, a 465-bp fragment was amplified by 
using primers dV-F1-F: 5’-TGATCCGGTGGCCGACACAATCGAG-3’; dV-F1-R: 5’-
TGTGGCCGCTTGGCGGATGCCTGCAGGCACAGTGGGTTTATCGGCGCG-3’ and 
plasmid pMCS.pV DNA as a template. Similarly, a 602-bp fragment was amplified by 
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PCR using primers dV-F2-F: 5’-GCCGATAAACCCACTGTGCCTGCAG 
GCATCCGCCAAGCGGCCACAGTAAC-3’; dV-F2-R: 5’-GTCCATGGCGTGTTAA 
CAAGCTGTG-3’ and plasmid pMCS.pV DNA as a template. In the third PCR, these 
two fragments were annealed and used as DNA temple to amplify the 1040-bp DNA 
fragment without pV by overlapping PCR using primers dV-F1-F and dV-F2-R. Finally, 
a 622-bp EcoRI-HpaI DNA fragment of the third PCR product was isolated and ligated to 
EcoRI-HpaI digested plasmid pMCS.pV creating plasmid pMSC.dV.  
A 1.6-kb SbfI fragment (containing kanamycin resistant gene) of plasmid pUC4K 
(Taylor and Rose, 1988) was isolated and ligated to SbfI digested plasmid pMCS.dV to 
create plasmid pMSC.dV.Kan. The recombinant plasmid pUC304.dV.Kan was generated 
by homologous recombination in E. coli BJ5183 between the plasmid pUC304A+ DNA 
and a 6.4-kb EcoRV-Bst1107I DNA fragment of plasmid pMCS.dV.Kan. Finally, 
plasmid pUC304.dV.Kan was digested with SbfI and large fragment was religated to 
create plasmid pUC304A.dV. 
 
5.2.4 Construction of pV expressing cell line CRL.pV 
Earlier, we successfully used lentivirus system to isolate VIDO DT1 cells 
expressing I-SceI endonuclease) (Du and Tikoo, 2010). To isolate the cell line stably 
expressing BAdV-3 pV, we used the second generation replication defective lentivirus 
system containing cloning plasmid pTrip-puro, plasmid pSPAX expressing HIV Gag/Pol 
proteins and plasmid pMD2.G, expressing vesicular stomatitis virus G protein . Briefly, a 
1.2 kb DNA fragment containing BAdV-3 pV gene was ligated to EcoRV-XhoI digested 
plasmid pTrip-puro (containing a puromycin resistant marker), creating plasmid pTrip-
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pV-Puro. The HEK293T cells were co-transfected with plasmid  (pTrip-pV-Puro, 
pSPAX2 and pSPAX) DNAs. At 48 h post-transfection, the lentivirus in media was 
collected and used to transduce CRL cells with 8ug/ul polybrene. At 24 h post-
transduction, the transduced cells were transferred to 10 cm2 dishes. After 24 h, media 
were replaced by fresh selection media containing 5 μg/ml of puromycin. The puromycin 
resistant cell clones were picked, propagated in puromycin containing media and tested 
for the expression of BAdV-3 pV.  
 
5.2.5 Western blot analysis 
Proteins from purified virus, virus infected cell lysates or pV expressing cell lysates 
were separated by Sodium dodecyl-sulfate (SDS) polyacrylamide gel electrophoresis 
(PAGE), transferred to nitrocellulose membrane (Bio-Rad) and probed by Western blot 
using protein specific anti-sera and Alexa Fluor 680 or IRDye800 conjugated antibodies. 
The membranes probed with fluorophore-conjugated secondary antibody were scanned 
and analyzed by Odyssey® CLx Imaging System (LI-COR). 
 
5.2.6 Confocal microscopy 
Monolayer of CRL.pV cells in 2-well chamber slides were fixed with 3.7% 
paraformaldehyde and permeabilized with 0.1 M PBS containing 0.5% Triton X-100. 
After blocking with 5% goat serum, the cells were stained with rabbit anti-pV sera and 
TRITC conjugated goat anti-rabbit IgG (Jackson Immunoresearch). Finally, the cells 
were mounted by mounting buffer (Vector Laboratories Inc.) containing DAPI and 
imagined under confocal microscope TCS SP5 (Leica). 
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5.2.7 Isolation of recombinant BAV.dV 
VIDO DT1 (Du and Tikoo, 2010) or CRL.pV (this report) cells in 6-well plates 
were transfected with PacI digested plasmid pUC304.dV using Lipofectamine 2000 
(Invitrogen). At 4 hrs post-transfection, the medium was replaced with fresh MEM 
containing 2% FBS. The cells showing cytopathic effect (CPE) were harvested and freeze 
thawed three times. Finally, the recombinant virus was propagated in CRL.pV cells and 
purified by CsCl gradient centrifugation (Tollefson et al., 1999).  
 
5.2.8 Virus DNA replication 
The CRL cells were infected with BAV304a or BAV.dV at a MOI of 2. At 12, 24 
and 36 hrs post infection, the infected cells were washed in phosphate buffered saline and 
used to purify low molecular weight DNA as described (Farina et al., 2001). Equal 
amount of DNA was digested with BmtI restriction enzyme and separated by agarose gel 
electrophoresis and analyzed by Gel DocTM XR+ System (Bio-Rad).   
 
5.2.9 Virus single cycle growth curve 
CRL cells in 24-well plates were infected with BAV304a or BAV.dV at MOI of 2. 
At different times post-infection, the infected cells were harvested, freeze-thawed three 
times and titrated by TCID50 in CRL.pV cells as described elsewhere (Kulshreshtha et al., 
2004). 
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5.2.10 Viral thermostability assay 
To determine if deletion of pV alters BAV.dV thermolability, 1×105 (from 
CRL.pV) or 1×104 (from CRL) infectious viral particles purified from CRL.pV or CRL 
in 10% glycerol containing PBS were incubated at different temperatures (-80C, -20C, 
4C, 25C and 37C) for three days. To analyze the dynamics of viral inactivation, 
purified 1×105 (from CRL.pV) or 1×104 (from CRL) infectious virus particles in 10% 
glycerol containing PBS were incubated at different temperatures (-80C, 4C and 37C) 
for 0, 1, 3 and 7 days. Finally, the infectivity of the treated virus particles was measured 
by TCID50 in CRL.pV cells. 
 
5.2.11 Transmission electron microscopy 
CRL cells were infected with BAV304a or BAV.dV at MOI of 2. At 24 hrs post-
infection, the cells were collected and fixed in 2.5% glutaraldehyde, and with 1% OsO4 in 
0.1M PBS. After dehydration with a graded ethanol series and propylene oxide, the 
samples were infiltrated with a mixture of propylene oxide and EMbed-812 embedding 
medium and polymerized in embedding capsules at 60C for 24-48 hrs. The pellets were 
sectioned by using a Reichert ultracut microtome, the sections were stained with 2% 
uranyl acetate and lead citrate. Finally, the stained sections were viewed using a Philips 
CM10 TEM. 
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5.3 RESULTS 
5.3.1 Isolation of BAV.dV in CRL cells 
To determine if pV is essential for BAV304a (Du and Tikoo, 2010) replication, we 
constructed a plasmid pUC304A.dV containing BAdV-3 genome with deletion of pV and 
insertion of CMV-EYFP gene cassette in E3 deleted region (Fig 5.1B). Individual 
plasmid pUC304A.dV or pUC304A+ (containing BAdV-3 genome with insertion of 
CMV-EYFP gene cassette in E3 deleted region) (Fig 5.1A) DNA were used to transfect 
VIDO DT1 cells.  At 6 days post-transfection, the EYFP expression and cytopathic 
effects were visible in the cells transfected with plasmid pUC304A+ DNA (Fig 5.1A). 
However, repeated transfection of VIDO DT1 cells with plasmid pUC304A.dV DNA did 
show EYFP expression in few cells but no any cytopathic effects even after 20 days post 
transfection (Fig 5.1B). Moreover, while the lysates from the cells transfected with 
plasmid pUC304A+ DNA produced cytopathic effects in freshly infected VIDO DT1 
cells, the lysates from the cells transfected with plasmid pUC304A.dV DNA did not 
produce any cytopathic effect or expression of EYFP in freshly infected VIDO DT1 cells 
(data not shown). These results suggest that pV is essential for the replication of 
BAV304a. 
 
5.3.2 Construction of CRL.pV cells expressing BAdV-3 pV 
To isolate a cell line expressing BAdV-3 pV, CRL cells were transduced with 
lentivirus expressing BAdV-3 pV and grown in the presence of puromycin as described 
earlier (Du and Tikoo, 2010). The puromycin resistant clones were analyzed initially for  
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Figure 5.1 Isolation of pV deleted BAdV-3. A) Schematic diagram of indicated plasmid 
DNA. Thick black box represents BAdV-3 genomic DNA. Dotted line represents deleted 
region. Thin lines represent plasmid DNA. The human cytomegalovirus immediate early 
promoter (CMV), enhanced yellow fluorescent protein gene (EYFP), ampicillin 
resistance gene (Amp), early region 3 (E3) and pV location is depicted. B) Direct 
fluorescence. Monolayer of VIDO DT1 cells (Du and Tikoo, 2010) were transfected with 
7.5ug indicated plasmid DNA and visualized for the expression of EYFP and 
development of cytopathic effects using fluorescent microscope TCS SP5 (Leica). 
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the expression of pV by Western blot and immnuofluorence assay using pV specific 
antisera. Earlier analysis using anti-pV sera suggested that pV is expressed as 55kDa in 
BAdV-3 infected cells and localizes predominantly in the nucleolus of BAdV-3 infected 
cells (Zhao and Tikoo, 2016, manuscript in preparation). As shown in Fig 5.2A, anti-pV 
serum detected a protein of 55 kDa in BAdV-3 infected cells. Similar protein could be 
detected in two puromycin resistant clones using anti-pV serum (Fig 5.2A, lanes 1,2). No 
such protein could be detected in CRL cells (Fig 5.2A, lane 4). Secondly, the sub cellular 
location of pV in puromycin resistant clones was analyzed by confocal microscopy. As 
seen in Fig 5.2B anti-pV serum detected protein predominantly localized in the nucleolus 
of pV expressing cells (CRL.pV1, CRL.pV2). No such protein could be detected in the 
nucleolus of CRL cells. 
 
5.3.3 Isolation of BAV.dV in CRL.pV cells 
To isolate pV deleted BAV304a, CRL.pV cells were transfected with PacI digested 
plasmid pUC304A.dV DNA and observed for the development of cytopathic effects (Fig 
5.3A). As shown in Fig 5.3B, the cytopathic effect and EYFP expression was firstly 
observed at 7 days post-transfection, which increased by day 12.  To confirm the identity 
of recombinant virus, named BAV.dV, first viral DNA was purified from infected 
CRL.pV cells, digested with KpnI and analyzed by agarose gel electrophoresis. As shown 
in Fig 5.3C, BAV304a (Lane 1) contains a fragment of 4.7 kb, which was missing in 
BAV.dV. Instead, BAV.dV (lane 2) contains a fragment of 3.5 kb because of the deletion 
of pV gene. Secondly, the expression of pV in virus infected CRL cells was analyzed by  
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Figure 5.2 Analysis of pV expression in CRL.pV cells. A) Proteins from the cell 
lysates of CRL.pV cells clone 1 (lane 1) and clone 2 (lane 2), BAdV-3 infected CRL cells 
(lane 3) and mock infected CRL cells (lane 4) were separated by 10% SDS-PAGE, 
transferred to nitrocellulose membrane and probed in Western blot by using rabbit anti-
pV serum and Alexa Fluor 680 conjugated antibodies goat anti-rabbit antibody 
(Invitrogen). The position of the molecular weight in kDa is shown on the left of the 
panel. The molecular weight in kDa of observed protein is shown on the right of the 
panel. B) Monolayers of CRL.pV (clone 1or 2) or CRL cells were fixed with 4% 
paraformaldehyde and visualized by indirect immunostaining with rabbit anti-pV serum 
followed by TRITC-conjugated goat anti-rabbit IgG using confocal microscope TCS SP5 
(Leica). The nuclei were stained by DAPI. 
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Western blot using anti-pV sera. As seen in Fig 5.3D, a 55 kDa protein could be detected 
in BAV304a infected CRL cells (lane 1). Similar mol wt protein could be detected in 
uninfected CRL.pV cells (lane 3). No such band could be detected in BAV.dV infected 
CRL cells (lane 2). 
To determine the influence of pV on the formation of BAdV-3 particle,  
CRL cells or CRL.pV cells were infected with purified BAV.dV (grown in CRL.pV cells) 
at a MOI of 2. At 48 hrs post infection, the lysates of infected cells were used to purify 
virions by CsCl gradient centrifugation. As seen in Fig 5.3E, deletion of pV 
predominantly produced population of virus representing mature virions. Moreover, no 
visible decrease in the production of the mature virus particles could be observed in 
BAV.dV grown in CRL.pV cells or CRL cells. 
 
5.3.4 Growth of BAV.dV in CRL cells 
To determine if BAV.dV can produce infectious viral particles in pV negative CRL 
cells, viral growth characteristics of CsCl purified BAV304a  (grown in CRL cells) and 
BAV.dV (grown in CRL.pV cells) was analyzed. Monolayers of CRL cells in 24 well 
plates were infected with BAV304a or BAV.dV at MOI of 2. The infected cells were 
harvested at different times (0, 6, 12, 24, 36, 48 hrs) post-infection. After freeze thawing 
three times, the samples were titrated by TCID50 in CRL.pV cells. As shown in Fig 5.3F, 
BAV304a grew to a titer of ~108 TCID50/ml at 48 h post-infection. In contrast, there was 
no detectable increase in the titer of BAV.dV. Similarly, no detectable increase in the 
titer of BAV.dV could be observed in MDBK cells (data not shown).  
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Figure 5.3 Construction and identification of BAV.dV. A) Schematic diagram of 
plasmid pUC304A.dV DNA.  B) Direct fluorescence. Monolayer of CRL.pV cells were 
transfected with 7.5ug pUC304A.dV plasmid DNA and visualized for the expression of 
EYFP and development of cytopathic effects using fluorescent microscope TCS SP5 
(Leica). C) Restriction enzyme analysis of BAdV-3 genomes. The viral DNA was 
extracted from CRL cells infected with BAV304a (lane 1) or BAV.dV (lane 2), digested 
with KpnI and analyzed by agarose gel electrophoresis. Lane M, GeneRuler 1kb DNA 
ladder (Thermo Fisher Scientific) was used for sizing the viral DNA fragments. 
Diagnostic bands are indicated with white arrows. Sizes of markers are shown on the left 
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of the panel. D) Western blot. Proteins from the lysates of BAV304a infected CRL cells 
(lane 1), BAV.dV infected CRL cells (lane 2) or uninfected CRL.pV cells (lane 3) were 
separated by SDS-PAGE, transferred to nitrocellulose membrane and probed in Western 
blot by using rabbit anti-pV anti-serum and Alexa Fluor 680 conjugated goat anti-rabbit 
antibody (Invitrogen). The position of the molecular weight in kDa is shown on the left of 
the panel. The molecular weight in kDa of the observed protein is shown on the right of 
the panel. E) CsCl gradient purification. The lysates of CRL.pV or CRL infected with 
BAV.dV were separated by centrifugation through continuous CsCl gradient and 
centrifuge tubes were photographed. f) Virus growth. Confluent monolayers of CRL cells 
were infected with BAV304a or BAV.dV at a MOI of 2. At different times post infection, 
the cell pellets were collected, freeze-thawed, and virus was titrated on CRL.pV cells as 
described previously (Ugai et al., 2007). Each values represents average of two 
independent repeats and error bars indicate the standard deviations. 
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5.3.5 Analysis of protein expression in BAV.dV infected cells 
To analyze if deletion of pV influences the expression of viral proteins, monolayers 
of CRL cells were infected with BAV304a or BAV.dV at MOI of 2. At 24 hrs post-
infection, the cells were harvested and lysed. The proteins from the cell lysates were 
separated by SDS-PAGE, transferred to nitrocellulose membrane and probed by protein 
specific anti-serum and secondary antibodies conjugated with fluorophores. Finally, the 
membranes were scanned and analyzed by Odyssey CLx Imaging System. As expected 
(Fig 5.4A, B), the expression of pV could be detected in BAV304a infected CRL cells 
but not in BAV.dV infected CRL cells.  No appreciable difference could be detected in 
the expression of early DBP protein in CRL cells infected with BAV304a or BAV.dV.  
However, compared to BAV304a, reduced expression of some late proteins, particularly 
100K, pX and pVII were observed in BAV.dV infected cells. Moreover, both precursor 
and cleaved form of pVII could be detected in BAV304a or BAV.dV infected cells. 
 
5.3.6 Analysis of BAV.dV DNA replication  
The CRL cells were infected with purified BAV304a or BAV.dV (grown in 
CRL.pV cells) at a MOI of 2. At 12, 24 or 36 hrs post infection, the cells were collected, 
washed with PBS and used to extract DNA as described (Farina et al., 2001).  The DNA 
isolated from equal number of cells was digested with restriction enzyme BmtI. Analysis 
of restriction enzyme digested DNA (Fig 5.4C) suggested that both BAV304a and 
BAV.dV replicated to similar levels in CRL cells.  
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Figure 5.4 Analysis of viral protein expression in BAV.dV infected cells. A) Proteins 
from the lysates of CRL cells were separated by SDS-PAGE, transferred to nitrocellulose 
membranes and probed by Western blot using anti-DBP (Zhou et al., 2001), anti-pVII 
(Paterson et al., 2012), anti-pV (Kulshreshtha et al., 2004), anti-pX (Paterson, 2010), anti-
Hexon (Kulshreshtha et al., 2004), anti-Fiber (Wu and Tikoo, 2004) and anti-100K 
(Makadiya et al., 2015) sera followed by Alexa Fluor 680 conjugated goat anti-rabbit 
antibody (Invitrogen). β-actin was detected by Western blot using mouse anti-β-actin 
monoclonal antibody (Sigma-Aldrich) followed by IRDye800 Conjugated goat anti-
mouse antibody (Rockland). The name of the proteins is depicted on the right of the 
panel. DBP (DNA binding protein). Early (E), Late (L). B) The results were analyzed by 
using Odyssey Infrared Imaging System. Values represent averages from two 
independent repeats and error bars indicate the standard deviations. C) DNA replication. 
Viral DNAs were extracted at indicated times post-infection with BAV304a (lane 2,4,6) 
or BAV.dV (lanes3, 5, 7) and digested with BmtI. The specific bands are indicated by 
white arrows. The sizes of markers (M) are depicted on left and right of the panel. 
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5.3.7 Analysis of protein incorporation in BAV.dV viral particles 
To determine the incorporation of pV in the progeny virions, proteins from purified 
virions were separated by 10% SDS-PAGE, transferred to nitrocellulose and probed in 
Western blot using anti-pV sera. As seen in Fig 5.5A, anti-pV detected a protein of 55 
kDa in purified BAV304a grown in CRL cells (lane 1). A protein band of similar 
molecular weight could be detected in purified BAV.dV grown in CRL.pV cells (lane 3). 
However, no such protein could be detected in BAV.dV grown in CRL cells (lane 2).   
Moreover, there was no detectable difference in the incorporation of the viral proteins in 
purified BAV304a or BAV.dV virions (grown in CRL cells or CRL.pV cells). As seen in 
Fig 5.5A, hexon and fiber proteins were efficiently incorporated in purified BAV304a 
grown in CRL cells (lane 1), purified BAV.dV grown in CRL cells (lane 2) or purified 
BAV.dV grown in CRL.pV cells (lane 3). 
 Anti-pVII serum detected both precursor and cleaved form of pVII in BAV304a 
infected cells (Fig 5.5B, lane 2) or BAV.dV infected CRL cells (Fig 5.5B, lane 4) or 
CRL.pV cells (Fig 5.5B, lane 6). As expected, a protein consistent with the cleaved form 
of pVII could be detected in purified BAV304a grown in CRL cells (Fig 5.5B, lane 1), 
purified BAV.dV grown in CRL cells (Fig 5.5B, lane 3) or grown in CRL.pV cells (Fig 
5.5B, lane 5). Similarly, a cleaved form of pVIII is incorporated in purified BAV304a 
grown in CRL cells (Fig 5.5A, lane 1), BAV.dV grown in CRL cells (Fig 5.5A, lane 2) or 
BAV.dV grown in CRL.pV cells (Fig 5.5A, lane 3).  
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Figure 5.5 Analysis of viral protein incorporation in purified virions. A) Proteins 
from the purified BAV304a grown in CRL cells (lane 1), BAV.dV grown in CRL cells 
(lane 2), BAV.dV grown in CRL.pV cells were separated by 10% SDS-PAGE, 
transferred to nitrocellulose and probed in Western blot using protein specific antisera. B) 
Proteins from purified BAV304a grown in CRL cells (lanes 1), BAV.dV grown in CRL 
cells (lane 3), BAV.dV grown in CRL.pV cells (lane 6) or proteins from the lysates of 
CRL cells (lane 2, 4) infected with BAV304a (lane 2), BAV.dV (lane 4) and CRL.pV 
cells infected with BAV.dV (lane 6) were separated by 10% SDS-PAGE, transferred to 
nitrocellulose and probed in Western blot by anti-pVII serum (Paterson, 2010). Purified 
virus (PV); infected cell (IC). 
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 5.3.8 Analysis of BAV.dV by transmission electron microscopy 
To examine if the deletion of pV affects the formation of BAdV-3 particles, CRL 
cells were infected with BAV304a or BAV.dV at an MOI of 2. At 24 hrs post infection, 
the cells were collected, processed and analyzed by TEM. As seen in Fig 5.6A, BAV304a 
(panel 3,4) appeared to produce more viral particles than BAV.dV (panel 5,6) in infected 
CRL cells. Moreover, BAV304a particles were uniform and loosely arranged (panel 3). 
In contrast, BAdV.dV particles appeared to be clustered together and appeared tightly 
organized in rows (panel 5). Analysis of the enlargement of selected areas of TEM 
images suggested that BAV304a are clearly of typical icosahedral in shape (panel 4). 
However, BAV.dV showed less clear morphology and did not possess clear icosahedral 
shape (panel 6). No such virions could be detected in mock-infected CRL cells (Fig 5.6A, 
panel 1,2) 
 Next, we analyzed the CsCl purified BAV304a or BAV.dV (grown in CRL cells) 
by TEM. The analysis of mature BAV304a virions detected intact capsids with typical 
icosahedral shape (Fig 5.6B, panel 1, 2). In contrast, most of the BAV.dV particles 
appeared circular in shape with partially degraded capsids (Fig 5.6B, panel 3, 4) 
 
5.3.9 Thermostability of BAdV.dV 
 To determine if the deletion of pV alters viral thermostability, purified viral 
particles in PBS containing 10% glycerol were incubated at different temperatures (-
80C, -20C, 4C, 25C and 37C) for 3 days or incubated at different temperatures (-
80C, 4C and 37C) for 0, 1, 3 and 7 days.  Finally, the infectivity was measured by 
TCID50 assay. As seen in Fig 5.7A, there appeared no difference in the thermostability or 
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dynamics of viral inactivation of BAV304a or BAV.dV grown in CRL.pV cells. In 
contrast, both thermostability and dynamics of viral inactivation of BAV.dV grown in 
CRL cells appeared significantly different from BAV304a (Fig 5.7B).  
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Figure 5.6 Electron microscopic analysis. A) Uninfected (panel 1), BAV304a infected 
(panel 3) or BAV.dV infected (panel 5) CRL cells. The arrows depicted the enlargement 
of selected boxed  (red) region of panel 1 (panel 2), panel 3 (panel 4) and panel 5 (panel 
6). B) Purified BAV304a (panel 1) or BAV.dV (panel 2). The arrows depicted the 
enlargement of selected boxed (red) region of panel 1 (panel 2) and panel 3 (panel 4). 
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Figure 5.7 Thermostability of BAdV-3.  A) Viruses grown in CRL.pV cells. Purified 
virions (105 TCID50) grown in CRL.pV cells were incubated at various temperatures for 3 
days (panel 1) and the residual viral infectivity was determined by titration on CRL.pV 
cells. Purified BAV304a (panel 2) or BAV.dV (panel 3) (105 TCID50) grown in CRL.pV 
cells were incubated at different temperatures for indicated periods of time and the 
residual viral infectivity was determined by titration on CRL.pV cells. B) Viruses grown 
in CRL cells. Purified virions (104 TCID50) grown in CRL cells were incubated at various 
temperatures for 3 days (panel 1) and the residual viral infectivity was determined by 
titration on CRL.pV cells. Purified BAV304a (panel 2) or BAV.dV (panel 3) (104 TCID50) 
grown in CRL cells were incubated at different temperatures for indicated periods of time 
and the residual viral infectivity was determined by titration on CRL.pV cells. 
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5.4 DISCUSSION 
The members of Mastadenovirus genus encode genus-specific unique proteins 
including pIX and pV (Davison et al., 2003). Earlier work has suggested that HAdV-5 pV 
protein is essential for virus replication in primary cells and may participate in virus 
assembly (Ugai et al., 2012). Moreover, pV may act as a bridge between the core and the 
capsid proteins of HAdV-5 (Chatterjee et al., 1985; Lehmberg et al., 1999; Matthews and 
Russell, 1998a; Vayda et al., 1983). The L2 region of BAdV-3 encodes pV, which shows 
28%-41% homology to pV encoded by other members of Mastadenovirus genus (Reddy 
et al., 1998). Since recent reports suggest that positional homologs of proteins encoded by 
human and animal adenoviruses of Mastadenovirus genus may differ in their structure 
and function (Li et al., 2009), we sought to determine the function of pV in BAdV-3 
replication. 
The pV appears essential for the replication of BAV304a as production of viable 
infectious BAV.dV required the isolation of helper cell line providing the pV protein in 
trans. Further analysis of BAV.dV demonstrated no significant difference in the 
infectivity and DNA replication of mutant BAV.dV and BAV304a. Moreover, no affect 
was observed in the early gene expression in BAV.dV infected cells. Despite down 
regulation of some late protein expression, the capsid formation and the virus assembly 
appeared to occur in BAV.dV infected cells suggesting that pV may not be essential for 
virion assembly. Earlier report suggested that pV is essential for the replication of HAdV-
5 in primary cells but not in cancer cells (Ugai et al., 2012). However, BAdV-3 pV 
appears essential for replication in primary CRL cells and continuous MDBK cells.    
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Although, BAV.dV does not appear to produce infectious progeny virions in CRL 
cells, the capsid formation and the virus assembly appears to occur in BAV.dV infected 
CRL cells as CsCl gradient analysis of BAV.dV infected CRL cells produced virions 
banding at CsCl gradient density consistent with the formation of mature virions. 
Moreover, the deletion of pV does not significantly affect the incorporation of other 
structural proteins. However, the analysis of these mature virions by TEM revealed that, 
compared to BAV304a, the capsids of BAV.dV did not appear icosahedral in shape and 
most of the capsids did not appear to be intact. These results suggest that deletion of 
BAdV-3 pV may not significantly alter the virus assembly, but instead make virion 
capsid more fragile leading to the detectable changes in virion morphology and 
infectivity.  
The deletion of pV did not affect the expression of early gene product namely DBP. 
However, the expression of late proteins particularly 100K, pX and pVII appeared down 
regulated in BAV.dV infected cells, suggesting that pV may be involved in the regulation 
of late gene expression probably by acting on major late promoter (Leong et al., 1990).  
Similar results have been earlier reported for HAdV-5 pV (Ugai et al., 2007).  
The production of infectious progeny adenovirus requires a maturation step 
involving the cleavage of capsid and core proteins by adenovirus protease (Anderson et 
al., 1973). However, the significance of cleavage of each precursor protein in determining 
the infectivity is not clear (Mangel and San Martín, 2014). Analysis of viral protein 
expression in BAV.dV infected cells revealed that deletion of pV did not significantly 
inhibits the cleavage of pVII. Similarly, analysis of purified BAV.dV demonstrated that 
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mainly the cleaved form of pVII or pVIII could be detected in purified mature BAV.dV 
virions. 
Unlike primary cells (Ugai et al., 2012) , HAdV-5 pV is not required for virus 
replication and formation of infectious virus particles in cancer cells (Ugai et al., 2012). 
This is due to apparent thermostable mutations (G13E and R17I) in the less conserved 
region of core protein X/Mu, which compensate for the lack of pV (Ugai et al., 2007). 
These mutations increase the expression of X/Mu, which helps to stabilize the capsid thus 
compensating the absene of pV.Moreover, analysis of CsCl gradient purified pV deleted 
HAdV-5 grown in cancer cells show increased incorporation of protein X\Mu in mature 
virions. In contrast, pV appears essential for the replication of BAdV-3 CRL or MDBK 
cells.  Despite conservation of arginine residue at amino acid 20 of BAdV-3 pV (Ugai et 
al., 2007), analysis of DNA sequence of different clones of BAV.dV grown (different 
passages) in CRL or MDBK cells did not reveal any mutation in the core proteins X\Mu 
or pVII (data not shown). Because of unavailability of reagents, the incorporation of the 
X\Mu could not be analyzed in CsCl gradient purified BAV.dV grown in CRL cell. Our 
results suggest that deletion of pV does not introduce compensatory mutations in core 
proteins X\Mu or pVII. 
In summary, we have demonstrated that BAdV-3 pV is essential for the replication 
of BAdV-3 in CRL (primary) and MDBK (continuous) cells. Analysis of BAV.dV 
suggested that pV appears to be required for maintaining the integrity of the capsid 
structure and helps in stability of BAdV-3 capsid. However, lack of pV did not introduce 
any compensatory mutations in other core proteins x\Mu or pVII. Moreover, pV may 
have a role in the proteolytic cleavage of pVII. 
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6.0 TRANSITION FROM SECTION 5.0 TO SECTION 7.0 
Viruses have relatively small genomes that cannot encode enough proteins for their 
replication; thereby they hijack many different cellular machineries, such as transcription 
and translation systems. They also have to evade the host immune system to finish their 
life cycles. To fulfill these processes, various cellular proteins are recruited for viral 
replication via protein-protein interaction. In the previous studies, pV has been proved to 
locate to nucleolus, regulate viral protein expression and mediate viral assembly. And all 
of these functions are probably realized by interaction of pV with cellular/viral proteins. 
To figure out which cellular/viral proteins can interact with pV and what biological 
significances these interaction have, the following chapter was performed.  
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7.0 INTERATION OF pV WITH CELLULAR/VIRAL PROTEINS AND THEIR 
BIOLOGICAL SIGNIFICANCE  
7.1 INTRODUCTION 
BAdV-3 belongs to Mastadenovirus genus in Adenoviridae family, and has been 
developed as a vector for vaccination in animals (Reddy et al., 1999b). It is also a 
promising vaccine vector for human, because the pre-existing immunity of human 
adenoviruses influences the efficiency of human adenovirus-based vectored vaccines 
significantly (Zakhartchouk et al., 2007). Like the other members of Adenoviridae 
family, BAdV-3 is a non-enveloped icosahedral particle with a double-stranded DNA 
genome, which is organized into early, intermediated and late regions (Reddy et al., 
1998). Early and intermediate proteins encoded by early and intermediate regions, 
respectively, are required for cell cycle modulation, DNA replication, and host immune 
response evision. In contrast, late proteins are all encoded by the major late transcription 
unit (MLTU), which is activated after the onset of viral DNA replication and controlled 
by the major late promoter (MLP). 
Protein-protein interaction plays an indispensible role in all stages of adenovirus 
life cycle to realize different purposes. To enter host cells, adenovirus fiber knob firstly 
interacts with cellular receptors, which followed by the Penton RGD motif interaction 
with integrins (Arnberg, 2009). Adenovirus modulates cell cycle via E1A protein 
interaction with cellular regulatory proteins and transcription factors (Avvakumov et al., 
2002), and inhibits apoptosis by E1B proteins interaction with tumor suppressor p53 
(Ben-Israel and Kleinberger, 2002) or pro-apoptotic protein BAK and BAX (Cuconati et 
al., 2003). The interaction between DBP, pTP and DNA pol are required for the initiation, 
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elongation and termination of viral DNA replication (van Breukelen et al., 2003). 
Adenovirus late proteins also interact with other viral or cellular proteins to facilitate 
viral assembly. Many interactions of adenovirus late proteins have been reported, such as 
52/55K and IVa2 or 33K (Ahi et al., 2015), 52/55K and pVII (Zhang and Arcos, 2005), 
pVI and hexon (Wodrich et al., 2003), 33K with 100K or pV (Kulshreshtha and Tikoo, 
2008), etc. 
The protein V (pV) is the only protein encoded by BAdV-3 L2 region (Reddy et al., 
1998). It is 423 amino acids in length and with 150-180 copies in each viral particle 
(Puntener et al., 2011; Ugai et al., 2012). As a structural protein, pV bridges the capsid 
and viral DNA to stabilize the viral particle by interacting capsid protein pVI (Matthews 
and Russell, 1998b) and core protein pVII (Harpst et al., 1977).  Besides, pV has been 
proved to play other functions in adenovirus replication. Human adenovirus pV interacts 
with a mitochondria-nucleus shuttle protein p32, and this interaction may be involved in 
viral particle transport from the cytoplasm to the nucleus after the release from the 
endosome (Matthews and Russell, 1998a). In another study, pV has been proved to 
interact with a nucleolar protein B23, and this interaction may be associated with the 
redistribution of nucleolin and B23 from nucleolus to cytoplasm and nucleoplasm 
(Samad et al., 2007).  
Nucleolin, which is predominantly located in the nucleolus, is one of the most 
abundant nucleolar proteins in the cell (Tajrishi et al., 2011). It is organized into three 
different domains: N-terminus, central and C-terminus (Tajrishi et al., 2011), and they are 
featured with different functional domains (Storck et al., 2009) and undergoes different 
post-translational modifications (Durut and Saez-Vasquez, 2015). As a multifunctional 
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protein, nucleolin is associated not only with ribosome biosynthesis (Ginisty et al., 1998; 
Rickards et al., 2007) but also with other cellular processes, such as regulation of RNA 
pol II based transcription (Mongelard and Bouvet, 2007), post-transcription translation 
(Jiang et al., 2014), DNA repair (Kobayashi et al., 2012; Lim et al., 2015), cell cycle 
regulation (Ugrinova et al., 2007; Wang et al., 2014a). Moreover, nucleolin functions in 
different viruses replication by interacting with viral proteins, such as rabies virus P3 
(Oksayan et al., 2015), hepatitis C virus NA5B (Shimakami et al., 2006), herpes simplex 
virus ICP8 (Calle et al., 2008), feline calicivirus NS6 and NS7 (Cancio-Lonches et al., 
2011), and for other viruses, nucleolin can facilitate their cellular entry by serving as a 
cellular receptor, including human respiratory syncytial virus (Tayyari et al., 2011), 
human parainfluenza virus type 3 (Bose et al., 2004) and enterovirus 71 (Su et al., 2015). 
Here, we report the interaction of BAdV-3 pV with viral and cellular proteins, confirm 
the interaction between pV and nucleolin and elucidate what functions this interaction 
may play in BAdV-3 replication. 
 
7.2 MATERIALS AND METHODS 
7.2.1 Cell lines and viruses 
Madin-Darby bovine kidney (MDBK) cells and VIDO DT1 (cotton rat lung 
fibroblast expressing endonuclease I-SceI [CRL-I-SceI]) cells (Du and Tikoo, 2010) were 
propagated in minimum essential medium (MEM) (Sigma Aldrich) supplemented with 10% 
fetal bovine serum (FBS) (Invitrogen). VERO cells and HEK293T cells were cultured in 
Dulbecco’s modified eagle’s medium (DMEM) supplemented with 5% FBS. Wild-type 
 145 
BAdV-3 and BAdV-3 expressing strep-tagged pV (BAV.ST) were grown in MDBK cells 
in MEM supplemented with 2% FBS (Invitrogen).  
 
7.2.2 Antibodies 
Production and characterization of BAdV-3 protein specific sera, namely anti-pV 
serum (Zhao and Tikoo, 2016, manuscript in preparation), anti-DBP serum (Kulshreshtha 
et al., 2004), anti-hexon serum (Kulshreshtha et al., 2004), anti-fiber serum (Wu and 
Tikoo, 2004), anti-pVII serum (Paterson et al., 2012) and anti-pX have been described. 
Anti-β-actin monoclonal antibody (Sigma-Aldrich), C23 antibody (MS-3) (Santa Cruz 
Biotechnology), alkaline phosphates (AP)-conjugated goat anti-rabbit antibody (Jackson 
Immunoresearch), Alexa Fluor 647-conjugated goat anti-rabbit IgG, Alexa Fluor 680 
conjugated goat anti-rabbit antibody (Invitrogen), and IRDye800 Conjugated goat anti-
mouse antibody (Rockland) were purchased. 
 
7.2.3 Plasmids construction  
The construction of plasmids pUC304A+ (contains insertion of EYFP in E3 region 
of pFBAV302) (Baxi et al., 2000), pUC304A.dV containing deletion of pV Orf 
(nucleotide 15068 to 16340) (Zhao and Tikoo, 2016, manuscript in preparation), 
pMCS.pV containing pV Orf and flanking sequences have been described (Zhao and 
Tikoo, 2016, manuscript in preparation). Plasmid pDsRed.NCL and pDsRed.B23, a gift 
from Dr. Denis Archambault, encode fusion protein DsRed with nucleolin and B23, 
respectively (Gomez Corredor and Archambault, 2012). Plasmid pLV-DDX3i#3, a gift 
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from Dr. Kato Nobuyuki, encodes shRNA of DDX3 (Ariumi et al., 2007). Plasmid 
pSUPER was purchased from Oligoengine. 
a) pUC304A.pVStrep. A 529-bp DNA fragment amplified by PCR using primers dV-F1-
F and pV-ST-F1-R (Table 7.1), and plasmid pUC304A+ DNA as a template. A 1787-bp 
DNA fragment amplified by PCR using primers pV-ST-F2-F and dV-F2-R (Table 7.1), 
and plasmid pUC304A+ DNA as a template. In the third PCR, these two PCR fragments 
were annealed and used to amplify a 2270-bp fragment with a Strep-tag II encoding 
sequence (Schmidt and Skerra, 2007) by overlapping PCR using primers dV-F1-F and 
dV-F1-F (Table 7.1). An 1190-bp EcoRI-SacI fragment of the 2270-bp PCR fragment 
was ligated to EcoRI-SacI digested plasmid pMCS.pV to create plasmid pMCS.pV-ST. 
Finally, the SbfI digested plasmid pUC304.dV was recombined with a 6.2-kb EcoRV-
Bst1107I fragment of pMCS.pV-ST to generate plasmid pUC304A.pVStrep. 
b) pEY-pV. A 1291-bp DNA fragment was amplified by PCR using primers pV-EYXhoI-
F and pV-EYBamHI-R (Table 7.1), and plasmid pUC304A+ DNA as a template.  A 
1277-bp BamHI-XhoI fragment of the 1291-bp PCR fragment was ligated to BamHI-XhoI 
digested plasmid pEYFP-N1 (Clontech) to create plasmid pEY-pV. 
c) pRDI292-1117, pRDI292-1298 and pRDI292-1453. Sense and antisense 
oligonucleotide primer pairs targeting nucleolin, Bncl1117-S and Bncl1117-AS;  
Bncl1298-S and Bncl1298-AS;  Bncl1453-S and Bncl1453-AS, were annealed to 
generate 68-bp HindIII-BglII double-stranded DNA fragments and ligated to pSUPER 
(Oligoengine) to construct plasmids pSUPER-1117, pSUPER-1298 and pSUPER-1453, 
respectively. A 322-bp BamHI-SalI fragment of plasmids pSUPER-1117, pSUPER-1298 
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or pSUPER-1453 was individually ligated to HindIII-BglII digested pLV-DDX3i#3 to 
create plasmids pRDI292-1117, pRDI292-1298 and pRDI292-1453, respectively. 
 
7.2.4 Isolation of BAV.ST 
Monolayers of VIDO-DT1 cells in six-well plate were transfected with 5-7.5 ug of 
plasmid pUC304A.pVstrep with Lipofectamine 2000 (Invitrogen). At 4-hour post-
transfection, the medium was replaced with fresh MEM containing 2% FBS and cells 
were observed for fluorescence expression and cytopathic effects. The transfected cells 
showing cytopathic effect (CPE) were harvested, freeze-thawed three times and 
propagated in MDBK cells.  
 
7.2.5 Western blotting 
MDBK cells (mock infected or virus infected) or purified viruses were analysed 
by Western blot using protein-specific antisera and alkaline phosphatase (AP)-
conjugated goat anti-rabbit IgG (Sigma) or Alexa Fluor 680-conjugated goat anti-rabbit 
antibody (Invitrogen) or IRDye800-conjugated goat anti-mouse antibody (Rockland). 
Finally, the membranes were imagined and analyzed using the Odyssey infrared 
imaging system (Licor). 
 
7.2.6 Immunofluorescence microscopy 
MDBK cells infected with BAV304a or BAV.ST or VERO cells transfected with 
indicated plasmid DNA were fixed with 3.7% paraformaldehyde for 15 min and 
permeabilized with PBS supplied with 0.5% Triton X-100. The cells were then blocked  
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Table 7.1 List of primers used for PCR. 
Name Sequence 
dV-F1-F          5’-TGATCCGGTGGCCGACACAATCGAG-3’ 
pV-ST-F1-R 5’-TGCGCTTGTAGATCTTCTCGAATTGTGGGTGTGACCACTC 
AGGCGCCACGATGTCTAAC-3’ 
pV-ST-F2-F 5’-GCGCCTGAGTGGTCACACCCACAATTCGAGAAGATCTAC 
AAGCGCAAACGGCCCAG-3’ 
dV-F2-R 5’-GTCCATGGCGTGTTAACAAGCTGTG-3’ 
pV-EYXhoI-F 5’-TCGACTCGAGATGGCCTCCTCTCGGTTGATTAAAG-3’ 
pV-
EYBamHI-R 
5’-TATAGGATCCAAACGGCGGAGCCGGGTTACTGTG-3’ 
Bncl1117-S 5’- GATCCCCGCCTTGGAACTCACTGGTTTATTCAAGAGATAA  
ACCAGTGAGTTCCAAGGCTTTTTGGAAA-3’ 
Bncl1117-AS 5’-AGCTTTTCCAAAAAGCCTTGGAACTCACTGGTTTATCTCTT 
GAATAAACCAGTGAGTTCCAAGGCGGG-3’ 
Bncl1298-S 5’- GATCCCCGCAAGGATGGAAAGAGTAAAGTTCAAGAGACT  
TTACTCTTTCCATCCTTGCTTTTTGGAAA-3’ 
Bncl1298-AS 5’- AGCTTTTCCAAAAAGCAAGGATGGAAAGAGTAAAGTCTC  
TTGAACTTTACTCTTTCCATCCTTGCGGG-3’ 
Bncl1453-S 5’-GATCCCCGGTGGAAAGAACAGCACTTGGTTCAAGAGAC 
CA AGTGCTGTTCTTTCCACCTTTTTGGAAA-3’ 
Bncl1453-AS 5’ AGCTTTTCCAAAAAGGTGGAAAGAACAGCACTTGGTCTC 
TT GAACCAAGTGCTGTTCTTTCCACCGGG-3’ 
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with 5% goat serum, and and then incubated with rabbit anti-serum and Alexa Fluor 647-
conjugated goat anti-rabbit antibody (Jackson Immunoresearch). Finally, the cells were 
mounted using mounting buffer (Vector Laboratories Inc.) with DAPI and imagined 
under the confocal microscope TCS SP5 (Leica). 
 
7.2.7 CsCl gradient centrifugation 
Monolayers of MDBK cells in T-150 Flasks were infected with BAV304a or 
BAV.ST at a multiplicity of infection of 5. At 48 h post-infection, the cells were 
collected, freeze-thawed three times and the cell lysates was subjected to CsCl density 
gradient centrifugation at 35 000 rpm for one hour at 4C. The bands containing viruses 
were collected and subjected to a second centrifugation at 35 000 rpm for overnight at 
4C. Finally, the virus band was collected, dialyzed three times to remove the trace 
amount of CsCl and stored in small aliquots at -80C. 
 
7.2.8 Virus single-cycle growth curve 
Monolayers of MDBK cells in 24-well plate were infected with BAV304a or 
BAV.ST at a MOI of 1. At indicated times post-infection, the infected cells were 
harvested, lysed by freeze-thawing three times to released the virus into medium and 
used to determine virus titers byTCID50 as described (Kulshreshtha et al., 2004). 
 
7.2.9 Analysis of protein expression  
Monolayers of MDBK in six-well plate were infected with BAV304a or 
recombinant BAV.ST at a MOI of 1. At 24h post-infection, the cells were harvested and 
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probed by Western blot using protein-specific rabbit antisera or mouse anti-β-actin 
(Sigma) as primary antibodies, Alexa Fluor 680 goat anti-rabbit (Rockland) or IRDye 
800 goat anti-mouse (Invitrogen) as secondary antibodies. Finally, the membranes were 
imagined and analyzed by using the Odyssey infrared imaging system (Licor). 
 
7.2.10 Purification and identification of Strep-tagged protein complexes 
MDBK cells were infected with BAV304a or BAV.ST at a MOI of 5. At 24 hour 
post-infection, the cells were washed with PBS and lysed with cell lysis buffer (Cell 
signaling technologies) supplemented with phenylmethylsulfonyl fluoride (PMSF). The 
cell lysates were centrifuged at 14,000×g for 15 min at 4 C. Supernatant was collected 
and subjected to the strep-tagged protein complex purification by using Strep-tactin 
sepharose according to the manufacturer’s instruction with minor modifications. Briefly, 
the Strep-tactin sepharose was washed extensively with buffer W (100 mM Tris-Cl, pH 
8.0, 150 mM NaCl, 1 mM EDTA), followed by the incubation of the supernatant and the 
prewashed sepharose at 4 C. After overnight incubation, the lysate-sepharose mixture 
was transferred to a polyprolene column. After non-specific binding proteins were 
washed off thoroughly with buffer W, proteins attached to the sepharose were eluted with 
buffer E (buffer W containing 2.5 mM desthiobiotin). Finally, the protein samples were 
concentrated with an MWCO 10 kDa centrifugal filter (Millipore) and sent for mass 
spectrometry by LC-MS/MS. 
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7.2.11 Co-immunoprecipitation 
MDBK cells were infected with mutant BAdV-3s at MOI of 2. At 24 hrs post-
infection, the cells were washed with PBS and lysed with cell lysis buffer supplemented 
with PMSF. After centrifugation at 14,000×g for 15 min at 4 C, the supernatant was 
incubated with anti-pV serum and protein A sepharose beads (GE Healthcare) overnight 
at 4 C. After extensive washes to remove the non-specific binding, the proteins attached 
to the beads were eluted, and subjected to SDS-PAGE and detected by Western blot 
using C23 antibody (MS-3) (Santa Cruz Biotechnology) and IRDye800 Conjugated goat 
anti-mouse antibody (Rockland). 
 
7.2.12 Nucleolin knockdown 
To knockdown the expression of nucleolin, the second generation replication 
defective lentivirus system was used (Du and Tikoo, 2010).  Briefly, HEK293T cell were 
co-transfected with plasmids pRDI292-1117+pSPAX2+pMD2G DNAs, plasmids 
pRDI292-1298+pSPAX2+pMD2G DNAs or plasmids pRDI292-1453 + pSPAX2 + 
pMD2G DNAs. At 48 hrs post-transfection, the lentivirus in media was collected and 
used to transduce CRL cells in the presence of 8ug/ul polybrene. At 24 hrs post-
transduction, the transduced cells were transferred to 10 cm2 dishes. After 24 hrs, the 
transduced cells were cultivated in medium containing 5ug/ml of puromycin. The 
puromycin-resistant cell clones were picked, propagated in puromycin-containing media 
and tested by Western blot using C23 antibody (MS-3) (Santa Cruz Biotechnology). 
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7.3 RESULTS 
7.3.1 Construction of BAdV-3 with strep-tagged pV  
To determine if pV interacts with other viral or cellular proteins during viral 
infection, we attempted to isolate recombinant BAdV-3 containing Strep-Tag II motif 
(WSHPQFEK) inserted in pV Orf. Since deletion of amino acid 20-50 of pV did not alter 
the biological properties of BAdV-3 (Zhao and Tikoo, 2016, manuscript in preparation), 
we constructed a plasmid pUC304A.pVstrep containing full length genomic DNA of 
BAV304a with insertion of Strep-tag motif between amino acid 18EI19 of pV Orf. The 
transfection of VIDO DT1 cells with 5-7.5ug of pUC304A.pVstrep DNA produced 
cytopathic effects in 9 days (Fig 7.1). The cells showing cytopathic effects were collected; 
freeze-thawed and recombinant virus named BAV.ST was propagated in MDBK cells. 
The presence of Strep-tag in pV was confirmed by DNA sequencing and restriction 
endonuclease (RE) analysis of BAV.ST genomic DNA.  The DNAs isolated from MDBK 
cells infected with BAV.ST or BAV304a were digested with BglII (since an additional 
BglII recognition site was introduced into the viral genome of BAV.ST) and analyzed by 
agarose gel electrophoresis. As shown in Fig 7.2A, two DNA fragments of 6.1 kb and 1 
kb were detected in BAV304a genome. In contrast, two DNA fragments of 5.1 kb and 1 
kb were detected in BAV.ST  (Fig 7.2A).  
The expression of recombinant protein in infected cells was analyzed by Western 
blot analysis using anti-pV serum. As seen in Fig. 7.2B, a 55 kDa protein was detected in 
both BAV304a and BAV.ST infected cells. 
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7.3.2 Characterization of BAV.ST 
To determine if insertion of Strep-tag in BAdV-3 pV affects the replication of 
BAV.ST, we performed single step growth assay. Briefly, monolayers of MDBK cells 
were infected with BAV304a or BAV.ST at a MOI of 2. At indicated times post-
infection, the infected cells were collected, freeze-thawed three times, and virus titers 
were determined in MDBK cells using TCID50 assay.  As seen in Fig 7.3 BAV304a or 
BAV.ST exhibited similar growth characteristics.  
Since alterations in pV expression can affect the expression of other viral proteins 
in infected cells without affecting the incorporation of the viral proteins in progeny 
virions (Zhao and Tikoo, 2016, manuscript in preparation), we determined the effect of 
the Strep-tag insertion in pV on the expression of early and late viral proteins in 
BAV304a or BAV.ST infected MDBK cells by Western blot using protein specific sera. 
As seen in Fig 7.4, the expression of DNA binding protein, an early protein appeared 
similar in BAV304a or BAV.ST infected cells. Hexon, Fiber, pV and pX in BAV.ST 
infected cell was slightly lower in BAV304a infected cells by approximately 10%-25%. 
However, expression of 100K and pVII was significantly decreased by 70% and 80%, 
respectively. 
The subcellular localization of pV-ST was examined by confocal microscopy. CRL 
cells were firstly transfected with pDsRed-B23, which expresses a fusion protein 
composed of a red fluorescent protein DsRed and a nucleolar marker B23. At 48 hours 
post-transfection, cells were infected with BAV304a or BAV.ST at a MOI of 1. At 24 
hours post-infection, cells were fixed with 3.7% paraformaldehyde, and then pV or pV-
ST were stained with anti-pV serum and Alexa Fluor 647-conjugated goat anti-rabbit IgG,  
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Figure 7.1 Isolation of pV deleted BAdV-3. A) Schematic diagram of indicated plasmid 
DNA. Thick black box represents BAdV-3 genomic DNA. Red box represents pV with 
Strep-tag. Thin lines represent plasmid DNA. The human cytomegalovirus immediate 
early promoter (CMV), enhanced yellow fluorescent protein gene (EYFP), ampicillin 
resistance gene (Amp), early region 3 (E3) and pV location is depicted. B) Direct 
fluorescence. Monolayer of VIDO DT1 cells (Du and Tikoo, 2010) were transfected with 
7.5ug indicated plasmid DNAs and visualized for the expression of EYFP and 
development of cytopathic effects using fluorescent microscope TCS SP5 (Leica). 
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Figure 7.2 Identification of BAV.ST. A) Restriction enzyme analysis of BAV304a or 
BAV.ST genomes. The viral DNAs were extracted from VIDO DT1 cells infected with 
BAV304a (lane 1) or BAV.ST (lane 2), digested with BglII and analyzed by agarose gel 
electrophoresis. Lane M, GeneRuler 1kb DNA ladder (Thermo Fisher Scientific) was 
used for sizing the viral DNA fragments. Diagnostic bands are indicated with white 
arrows. Sizes of markers are shown on the right of the panel. B) Western blot. Proteins 
from the lysates of BAV304a infected VIDO DT1 cells (lane 1), BAV.ST infected VIDO 
DT1 cells (lane 2) or uninfected VIDO DT1 cells (lane 3) were separated by SDS-PAGE, 
transferred to nitrocellulose membrane and probed in Western blot by using rabbit anti-
pV anti-serum and AP-conjugated goat anti-rabbit antibody (Jackson Immunoresearch). 
The position of the molecular weight in kDa is shown on the left of the panel. The 
molecular weight in kDa of the observed protein is shown on the right of the panel. 
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Figure 7.3 Virus titers. Monolayers of MDBK cells were infected with BAV304a or 
BAV.ST. At different time points post infection, infected cells were collected, freeze-
thawed and titrated on MDBK cells as described. Values represent averages of two 
independent repeats and error bars indicate the standard deviations.  
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Figure 7.4 Analysis of gene expression in BAV.ST infected cells. A) Proteins from 
lysates of MDBK cells infected with BAV304a (Lane 1) or BAV.ST (Lane 2) were 
separated by 10% SDS-PAGE, transferred to nitrocellulose and probed with protein 
specific antisera and Alexa Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen). 
β-actin was used as a loading control and was detected using anti-β-actin monoclonal 
antibody (Sigma-Aldrich) and IRDye800 Conjugated goat anti-mouse antibody 
(Rockland). Protein names are depicted on the right of the panel. E (Early), L(Late), DBP 
(DNA binding protein). B) The values were analyzed by using Odyssey® CLx Imaging 
System (LI-COR). Values represent averages of two independent repeats and error bars 
indicate the standard deviations. 
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followed by analysis of confocal microscopy. As seen in Fig 7.5, pV-ST was still 
predominantly located in nucleolus after the introduction of strep tag, and there was no 
detectable difference between pV and pV-ST cellular localization.  
To determine the incorporation of structural proteins in the progeny virions, 
proteins from purified virions were separated by 10% SDS-PAGE, transferred to 
nitrocellulose and probed in Western blot using protein specific sera. As seen in Fig 7.6, 
there was no detectable difference in the incorporation of the viral proteins in purified 
BAV304a or BAV.ST virions. 
 
7.3.4 Purification and identification of cellular/viral proteins interacted with pV 
After construction and characterization of recombinant BAV.ST, Strep-tag 
introduction did not influence viral replication significantly. Therefore, the newly 
constructed BAV.ST was used to determine cellular/viral proteins interacting with pV. 
To purify cellular/viral proteins interacted with pV, MDBK cells were infected with 
BAV304a or BAV.ST at the MOI of 1. At 24 hour post-infection, infected cells were 
lysed and cell lysates were subjected to protein purification using Strep-tactin sepharose 
beads. Proteins in the purified samples were separated by SDS-PAGE followed by silver 
staining of the gel. As shown in Fig 7.7, protein bands were detected after the silver 
staining in lanes with 10, 20 and 40 μl of the protein samples purified from BAV.ST 
infected MDBK; while no band was found in lanes of protein samples purified from 
BAV304a infected MDBK cells. 
To identify these cellular/viral proteins purified from BAV.ST infected MDBK 
cells, protein complexes were sent to University of Victoria-Genome BC Proteomics  
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Figure 7.5 Confocal microscopy. VIDO DT1 cells were transfected with plasmid 
pDsRed.B23 DNA and infected with indicated BAdV-3s. Infected cells were fixed at 48 
hrs post-infection. The DsRed.B23 was visualized by direct fluorescence microscopy 
(panels b, f). BAdV-3 pV (panels c, g) was visualized by indirect immunofluorescence 
microscopy using anti-pV serum and Alexa Fluor 647-conjugated goat anti-rabbit IgG. 
The nuclei were stained with DAPI.  
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Figure 7.6 Structural protein incorporation assay. Structural proteins from the 
purified BAV304a (lane 1) or BAV.ST (lane 2) grown in MDBK cells were separated by 
10% SDS-PAGE, transferred to nitrocellulose and probed by Western blot using protein 
specific antisera. Protein bands were visualized by Odyssey® CLx Imaging System (LI-
COR). Protein names are depicted on the right of the panel. 
 
 
 
 
 
 
 161 
Centre for LC-MS/MS. Cellular or viral proteins with different functions and cellular 
localizations were detected from these protein complexes. Seventeen cellular proteins 
(ribosomal proteins excluded), whose scores were higher than 200, were listed in Table 
7.2. In these identified proteins, the most abundance ones were carboxylase and proteins 
implicated with gene expression, like Y box binding protein, poly A binding protein, 
DDX21 and UPF1, which suggesting pV may play a function in cellular/viral 
transcription regulation. Three nucleolar proteins were detected: nucleolin, DDX21 and 
LYAR, suggesting pV may play a function in nucleolus or ribosome biosynthesis 
regulation. Trypsinogen, drebrin 1, histone H2A, Uracial-DNA glycosylase superfamily 
and MYH9 are also presented in the protein sample. In Table 7.3, there were 16 
ribosomal proteins whose scores were more than 200 were identified form the protein 
complexes, suggesting pV may be involved in ribosome biosynthesis or translation 
regulation. Including pV, six viral proteins, whose scores were higher than 100, were 
detected and listed in Table 7.4. 
 
7.3.5 Interaction between nucleolin and pV 
Among the identified cellular or viral proteins, we are particular interested in 
nucleolin. Since nucleolin has been identified from the protein complexes purified form 
BAV.ST infected MDBK cells with a high score, we suspected that pV can interact with 
nucleolin and this interaction may play a function in viral replication. To confirm this 
interaction, MDBK cells infected with BAV304a or BAV.dV were harvested at 24 hours 
post-infection, and the cell lysates were subjected immunoprecipitation with anti-pV 
serum and Western blot with anti-NCL antibody (C23 antibody, Santa Cruz Biotech). As  
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Figure 7.7 Silver staining of proteins interacting with pV. Proteins were purified from 
the BAV304a (Lane 3, 5, 7) or BAV.ST (Lane 2, 4, 6) infected MDBK cells by strep-
tactin sepharose beads (Ginisty et al.). 10 μl (Lane 2, 3), 20 μl (Lane 4, 5) or 40 μl (Lane 
6, 7) of purified protein samples were separated by 10% SDS-PAGE, and the gel was 
stained with silver staining. Lane 1, PageRuler Prestained Protein Ladder (Thermo Fisher 
Scientific) was used for sizing the protein bands. The position of the molecular weight in 
kDa is shown on the left of the panel. 
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Table 7.2 Cellular proteins identified from LC-MS/MS 
 Access # Score Protein Identity 
1 A4FV90 1508 Propionyl-CoA carboxylase 
2 E1BPP6 1257 Methylcrotonoyl-CoA carboxylase 
3 E1BGH6 1231 Acetyl-CoA carboxylase 
4 L8I3L1 1065 Pyruvate carboxylase  
5 E1BGC1 899 MCCC1 
6 B5ABI3 839 Y box binding protein 
7 C5IWV5 643 Trypsinogen 
8 E1BBK6 593 Nucleolin 
9 H0ZPA7 354 Poly A binding protein 
10 Q1RMT6 295 Drebrin 1 
11 G3HDT6 249 Histone H2A 
12 D5BU13 228 Uracil-DNA glycosylase superfamily 
13 F1MQ37 222 MYH9 
14 A4FV23 221 DDX21 
15 H0X7W8 215 UPF1 
 
 
Table 7.3 Ribosomal proteins identified from LC-MS/MS 
 Access # Score Protein Identity 
1 Q76MY1 434 RPS4X 
2 Q5E9E6 431 RPL10A 
3 Q4R5P9 422 RPL4 
4 O18789 392 RPS2  
5 Q58DQ3 373 RPL6 
6 Q2TBQ5 350 RPL7a 
7 Q56JV9 345 RPS3a 
8 P39872 344 RPL3 
9 Q56K10 309 RPS15 
10 P05387 300 RPLP2 
11 Q5R9R4 286 RPL7 
12 Q4R6P8 248 RPS8 
13 E2RR58 237 RPL12 
14 P62978 236 RPS27A 
15 E2QXF3 213 RPL15 
16 Q3T025 203 RPL17 
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Table 7.4 Viral proteins identified from LC-MS/MS 
 Access # Score Protein identity 
1 G9HQI4 1381 100 kDa protein 
2 G9HQH8 1116 pV 
3 071098 215 IVa2 
4 071104 168 33 kDa protein 
5 G9HQH3 153 Terminal protein 
6 071097 122 pVII 
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shown in Fig 7.8A, a band indicating nucleolin was detected with anti-NCL antibody in 
BAV304a infected MDBK sample immunoprecipitated with rabbit anti-pV serum, while 
no such band detected neither in BAV304a infected MDBK sample immunoprecipitated 
with pre-bleed rabbit serum nor in BAV.dV infected MDBK sample immunoprecipitated 
with rabbit anti-pV serum.  
To examine if pV and nucleolin share the same cellular localization, plasmid pEY-
pV (expressing fluorescent protein EYFP fused with pV) and plasmid pDsRed.B23 
(expressing fluorescent protein DsRed fused with nucleolin) were used 
individually/together to transfect/co-transfect Vero cells. Transfected cells were fixed at 
24-hour post-transfection and followed by imagined under the confocal microscope TCS 
SP5 (Leica). As shown in Fig 7.8B, both pV and nucleolin were localized in the 
nucleolus in single plasmid transfected and double plasmids co-transfected cells.  
 
7.3.6 Knockdown of Nucleolin expression  
In previous reports, nucleolin knockdown was used to study its role in viral 
replication (Oksayan et al., 2015; Su et al., 2015); herein we also tried to knockdown 
nucleolin to investigate the functions of nucleolin in BAdV-3 replication. Lentiviruses 
expressing shRNAs targeting bovine nucleolin mRNA were produced in transfected 
HEK293T cells and used to transduce MDBK cells. The difference of nucleolin 
expression between MDBK and shRNA expressing lentivirus transduced MDBK was 
detected by Western blot. As shown in Fig 7.9, compare to MDBK cells, no significant 
decrease of nucleolin expression was detected in lentiviruses transduced MDBK cells. 
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Figure 7.8 The interaction between pV and nucleolin. A) Co-IP. Lysates of MDBK 
cells infected with BAV304a (Lane 1, 2, 3) or BAV.dV (Lane 4, 5, 6) were 
immunopecipitated with anti-pV serum (Lane 1, 4) or pre-bleed serum (Lane 2, 5), 
followed by Western blot using C23 antibody (MS-3) (Santa Cruz Biotechnology) and 
AP-conjugated goat anti-rabbit antibody (Jackson Immunoresearch). B) Confocal 
microscopy. Vero cells were transfected with indicated plasmid DNAs. Transfected cells 
were fixed at 48 hrs post-transfection. DsRed-NCL and EYFP-pV were visualized by 
direct fluorescence microscopy. The nuclei were stained with DAPI. 
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Figure 7.9 Nucleolin knockdown assay. Proteins of MDBK or lentivirus transduced 
MDBK were separated by 10% SDS-PAGE, transferred to nitrocellulose and probed by 
Western blot using C23 antibody (MS-3) (Santa Cruz Biotechnology) and IRDye800 
Conjugated goat anti-mouse antibody (Rockland). β-actin was used as a loading control 
and was detected using anti-β-actin monoclonal antibody (Sigma-Aldrich) and IRDye800 
Conjugated goat anti-mouse antibody (Rockland). Protein bands were visualized by 
Odyssey® CLx Imaging System (LI-COR). Protein names are depicted on the right of the 
panel. Lentiviruses used to transduce MDBK are depicted on the left of the panel. 
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7.3.7 Interactions between nucleolin and pV mutants 
Accumulation of nucleolar proteins in the nucleolus results from their interactions 
with nucleolar components, such as ribosome RNA, DNA, and proteins (Carmo-Fonseca 
et al., 2000). The nucleolar localization signal, or called nucleolar retention signal, is 
responsible for nucleolar retention of nucleolar proteins (Musinova et al., 2011). To 
investigate if the pV nucleolar localization is because of its interaction with nucleolin, 
interactions between nucleolin and pV mutants were detected by co-immunoprecipitation. 
Briefly, MDBK cells were infected with recombinant BAdV-3s, and infected cell lysates 
were immunoprecipitated with anti-pV serum, and followed by Western blotting using 
anti-NCL antibody (C23 antibody, Santa Cruz Biotech). As shown in Fig 7.10, like 
BAV304a, anti-NCL antibody detected bands around 100 kDa representing nucleolin in 
all three recombinant BAdV-3s infected MDBK cells when anti-pV serum was used for 
immune-precipitation. However, no such band was detected in lanes when pre-bleed 
serum was used for immunoprecipitation.  
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Figure 7.10 The interaction between NoLSs deleted pV and nucleolin. Lysates of 
MDBK cells infected with BAV304a, BAV.pVd1, BAV.pVd2 or BAV.pVd1d2 were 
immunopecipitated with anti-pV serum (Lane 1) or pre-bleed serum (Lane 2), followed 
by Western blot using C23 antibody (MS-3) (Santa Cruz Biotechnology) and IRDye800 
Conjugated goat anti-mouse antibody (Rockland). 
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7.4 DISCUSSION 
BAdV-3 pV is a structural protein and bridges the viral capsid and nucleic acid core 
(Russell, 2000), but ts function in adenovirus replication is still poorly understood since 
only few studies regarding pV functions have been reported (Matthews and Russell, 
1998a, b; Samad et al., 2007). In addition, adenovirus replicates and assembles in nucleus 
while pV has been demonstrated to be predominantly in nucleolus by our previous study 
(section 3.3) and others (Matthews and Russell, 1998a, b; Puntener et al., 2011; Ugai et 
al., 2012), also suggesting pV may play a role in nucleolus to optimize BAdV-3 
replication rather than just being a structural protein.  
To purify and identify proteins interacting with pV, a Strep-tag II was introduced 
into pV Orf to construct a recombinant BAdV-3. Strep-tag II is a peptide of eight amino 
acids (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) reversibly interacts with a variant streptavidin 
Strep-tactin (Schmidt and Skerra, 2007; Voss and Skerra, 1997), thus makes it is easy to 
pull-down Strep-tag II by Strep-tactin sepharose beads. The Strep-tag is often used as a 
tag for protein purification because it does not influence protein folding or secretion as 
well as protein functions (Schmidt and Skerra, 2007). Compare to His-tag or Flag-tag, 
Strep-tag II is suitable for purification and analysis of functional protein (Lin et al., 
2012). Therefore, after the introduction of Strep-tag into pV Orf, a recombinant BAdV-3 
expressing strep-tagged pV was rescued from VIDO DT1 cells and the cellular 
localization of Strep-tagged pV was the same as the wild-type pV in infected cells. 
Moreover, the introduction of Strep-tag just slightly decreased the expression of late 
proteins, and viral replication characteristics were reduced gently after the introduction of 
Strep-tag in pV Orf. The Strep-tag II was inserted between pV amino acids 18EI19. The 
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first reason for this position is that it locates in a hydrophilic region (data not shown), 
which ensures the Strep-tag exposed on the surface of pV and accessible to its ligand 
Strep-tactin, thereby allowing the purification of protein complexes containing strep-
tagged pV from the infected cell lysates, and it is also because the amino acids 21-50 are 
dispensable for BAdV-3 replication (Section 3.3) so that the BAdV-3 replication will not 
be influenced by the introduction of Strep-tag II. 
LC-MS/MS result revealed many cellular/viral proteins that may associate with pV. 
In those five viral proteins identified from the Strep-tactin purified protein complexes, 
two proteins, protein 33K and pVII, were detected to interact with pV. This is in 
agreement with the previously studies of pV in BAdV-3 or HAdV-5 (Harpst et al., 1977; 
Kulshreshtha et al., 2004). 100K was the most abundant viral protein identified form the 
protein complexes. Although there was no study reported its interaction with pV, 
interactions of 33K with 100K or pV have been proved by our previous study 
(Kulshreshtha et al., 2004), suggesting that these three viral proteins may form a complex 
in the process of BAdV-3 replication. Mass spectrometry identified IVa2 is associated 
with pV for the first time. Several possibilities regarding this interaction can be expected. 
IVa2 may indirectly interact with pV via other viral proteins since both 33K (Ahi et al., 
2015) and pVII (Zhang and Arcos, 2005) have been proved to interact with both pV and 
IVa2. Another possibility for this interaction is that it depends on viral DNA since pV 
binds to viral DNA in a sequence-independent manner in encapsidation (Matthews and 
Russell, 1998a, b), while IVa2 binds to viral DNA for its packaging (Zhang and 
Imperiale, 2003) and major late promoter activation (Tribouley et al., 1994). Moreover, 
both pV and IVa2 are localized in the nucleolus (Lutz et al., 1996; Matthews and Russell, 
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1998b). These findings suggest that they may form a complex in the nucleolus or 
indirectly interact with each other via nucleolar components. Another viral DNA binding 
protein, pTP, was detected to interact with pV, which may also be because of its binding 
to viral DNA (Mysiak et al., 2004). 
Several proteins involved in gene expression regulation were identified by mass 
spectrometry. Nuclease-sensitive element-binding protein 1, or Y box binding protein 1 
(YBX-1), was identified to interact with pV. YBX-1 is a multifunctional protein 
(Eliseeva et al., 2011). It has been proved essential for oncolytic adenovirus in tumor 
control (Mantwill et al., 2013), and to enhance E2 gene expression (Holm et al., 2002). 
However, the function of the interaction between pV and YBX-1 is still unclear. Another 
protein, dead box helicase 21 (DDX21), also intrigued us because of its function in 
promoting AP-1 activity in innate immunity (Zhang et al., 2014) and inhibiting virus 
replication (Chen et al., 2014), which suggest pV may be involved in inhibiting host 
innate immunity. Indeed, pV has been proved to inhibit the expression of type I interferon 
and phosphorylation of interferon regulatory factor 3 (Data not shown). In addition, some 
proteins, such as carboxylase, poly A binding protein, UPF1, LYAR and some ribosomal 
proteins, were firstly detected to interact possibly with pV, but the functions of these 
interactions remain to be determined. Although B23 interacts with HAdV-5 pV in 
infected cells (Samad et al., 2007) , BAdV-3 pV does not appear to be interacting with 
B23. This may explain why B23 is not redistributed in pV expressing cells. 
Nucleolin is one of the most abundant nucleolar proteins and plays multiple 
functions in different cellular processes, such as ribosome synthesis (Rickards et al., 
2007), transcription (Grinstein et al., 2007), DNA metabolism (Jiang et al., 2014; Lim et 
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al., 2015; Wang et al., 2014a), and cell cycle regulation (Jiang et al., 2014; Lim et al., 
2015; Wang et al., 2014a). In the ribosome synthesis, nucleolin is involved in both rDNA 
transcription (Rickards et al., 2007) and pre-rRNA processing (Ginisty et al., 1998). 
Nucleolin has been proved to interact with both the UCGA motif of the pre-rRNA 
(Ginisty et al., 2000) and the U3 small nucleolar ribonucleoprotein (Kass et al., 1990), 
which is essential for the first cleavage of the pre-rRNA processing. Therefore, the pre-
rRNA may recruit the U3 small ribonucleoprotein via its interaction with nucleolin and 
the interaction of nucleolin with U3. Recently, nucleolin has been found to facilitate the 
replication of some viruses (Cancio-Lonches et al., 2011; Oksayan et al., 2015; Su et al., 
2015; Tayyari et al., 2011).  Both HAdV-5 (Lawler et al., 1989) and BAdV-3 (Paterson, 
2010) infection can inhibit the pre-rRNA processing, while the 52K, a BAdV-3 
nonstructural protein, is not involved in inhibition of pre-rRNA processing (Paterson, 
2010). 
BAdV-3 pV, a nucleolus localized protein, interact with nucleolar protein nucelolin 
as determined by the mass spectrometry data and co-immunoprecipitation. Unlike 
HAdV-5 (Matthews, 2001), the interaction and localization of both pV and nucleolin to 
nucleolus does not lead to redistribution of nucleolin to the cytoplasm. A possible 
explanation for this is that pV and nucleolin may competitively bind to the same 
nucleolar component in HAdV-5, but not BAdV-3, infected cells. Nucleolar localization 
signals deleted pV can interact with nucleolin in infected cells, suggesting that pV motif 
interacting with nucleolin is different from its nucleolar localization signals and the 
nucleolar localization of pV is not via its interaction with nucleolin. Since both pV and 
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nucleolin are also localized in the nucleoplasm (Matthews, 2001), their interaction may 
occur, at least partially, in the nucleoplasm. 
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8.0 GENERAL DISCUSSION AND CONCLUSION 
The inherent property of viruses to efficiently deliver genetic material to eukaryotic 
cells has led to the development of viruses as gene delivery vectors (Choi and Chang, 
2013; Draper and Heeney, 2010). Based on the successful development of human 
adenoviruses as a vector for humans (Draper and Heeney, 2010; Wold and Toth, 2013), 
animal species-specific adenoviruses are being evaluated as gene delivery vehicles for 
animals (Hammond et al., 2001; Mittal et al., 1995; Singh et al., 2008; Wright et al., 
2013). Our laboratory is evaluating bovine adenovirus-3 as a vaccine delivery vehicle for 
vaccination of cattle (Baxi et al., 2000; Brownlie et al., 2015; Reddy et al., 1999b; 
Zakhartchouk et al., 1998) and have demonstrated the potential of using replication-
competent bovine adenovirus-3 as vaccine delivery vector in cattle (Baxi et al., 2000; 
Brownlie et al., 2015; Reddy et al., 1999b; Zakhartchouk et al., 1998).  However, use of 
replication competent BAdV-3 vectors may raise certain regulatory concerns in future for 
registration of BAdV-3 based vaccines for use in the field.  Thus, to exploit the potential 
of using BAdV-3 as vaccine delivery vehicle in cattle, safer and more efficient vaccine 
vector based on BAdV-3 has to be developed. One way to achieve this is by developing 
disabled infectious single cycle (DISC) BAdV-3 as vector. DISC virus vectors are safer 
than replication competent virus vectors and more officious than replication defective 
vectors due to the expression of antigen gene. To develop a safe and efficient DISC 
vaccine vector based on BAdV-3, elucidation of structure and function of structural and 
non-structural proteins of BAdV-3 is essential (Boursnell et al., 1998; Rees et al., 2002). 
Earlier, analysis of BAdV-3 DNA sequence predicted to encode a protein of 423 amino 
acids, which showed variable degree of sequence identity (28%-41%) to pV encoded by 
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other members of Mastadenovirus (Reddy et al., 1998).  The main objective of the 
present work was to elucidate the function of BAdV-3 core protein pV in virus 
replication, including a) characterizing the protein and its distributions in transfected \ 
infected cell; b) analyzing the effect of pV deletion on viral replication; and c) 
determining the interaction of pV with other viral\cellular proteins. 
Like other BAdV-3 late proteins (Kulshreshtha et al., 2004; Makadiya et al., 2015; 
Wu and Tikoo, 2004; Zhou et al., 2001), anti-pV sera raised against peptides representing 
amino acids 1MASSRLIKEEMLDIVAPEIYKRKR24 and 180SRKRGVGKVEPTIQVLA 
SKKRRMA212 detected a protein of 55 kDa at late times post infection.  Analysis of the 
intracellular distribution of protein demonstrated that pV localized predominantly in the 
nucleolus of the transfected and BAdV-3 infected cells. Deletion analysis identified 
redundant nucleolar localization signals residing in amino acid 21-50 and 380-389 and 
redundant NLS residing in amino acids 80-120, 190-210 and 380-389. Although the 
presences of both separate and overlapping NLS and NoLs have been reported in other 
proteins, including viral proteins (Li et al., 2011a; Mori et al., 2005), their individual 
contribution has not been investigated. It will be interesting to determine the individual 
contribution of NoLS motifs by constructing and analyzing recombinant BAdV-3 
expressing pV containing mutations in identified NoLS.   
Unlike primary cell, pV is not essential for the replication of HAdV-5 in cancer 
cells, due to the introduction of compensatory mutations in another protein pX\Mu 
protein (Ugai et al., 2007).  In contrast, BAdV-3 pV appears essential for proper 
assembly of progeny virus in primary and continuous cell lines. This could be due to the 
difference in protein structure and possible function of pV or pX\Mu of HAdV-5 and 
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BAdV-3. The amino acid sequence of pV of BAdV-3 and HAdV-5 show low (41%) 
(Reddy et al., 1998). Moreover, amino acids involved in introducing compensatory 
mutations show only 50% homology between pX\Mu of BAdV-3 and HAdV-5 (Reddy et 
al., 1998). Alternatively, this could be due to difference in the cell lines use for the rescue 
and propagation of pV deleted BAdV-3 and HAdV-5. 
Earlier, proteins encoded by adenovirus late genes have been shown to be able to 
regulate expression of other late genes (Morris and Leppard, 2009; Wright et al., 2015; 
Wu et al., 2013) by acting on major late promoter (Wu et al., 2013) tripartite leader 
sequence or processing of viral mRNAs. Like HAdV-5 (Ugai et al., 2007), BAdV-3 pV 
appears to be involved in the regulation of selected late gene expression. Further studies 
should explore the mechanism involved in regulating the expression of selected late 
genes. 
Localization of pV predominantly in the nucleus \nucleolus suggests that pV uses 
active import pathways. Unlike BAdV-3 33K (Kulshreshtha et al., 2014) which uses both 
classical Imp \ and transportin dependent nuclear import pathway,  the nuclear 
transport of pV appears to be mediated only by classical Imp \ heterodimer dependent 
pathway by interacting with Imp 3. The active nuclear transport of pV mediated by Imp 
3 requires at least one of the three identified NLS motifs of pV. Interestingly, the 
nuclear import of BAdV-3 52K (Paterson et al., 2012) and pVIII (Ayalew et al., 2014) 
also appears to be mediated by interacting with Imp 3 of classical Imp \ dependent 
pathway.  
Earlier reports demonstrated the relationship between nucleolar localization of a 
viral protein and viral replication (Li et al., 2011a). Depending on the virus, nucleolar 
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localization of a viral protein may (Li et al., 2011a) or may not be (Boyne and 
Whitehouse, 2006; Lee et al., 2006b; Li et al., 2011a) essential for viral replication.  Our 
results demonstrate that nucleolar localization of pV appears essential for production of 
infectious BAdV-3.  Analysis of the mutant BAdV-3 viruses revealed alteration in the 
expression of some late viral proteins particularly 100K and hexon, and changes in virus 
thermostability.  It is possible that decrease in the expression of 100K may lead to less 
production of hexon (Hayes et al., 1990) or impaired transport of hexon trimerization and 
nuclear transport to the nucleus (Hong et al., 2005), thus leading to formation of reduced 
amount of capsids (Fig 3.9A). Secondly, decreased thermostability of mutant viruses, 
particularly BAVd1d3, appears to produce fragile capsids prone to disintegration and 
leading to the production of non-infectious progeny virions.  
Protein-protein interaction appears to play important functions in adenovirus 
replication (Arnberg, 2012; Gustin et al., 1996; Matthews and Russell, 1994; Ostapchuk 
et al., 2005) including BAdV-3 (Ayalew, 2014; Kulshreshtha and Tikoo, 2008). Previous 
report suggested that 100K and 33K interact with pV in BAdV-3 infected cells 
(Kulshreshtha and Tikoo, 2008). Mass spectrophotometry analysis of proteins purified 
from recombinant BAV.ST infected cells using Strep-actin sepharose beads detected a 
number of cellular and viral proteins that may have the potential of interacting with 
BAdV-3 pV. The validity of our approach was confirmed by demonstrating the 
interaction of one of the identified proteins named nucleolin with pV in BAdV-3 infected 
cells.   
Nucleolin is involved in different steps of virus replication (Calle et al., 2008; 
Cancio-Lonches et al., 2011; Oksayan et al., 2015; Shimakami et al., 2006) and cellular 
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processes including ribosomal RNA processing (Ginisty et al., 1998). Earlier, we have 
demonstrated that ribosomal RNA processing is altered at late times post infection of 
BAdV-3 infected cells (Paterson, 2010). We postulate that interaction of BAdV-3 pV 
with nucleolin may play a role. As such future work will elucidate the role of pV-
nucleolin interaction in ribosomal RNA processing in BAdV-3 infected cells.  
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APPENDIX A PLASMIDS USED IN SECTION 3.0 
Plasmid pDsRed.B23 (expression a fusion protein DsRed and nucleolar marker 
B23) was a gift from Dr Denis Archambault. 
Plasmid pCMVGbeta epresses a fusion protein of GFP/β-galactosidase 
a) Plasmid pcV  
A 1292-bp DNA fragment was amplified by PCR using primers pV-EcoRI-F and 
pV-XhoI-R (Table A1), and pUC304A+ as a DNA template. A 1272-bp EcoRI-XhoI 
fragment of the 1292-bp DNA fragment was ligated to a 5413-bp EcoRI-XhoI DNA 
fragment of plasmid pcDNA3 to create pcV.  
b) Plasmid pcV.d2 
A 599-bp DNA fragment was amplified by PCR using primers pV-EcoRI-F and 
d(190-210)-F1-R (Table A1), and plasmid pcV as a template. A 657-bp DNA fragment 
was amplified by PCR using primers d(190-210)-F2-F and pV-XhoI-R (Table A1), and 
plasmid pcV as a template. In the third PCR, two PCR fragments were annealed and used 
to amplify a 1299-bp DNA fragment by overlapping PCR using primers pV-EcoRI-F and 
pV-XhoI-R. A 1225-bp EcoRI-XhoI DNA fragment of the 1299-bp fragment was ligated 
to EcoRI-XhoI digested plasmid pcDNA3 to create plasmid pcV.d2. 
c) Plasmid pcV.d3 
A 1171-bp fragment was amplified by PCR using primers pV-EcoRI-F and d(380-
389) F1-R (Table A1), and plasmid pcV as a template. A 592-bp fragment was amplified 
by PCR using primers d(380-389) F2-F and d(380-389)-F2-R (Table A1), and plasmid 
pcV as a template. In the third PCR, two PCR fragments were annealed and used to 
amplify a 1713-bp DNA fragment by overlapping PCR using primers EcoRI-F and 
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d(380-389)-F2-R. A 1247-bp EcoRI-XhoI fragment of 1713 bp fragment was ligated to 
EcoRI-XhoI digested plasmid pcDNA3 to create plasmid pcV.d3. 
d) Plasmid pcV.d1d2 
A 761-bp SnaBI band of pcV.d1 was isolated and ligated to SnaBI digested pcVd2 
to create pcV.d1d2. 
e) Plasmid pcV.d1d3, pcV.d2d3 and pcV.d1d2d3 
A 552-bp AgeI-XhoI fragment of pcV.d3 was isolated and ligated to AgeI-XhoI 
digested pcV.d1, pcV.d2 and pcV.d1d2 to construct pcV.d1d3, pcV.d2d3 and 
pcV.d1d2d3, respectively. 
f) Plasmid pcV.m1d3 
A 984-bp DNA fragment was amplified by PCR using primers M-F and m1-F1-R 
(Table A1), and plasmid pcV.d3 as a template. An 1102-bp DNA fragment was amplified 
by PCR using primers m1-F2-F and pV-XhoI-R (Table A1), and plasmid pcV.d3 as a 
template. In the third PCR, two PCR fragments were annealed and used to amplify a 
2043-bp DNA fragment by overlapping PCR using primers M-F and pV-XhoI-R. An 
1144-bp EcoRI-XhoI DNA fragment of the 2043-bp fragment was ligated to EcoRI-XhoI 
digested plasmid pcDNA3 to create plasmid pcV.m1d3 
g) Plasmid pcV.m2d3 
A 996-bp DNA fragment was amplified by PCR using primers M-F and m2-F1-R 
(Table A1), and plasmid pcV.d3 as a template. A 1087-bp DNA fragment was amplified 
by PCR using primers m2-F2-F and pV-XhoI-R (Table A1), and plasmid pcV.d3 as a 
template. In the third PCR, two PCR fragments were annealed and used to amplify a 
2043-bp DNA fragment by overlapping PCR using primers pV-M-F and pV-XhoI-R. An 
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1144-bp EcoRI-XhoI DNA fragment of the 2043-bp fragment was ligated to EcoRI-XhoI 
digested plasmid pcDNA3 to create plasmid pcV.m2d3. 
h) Plasmid pcV.m12d3 
A 987-bp DNA fragment was amplified by PCR using primers M-F and m12-F1-R 
(Table A1), and plasmid pcV.d3 as a template. A 1088-bp DNA fragment was amplified 
by PCR using primers m12-F2-F and pV-XhoI-R (Table A1), and plasmid pcV.d3 as a 
template. In the third PCR, two PCR fragments were annealed and used to amplify a 
2043-bp DNA fragment by overlapping PCR using primers pV-M-F and pV-XhoI-R. An 
1144-bp EcoRI-XhoI DNA fragment of the 2043-bp fragment was ligated to EcoRI-XhoI 
digested plasmid pcDNA3 to create plasmid pcV.m12d3. 
i) Plasmid pcV.m3d3, pcV.m13d3, pcV.m23d3and pcV.m123d3 
Four 1060-bp DNA fragments were amplified by PCR using primers pV-M-F and 
m3-F1-R (Table A1), and plasmid pcVd380-380, pcVm1d380-380, pcVm2d380-380 or 
pcVm12d380-380 as templates. A 1024-bp DNA fragment was amplified by PCR using 
primers m3-F2-F and pV-XhoI-R (Table A1), and plasmid pcV.d3 as a template. In the 
third PCR, each fragment from the first PCR and the fragment from the second PCR were 
annealed and used to amplify four 2043-bp DNA fragments by overlapping PCR using 
primers pV-M-F and pV-XhoI-R. Each 1144-bp EcoRI-XhoI DNA fragments of these 
four 2043-bp fragments were ligated to EcoRI-XhoI digested plasmid pcDNA3 to create 
plasmid pcV.m3d3, pcV.m13d3, pcV.m23d3 and pcV.m123d3, respectively. 
j) Plasmid pcV.d4 
A 1157-bp DNA fragment was amplified by PCR using primers pV-EcoRI-F and 
d(380-423)XhoI-R (Table A1), and pcV as a template. A 1143-bp EcoRI-XhoI fragment 
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of the 1157-bp fragment was isolated and ligated to EcoRI-XhoI digested pcDNA3 to 
construct pcV.d4. 
k) Plasmid pcV.d5 and pcV.d6 
995-bp and 842-bp DNA fragments were amplified by PCR using primers pV-
EcoRI-F and d(323-423)XhoI-R (Table A1), and pcV and pcV.d1d2 as template, 
respectively. 883-bp and 828-bp EcoRI-XhoI DNA fragments of the 995-bp and 842-bp 
DNA fragment, respectively, were ligated to the EcoRI-XhoI digested pcDNA3 to create 
pcV.d5 and pcV.d6, respectively. 
l) Plasmid pcV.d21-50/380-423, pcV.d18 and pcV.d12  
A 445-bp AgeI-XhoI fragment of pcV.d4 was isolated and ligated to AgeI-XhoI 
digested pcV.d1, pcV.d2 and pcV.d1d2 to create pcV.d21-50/380-423, pcVd18 and 
pcV.d12, respectively.  
m) Plasmid pcVd10 
A 905-bp DNA fragment was amplified by PCR using primers d(1-100)EcoRI-F 
and pV-XhoI-R (Table A1), and pcV.d18as template. A 891-bp EcoRI-XhoI band of the 
905-bp fragment was ligated to EcoRI-XhoI digested pcDNA3-HA to construct pcV.d10. 
n) Plasmid pcV.d9 
A 1130-bp DNA fragment was amplified by PCR using primers pV-M-F and 
d(101-210)-F1-R (Table A1), and plasmid pcV.d21-50/380-423 as a template. A 648-bp 
DNA fragment was amplified by PCR using primers d(101-210)-F2-F and d(380-
423)XhoI-R (Table A1), and plasmid pcVd21-50/380-423 as template. In the third PCR, 
two PCR fragments were annealed and used to amplify a 1733-bp DNA fragment without 
by overlapping PCR using primers pV-M-F and d(380-423)XhoI-R. An 834-bp EcoRI-
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XhoI DNA fragment of the 1733-bp fragment was ligated to EcoRI-XhoI digested 
plasmid pcDNA3 to create plasmid pcV.d11. 
o) Plasmid pcV.d7 and pcV.d8 
590-bp and 500-bp fragments were amplified by PCR using primers pV-EcoRI-F 
and d(190-423)XhoI-R (Table A1), and pcV and pcV.d1, respectively,  as templates. 576-
bp and 486-bp EcoRI-XhoI bands of the 590-bp and 500-bp fragments, respectively, were 
ligated to EcoRI-XhoI digested pcDNA3 to construct pcV.d7 and pcV.d8, respectively. 
p) Plasmid pcV.d15 and pcV.d11 
1156-bp and 1066-bp DNA fragments were purified by PCR using primers M-F 
and d(81-120)-F1-R (Table A1), and pcV and pcV.d1, repectively, as templates. An 853-
bp DNA fragment was amplified by PCR using primers d(81-120)-F2-F and pV-d(380-
423)XhoI-R (Table A1), and plasmid pcV.d18 as a template. In the third PCR, each 
fragment from the first PCR and the fragment from the second PCR were annealed and 
used to amplify 1967-bp and 1877-bp fragments by overlapping PCR using primers pV-
M-F and pV-d(380-423)XhoI-R. 1099-bp and 1009-bp BamHI-XhoI DNA fragments of 
the 1967-bp and 1877-bp fragments, respectively, were ligated to BamHI-XhoI digested 
plasmid pcDNA3 to create plasmid pcV.d15and pcVd11, respectively. 
q) Plasmid pcV.d13 and pcV.d14 
A 641-bp SnaBI DNA fragment from plasmid pcV.d11 was isolated and ligated to 
SnaBI digested plasmid pcV.d4 and pcV.d2 to create pcV.d13 and pcVd14, respectively. 
r) Plasmid pcV.d19  
A 582-bp AgeI-XhoI DNA fragment from plasmid pcV.d15 was isolated and ligated 
to AgeI-XhoI digested pcV to create pcV.d15.  
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s) Plasmid pcV.d17 
A 731-bp SnaBI fragment of plasmid pcV.d15 was isolated and ligated to SnaBI 
digested pcV.d4 to construct pcV.d17. 
t) Plasmid pcV.d16 
A 1895-bp DNA fragment was amplified by PCR using primers M-F and d(390-
423)XhoI-R, and plasmid pcV.d19 as a template. A 1027-bp BamHI-XhoI band of the 
1895-bp fragment was ligated to BamHI-XhoI digested pcDNA3 to create pcV.d16. 
u) Plasmid pNoLS1.EY 
A 112-bp DNA fragment was purified by PCR using primers NoLS1-EY-F and   
NoLS1-EY-R (Table A1), and pcV as a template. A 98-bp BamHI-SalI band of the 112-
bp fragment was ligated to BamHI-SalI digested pEYFP-N1 to construct pNoLS1.EY. 
v) Plasmid pNoLS2.EY 
A 1237-bp DNA fragment was amplified by PCR using primers NoLS2-EY-F and 
NoLS2-EY-R (Table A1), and plasmid pEYFP-N1 as a template. A 772-bp BamHI-SalI 
band of the 1237-bp fragment was ligated to BamHI-SalI digested pEYFP-N1 to create 
pNoLS2.EY. 
w) Plasmid pNoLS1-GFPβGal 
A 116-bp DNA fragment was amplified by PCR using primers GB-NoLS1-BamHI-
F and GB-NoLS1-NheI-R (Table A1), and plasmid pcV as a template. A 102-bp BamHI-
NheI band of the 116-bp fragment was isolated and ligated to BamHI-NheI digested 
pCMVGbeta to create pNoLS1-GFPβGal. 
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Table A1 List of primers used for PCR 
Name Sequence 
pV-EcoRI-F 5’- GGAGCCGAATTCATGGCCTCCTCTCGGTTGATTAAAGAAG 
M-F                          5- TCTGCTCTGA TGCCGCATAGTTAAGCC 
d(21-50)-F1-R          5- CGCTTTCTAGAGCCGCGGTAAATCTCAGGCGCCACGA 
TGTC 
d(21-50)-F2-F          5-TCGTGGCGCCTGAGATTTACCGCGGCTCTAGAAAGCGGG  
CCTTG 
pV-XhoI-R               5-AATACTCGAGAGCGCTTAACGGCGGAGCCGGGTTAC 
d(190-210)-
F1-R 
5’-GGTCATCCTCATTCTCGGCCATGGAAAGAATAACTTTCTG 
CTCGG 
d(190-210)-
F2-F 
5’-CCGAGCAGAAAGTTATTCTTTCCATGGCCGAGAATGAGGA 
TGACCG 
d(380-389) 
F1-R 
5’-CAGCGCTGAGGCGGGGAGTCGCGACTGCAGGCAGGCG 
CACAC 
d(380-389) 
F2-F 
5’-GTGTGCGCCTGCCTGCAGTCGCGACTCCCCGCCTCAGC 
GCTG 
d(380-389)-
F2-R 
5’- GTGGCGAGAAAGGAAGGGAAGAAAG 
m1-F1-R 5’-CGCGTTCTCGCCTGGGTGCAGCTCCTGCGTAGATCTCAG 
GCGCCACGATGTC 
m1-F2-F 5’- TGCGCCGGGTTTTGCGTCCCAGATCTATGGCCGAGAATG 
AGGATGACC 
m2-F1-R 5’-CATATGGTGCTGCTGCTGCTGCTGCGGGCCGTTTGCGCTT 
GTAAATCTC 
m2-F2-F 5’- AAGCGCAAACGGCCCGCAGCAGCAGCAGCAGCACCAT 
ATGCTGTGAAGCAGGAG 
M12-F1-R               5-CTGCAGCAGCTGCTGCGGGTGCAGCTCCTGCGTAAATCTC  
AGGCGCCACGATG 
M12-F2-F 5-CGCAGGAGCTGCACCCGCAGCAGCTGCTGCAGCACCGTA  
TGCTGTGAAG 
M3-F1-R 5-TTTCTAGAGCCGCGAGCAGCTGCTGCCTCCGCCTTTACTA 
AAGGCTTCTC 
M3-F2-F 5-TTAGTAAAGGCGGAGGCAGCAGCTGCTCGCGGCTCTAG 
AAAGCG GGCCTTG 
d(380-
423)XhoI-R 
5’-TAATCTCGAGTTACCTGCGGGTACGGCGGCGACGG 
pV-d(323-
423)XhoI-R 
5’- GATCCTCGAGTCAGTCAGTTTGGGTGCTGAGTG 
d(1-
100)EcoRI-F 
5’-CGATGAATTCATGGGCGTGGCCGTTAGTTTCAC 
d(101-210)-
F1-R 
5’- CATCCTCATTCTCGGCCATAGATCTGGGACGCAAAACCC 
GGCGCACC 
d(101-210)-
F2-F 
5’- TGCGCCGGGTTTTGCGTCCCAGATCTATGGCCGAGAAT 
GAGGATGACC 
d(190- 5’- GATACTCGAGTTAGCGCCGCTTCTTGCTAGCTAAAACC 
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423)XhoI-R 
dV-F2-R 5-GTCC-ATGGCGTGTTAACAAGCTGTG 
d(81-120)-F1-
R 
5’- GTCTGCGTACACCTCGTCATACACGAATTCTATGTGGG 
GCTCGTCG 
d(81-120)-F2-
F 
5’- GAGCCCCACATAGAATTCGTGTATGACGAGGTGTAC 
GCAGAC 
d(390-
423)XhoI-R 
5’- TAATCTCGAGATGGCGACTCCCCGCCTCAGCGCTGC 
NoLS1-EY-F 5’-TTAGGTCGACATGAAGCGCAAACGGCCCAGGCGAGAAC 
NoLS1-EY-R 5’-GCACGGATCCTTAATTTTGCGCTCCGCCTTTAC 
NoLS2-EY-F 5’-TTAAGGATCCTATGCGGCGCCGCCGTCGCCGCCGTACCCG 
CAGGATGGTGAGCAAGGGCGAGGAGCTGTTC 
NoLS2-EY-R 5’-AGTGGGCCATCGCCCTGATAGAC 
GB-NoLS1-
BamHI-F 
5’-TAATGGATCCATGAAGCGCAAACGGCCCAGGCGAGAAC 
GB-NoLS1-
NheI-R 
5’-CTTTGCTAGCCATCTTAATTTTGCGCTCCGCCTTTAC 
 
 
 
